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Abstract
Endotoxin, a lipopolysaccharide component of the membrane of gram-negative
bacteria, is responsible for rapid triggering of innate defence mechanisms in the lung.
Such mechanisms, featuring local accumulation of neutrophil leucocytes, concomitant
modulation of local immunoregulatory cytokine expression and the development of
interstitial oedema are the hallmarks of an intense inflammatory response and
comprise the clinical definition of acute lung injury (ALI). Although a proportion of
individuals with ALI will progress towards a more severe form of lung injury referred
to as the acute respiratory distress syndrome (ARDS) the mechanisms underlying
such susceptibility are unknown. One potential avenue through which individuals may
exhibit variable susceptibility to progression is in the nature and extent of the whole
organ response to a local challenge. However, there is relatively little known in
relation to whether the lung will mount such a 'remote' response to local challenge.
The central hypothesis underlying this thesis is that the whole lung will respond to
local challenge with endotoxin in the absence of any overt phenotypic change
throughout the organ.
The work presented here is directed towards characterising the molecular aspects of
this response using an ovine model. Quantitative RT-PCR analysis of the cytokine
expression in directly challenged and contra lateral 'remote' lung segments showed
that the lung produced the anti-inflammatory cytokine IL-10 remotely whilst the pro¬
inflammatory cytokines IL-1 (3, IL-6 and TNFa, which are associated with acute
inflammation, were expressed in the directly challenged segment and correlated with
the observed neutrophil influx to the challenged lung segment.
To further this characterisation a novel microarray platform was designed to
specifically probe the genomic profile of the sheep lung. This process included the
construction of a subtracted lung library and the identification of ovine homologs
within a commercially available bovine genomic library. The selected elements were
combined to make a cDNA microarray which was used to probe the nature of the
remote response after LPS instillation. A remote response was observed.
The response was highly complex, involving mediators from diverse pathways and
functional groups including cytoskeletal genes, ribosomal genes, mitochondrial
products, prostaglandins and immune mediators. The characteristics of the
transcriptional response in the remote segment were considered broadly anti¬
inflammatory in nature.
This study has shown for the first time that the lung responds as a whole organ to
local inflammatory insult. Variation in the nature and extent of this remote response
amongst individuals is proposed as a factor underlying susceptibility to progressive
lung injury and ARDS. The study has also generated and utilised a novel ovine
microarray, and produced a subtracted library of ovine lung sequences. Both of these
represent considerable new resources for the study of pulmonary responses in both
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Chapter 1 General introduction
Rationale for thesis
Direct lung injury and the pathogenesis of the Acute Respiratory Distress
Syndrome
The lung functions as the interface between air and blood, enabling oxygen uptake
and carbon dioxide release for the process of respiration. As a consequence, the
mucosal interface of the respiratory tract is exposed continuously to noxious agents,
microbial organisms, particles, and allergens present in the environment and inhaled.
An important evolved function of this interface is to prevent inhaled bacteria from
causing infection. The first line of defence against such insult is provided by the
innate immune response and is followed by the development of acquired immune
responses associated with activation of T and B cells to specific antigens. In certain
circumstances, such defences may be compromised and pneumonia (inflammation of
the lung parenchyma) may develop. Such circumstances can include direct damage
through pulmonary infection or aspiration, or may relate to sepsis (especially gram-
negative), pancreatitis or multiple traumas.
The epithelium plays a central role in the immune and inflammatory response to lung
challenge (Crestani & Aubier 1998) acting as the primary barrier between inhaled
environmental factors, including pathogens and other inflammatory stimuli, and the
circulation. Further, in addition to the barrier function, the bronchial and alveolar
epithelia play a crucial role in mediating the acute inflammatory response to stimuli
(Cooper et al. 2001).
Most people with pneumonia recover. However, in a proportion of susceptible
individuals the condition progresses to diffuse pulmonary parenchymal injury
associated with non-cardiogenic pulmonary oedema and results in severe respiratory
distress and hypoxemic respiratory failure. This progression is referred to as the acute
respiratory distress syndrome (ARDS). Figures from a recent British Thoracic Society
survey show that a total of 65,929 people died as a result of pneumonia in Great
Britain in 1999 (British Thoracic Society 1999), making it the most common cause of
death due to respiratory disease in that period. As highlighted by Pelosi et al (2003)
the American-European Consensus Conference defined, in 1994, two pathogenetic
pathways leading to ARDS: a direct ("primary" or "pulmonary") insult, that directly
affects lung parenchyma, and an indirect ("secondary" or "extrapulmonary") insult,
that results from an acute systemic inflammatory response (Pelosi et al. 2003).
Distinct morphological aspects, respiratory mechanics and response to ventilatory
strategies in patients with ARDS appear to reflect the pathogenetic pathway involved.
Only a proportion of people with direct lung injury go on to develop ARDS and the
exact proportions and levels of severity associated with progression remain highly
variable and unpredictable. Understanding the mechanisms underlying this
progression is key to identifying markers of susceptibility and potential prophylactic
and/or therapeutic targets.
Large Animal Models of ARDS
Animal models have contributed significantly to our understanding of the
pathophysiology of ARDS over the past 50 years (Brigham & Staub 1998). Early
animal models of ARDS focussed on recreating the perceived clinical entity of 'non-
cardiac oedema'. These models used chemicals to directly injure the lungs and
increase vascular permeability leading to pulmonary oedema in the absence of raised
vascular pressures. However, with the emerging consensus that the pathogenesis
instead involved acute lung injury and inflammation, animal models began to focus
on inflammatory responses, particularly those following exposure to gram-negative
bacteria and endotoxin.
Challenging hypotheses relating to the pathogenesis of non-cardiac oedema demanded
the use of large animal models in which surgery and/or the placement of complex
physiological instrumentation could be employed. Sheep figured prominently in this
regard and the various modelling applications of this species have significantly
contributed to the evolution of understanding away from oedema formation per se to
inflammation as a consequence of exposure to gram negative bacteria and endotoxin.
Indeed the first reports of altered vascular permeability as a consequence of
Pseudomonas aeruginosa bacteraemia were reported some 30 years ago in this
species (Brigham et al. 1974) and since this point in time there have been over 140
citations involving systemic endotoxin-induced lung injury in sheep, a reflection of
the continued interest in this species as a relevant model for acute lung injury and
ARDS.
In these models, systemic infusion of a single low dose of endotoxin causes
pulmonary hypertension, hypoxemia, leucopoenia, reduced dynamic lung compliance
and increased airway resistance. These changes are consistent with those seen in
human sepsis and sepsis-induced extrapulmonary (or indirect) ARDS. The recent
literature suggests that these models, whilst excellent models for the extrapulmonary
ARDS phenotype, are of more limited value as models for the direct or pulmonary
ARDS syndrome. This is a significant limitation as understanding the nature of
progression from local direct lung injury to ARDS might offer therapeutic
opportunities.
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Direct lung injury, ARDS and the concept of whole organ susceptibility
Importantly, clues exist from other animal models that the consequence of direct lung
insult may extend to change the susceptibility of the whole organ to further challenge.
In particular Pseudomonas instillation in rats (Terashima et al. 1996) and acid
instillation in a rabbit model (Miyazaki et al. 1999) have been used to model
pulmonary ARDS and are reviewed below. Large animal models are of potential
value in modelling whole organ responses to local challenge in that lung size and
architecture favours discrimination of local and remote effects. Although the response
of the lung to direct instillation of endotoxin has been studied in a number of large
animal models, including sheep (Brogden, Ackermann, & Debey 1995), such models
have largely failed to explore the mechanism of progression from local injury to
ARDS.
With its placement at the air-blood interface it is accepted that the airway epithelium
is highly susceptible to damage and will figure prominently in initiating any
inflammatory response to local injury (Baeza-Squiban et al. 1999; Diamond, Legarda,
& Ryan 2000; Holgate et al. 1999). Whilst the specific nature of the local response
will vary according to the insult and the species involved, the principal characteristics
of the response generally involve the activation of resident alveolar macrophages and
neutrophils, local increases in inflammatory cytokines and chemokines in the
bronchoalveolar space, and further activation and trafficking of neutrophils from the
pulmonary circulation. However, the factors that both render an individual susceptible
to progression and contribute to the maintenance of established ARDS are ill defined.
It is perceived that with progressively more severe local inflammation the integrity of
the alveolar-capillary barrier will be lost and local events will contribute, in the form
of increased blood cytokine concentrations, to systemic inflammatory responses and
subsequent remote tissue damage. However, it is clear that there is a spectrum of
susceptibility in individuals at risk for the development of ARDS and factors other
than the severity of the local inflammatory event are likely to influence progression
In this regard, whilst the specific mechanisms remain undefined it is suggested that a
change in the physiological 'state' of the whole organ facilitates the rapid progression,
rather than a simple progressive spread from one or more initial foci of injury.
Further, it is tempting to speculate that the nature and extent of any 'remote' response
will vary amongst individuals and might indeed factor in the susceptibility of an
individual's progress towards ARDS. Such a mechanism would seem intuitively
reasonable in that, in addition to controlling the inflammatory process and
implementing repair in the area subject to insult, there would be value in reducing the
susceptibility to further insult in either adjacent or disparate parts of the system.
However the converse, that a localised insult brings about a generalised increase in
susceptibility is equally possible.
Indeed it is intriguing and significant that, in a rodent model of aspiration pneumonia,
local lung instillation of acid significantly enhanced the inflammatory response of the
contra lateral lung to LPS instillation at a later time point (24h). The implication is
that an organ-wide response, in the form of increased susceptibility to LPS, was
elicited by the initial local inflammatory event (Terashima et al. 1996).
Further, experimental gastric acid aspiration in rabbits rendered them more
susceptible to develop an ARDS phenotype in response to increased ambient oxygen
concentrations, suggesting an alteration of the "set point" for oxygen toxicity in the
lungs, possibly by "priming" cells through activation of inflammatory pathways
(Miyazaki et al. 1999).
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Identifying the nature of such 'whole organ' responses to local lung challenge or
indeed if they occur at all is the key objective of this thesis.
Lipopolysaccharide (LPS) and direct lung injury
Prior literature serves to indicate the validity of ovine models of ARDS based on
systemic administration of lipopolysaccharide (LPS). With the stated objective of
defining the whole organ response to local lung challenge and the lack of a validated
model system to explore the mechanism of ARDS pathogenesis following direct lung
insult it is appropriate to utilise this bacterial cell wall component as the basis of the
insult. To this end a brief review of LPS in relation to known and anticipated effects
in the lungs appears warranted.
Overview
Lipopolysaccharide (LPS) is a sugar-lipid component of the outer membrane of gram-
negative bacteria (Redl et al. 1993) which is ubiquitous in the environment and to
which the lung epithelium is continuously exposed (Vernooy et al. 2001). Gram-
negative sepsis has been shown to be a primary cause of pneumonia (Standiford et al.
1996) and is implicated in the morbidity associated with ARDS (Terashima et al.
1996) and COPD exacerbation (Rennard 1999). Gram-negative bacteria are also
involved in colonisation of the lungs of patients with cystic fibrosis and contribute
significantly to tissue damage in this setting (De, V 2002). Experimental lung
instillation of LPS has been used to model the above as well as effects analogous to
toxic shock and environmentally initiated inflammation (Becker et al. 1999). LPS is
recognised by receptors in the alveolar and bronchial epithelium (Levine 1995) as
well as resident alveolar macrophages (Mantovani et al. 2001). These cells activate
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the innate immune system in order to initiate and potentiate anti-bacterial responses as
part of the acute-phase inflammatory response (Murtaugh et al. 1996).
Acute bacterial sepsis modelled by LPS instillation in the lung induces marked
inflammatory effects at both gross and histopathological levels (Vernooy et al. 2001).
These effects include tissue destruction and lesion formation in the pulmonary spaces
caused by immuno-inflammatory mediator release and immune complex deposition in
the alveolar wall (Rennard 1999). The major cellular mediator in acute sepsis is the
neutrophil (PMN). Indeed a massive acute neutrophilia is a characteristic pathological
indicator of bacterially induced sepsis and inflammation (Takizawa 1998). Such local
effects of LPS instillation are paralleled by systemic changes in vivo (Traber et al.
1992), changes which are broadly dose-dependent, and of such significant import as
to precipitate pulmonary failure and death in subjects exposed to sufficient quantities
(Moore & Standiford 1998).
The molecular basis of the acute inflammatory response to LPS and bacterial invasion
is well established and extensively reviewed (Moore & Standiford 1998; Shanley,
Warner, & Ward 1995; Toews 2001; Xing et al. 1999; Levine 1995). The innate
immune effector arm responsible for the reaction to LPS is initiated via activation of
alveolar macrophages. Activated alveolar macrophages release cytokines, a number of
which induce division of myeloid precursors in bone marrow thus releasing PMNs
into the circulation and causing a characteristic neutrophil leukocytosis (Standiford et
al. 1990). The circulating PMN population is then localised via a number of
chemotactic factors released by the alveolar macrophages and epithelial cells that
draw the neutrophils into the alveolar spaces (Takizawa 1998). Activation of the
complement system is concurrent with this PMN induction and serves to increase the
phagocytosing properties of the PMNs through the opsinisation of pathogenic material
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within the alveolar space (Rabinovici et al. 1992; Worthen et al. 1987) though
complement is not a necessary part of this process (Brauer et al. 2000; Cardozo et al.
1991). The neutrophils are also potent producers of chemokine and cytokine
mediators and thus further potentiate the inflammatory response. The most important
cytokine mediators of acute inflammation in its initial phase are the interferons
(Heremans et al. 2000), tumour necrosis factor (TNF) a (Xing et al. 1993;
Rochemonteix-Galve et al. 1991; Remick et al. 1990) and interleukins (IL) lp
(Rochemonteix-Galve et al. 1991) and 6 (Benbernou et al. 1992; Gallery et al. 1991)
which are produced by epithelial cells and a number of immune cells as well as
neutrophils. The chemokine interleukin 8 is also an important factor in the neutrophil
infiltration during acute inflammation (Harada et al. 1994; Koyama et al. 2000; Lin et
al. 1994; Standiford et al. 1990). In limiting the inflammatory response the anti¬
inflammatory interleukin 10 plays a central role and is considered the major factor in
the negative feedback loop preventing self-harm by blocking the hyper-inflammatory
reaction (Inoue 2000; Kwong et al. 1998; Lo, Fu, & Cryer 1998; Raychaudhuri et al.
2000; Shanley, Vasi, & Denenberg 2000).
ILip activates lymphocytes and mediates tissue destruction (Dinarello 1994; Ulich et
al. 1991) whilst TNFa improves IgG infiltration to pulmonary spaces as well as
improving traffic of immune cells into tissue (Ulich et al. 1991; Zhao et al. 2003).
Systemic effects of IL 1 p include pyrexia and increased production of IL6 (Dinarello
1994). TNFa also induces pyrexia and the mobilisation of metabolites and can cause
shock at high levels (Xing et al. 1999). Following the production of IL 1 p and TNFa
by both airway and immune cells, and partly mediated by their presence, IL6 is
produced by epithelial cells and alveolar macrophages (Crestani et al. 1994). IL6 is a
potent activator and chemoattractant of lymphocytes and neutrophils (Dentener et al.
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2000), increases antibody production and stimulates 1L8 production from alveolar
macrophages as a co-factor with ILip and TNFa (Dinarello 1994; Koyama et al.
2000; Lin et al. 1994). Systemically IL6 induces pyrexia and up-regulates the
production of acute-phase protein production (Dentener et al. 2000). IL8 is the major
neutrophil chemoattractant and acts to improve access of effector cells to the affected
tissues as well as increasing binding of P2 integrins (Harada et al. 1994; Yamamoto et
al. 1998). Neutrophils are activated by the combined effects of TNFa and IL8 and
they in turn produce both factors as well as ILip forming a positive feedback loop
that persists and continues to be amplified as long as the tissue continues to be
stimulated by the LPS. Such progressive amplification and can result in systemic
organ failure and shock (Matthay, Uchida, & Fang 2002; Muller 1992).
As the inflammatory response progresses the combined effects of the above cytokines,
along with several other molecular mediators, including chemokines, complement and
other immune factors result in influx and activation of T helper cells and the switch
from an acute, innate response to a long-term adaptive response. This switch is
mediated by a number of factors with 1L10 predominant in down regulating the acute
phase response (Thomassen, Divis, & Fisher 1996). Type 2 T helper cells (TH2 cells),
essential for antibody-mediated immunity and which are attracted by IL6 production
are the major producers of 1L10, and thus act as key negative regulators of the acute
phase response (Inoue 2000; Mocellin et al. 2004; Raychaudhuri et al. 2000). IL10
inhibits the activation of alveolar macrophages and is a potent inhibitor of cytokine
release, in particular the macrophage associated cytokines such as IL6, IL8, ILip and
TNFa (Kwong et al. 1998; Lo, Fu, & Cryer 1998; Raychaudhuri et al. 2000; Shanley,
Vasi, & Denenberg 2000; Thomassen, Divis, & Fisher 1996).
The acute, non-adaptive immune response to endotoxin is mediated by a wide variety
of molecular factors. The underlying network of molecular immune effectors controls
and directs the cellular components of both the innate and the adaptive immune
systems.
The sheep as a model for LPS-mediated direct lung injury
In human subjects, local lung segmental instillation of LPS (1-4 ng/kg) induced a
focal inflammatory response characterised by an early phase (2h to 6h) influx of
neutrophils and elevated cytokine and chemokine levels in bronchoalveolar lavage
fluid (BALF) (O'Grady et al. 2001). The data demonstrated that endotoxin-induced
inflammation in the human lung has a unique qualitative and temporal pattern of
inflammatory mediator and cell marker expression compared with systemic endotoxin
responses.
Brogden et al (1984) evaluated the clinical and pathologic response to local
bronchoscopic instillation of E. coli and Pastenrella haemolytica LPS in sheep lungs
(Brogden, Cutlip, & Lehmkuhl 1984). The instillation caused an inflammatory
response characterised by both local and systemic neutrophilia and macroscopic
effects including fibrinopurulent inflammation, haemorrhage, oedema and
hyperaemia, with concomitant focal necrosis in the sheep instilled with P.
haemolytica LPS. The effects of the LPS deposition were comparable to those seen in
association with gram-negative pneumonia.
The results of local lung instillation of LPS in sheep bear favourable comparison with
those seen in human subjects and are consistent with the accepted picture of
inflammatory response to endotoxin.
As such an ovine model of direct lung injury based on local lung instillation of LPS
holds relevance as a primary insult with which to explore the concept of such local
insult inducing a shift in whole organ susceptibility, or a 'Remote response' to local
lung injury. The strategy of challenging one area of the lung and comparing the
response in that area with a further 'control' area mimics that commonly employed in
large animal models and is frequently referred to as a segmental approach.
Modelling responses at the lung segmental level
Experimental large animal models of lung inflammation frequently use segmental
challenges to model diseases such as COPD (Hiemstra, van Wetering, & Stolk 1998),
asthma (Bice, Seagrave, & Green 2000), ARDS (Pompe et al. 1996; Forsgren et al.
1990; Sielaff et al. 1987), emphysema (Susskind et al. 1985) and pneumonia (Monton
& Torres 1998). The lungs of large mammals are lobar and segmented, with each
segment being anatomically distinct from its neighbours and named to correspond to
the major airway entering it. Segmental challenge models in large animals assume
segmental independence in lung reactions such that each anatomically separate
segment reacts in an independent manner to challenge. This model allows for each
lung to act as its own control, thus reducing the need for control groups and hence
reducing the numbers of animals used in any given experiment. Segmental
independence also allows for investigations with three or more treatment groups and
controls within individual animals. This segmental independence in the lung has been
shown phenotypically (Collie et al. 2001) through gross histopathological study and
analysis of immune cell content of bronchoalveolar lavage fluid, but has not been
established at the molecular level. Thus, the study of remote responses has broader
implications in validating or disproving the assumption of segmental independence in
these models. Although lacking formal proof in the lungs, the precedent for local
events influencing whole organ physiology is well established in other organ systems.
Remote responses
A remote response is henceforth defined as evidence of change as a consequence of
direct perturbation of normal tissue processes in a spatially disparate location in the
same organ.
Lung
Prior data suggests that, at least at the phenotypic level, remote responses to direct
local lung insult are not commonly observed. The majority of data concerns larger
animal models where the benefits of a larger lung facilitate bronchoscopic
intervention and the design of protocols relying on the assumption of lung segmental
independence both with respect to delivery of substances and the respective segmental
responses.
Indeed in sheep Rawn et al (2000) in investigating the regional cellular and
histopathological effects of local lung antigen challenge concluded that the cellular
phenotypic response of the lung was compartmentalized to the area or segment
challenged (Rawn et al. 2000). These results are in agreement with several others in
this species where a lack of change manifest at the phenotypic level in control or
na'ive lung segments is taken as evidence that segmental responses in treated lung
segments remain focally localised and independent, and neither responsible for or
influenced by changes in other lung segments (Collie et al 2001, Emerson et al 2003,
Bischoff et al 2003).
Although lacking formal proof in the lungs, the precedent for local events influencing
whole organ physiology is well established in other organ systems.
Very few studies have deliberately investigated remote responses to inflammatory
stimulus as a primary investigative aim, however a number have elucidated organ-
wide changes by serendipitous happenstance as part of a local inflammatory or
traumatic challenge model (Hoang et al. 1997; Sun et al. 1998; Hanatani et al. 1998).
Almost all of the remote responses elucidated thus far are sub-phenotypic, and often
the effects are subtle and their impact poorly understood. Remote changes in gene
expression are not consistently quantitatively related to distance from the focus of
stimulus (Omura et al. 2000; Yoshiyama et al. 1997) and many appear to be regulated
in an entirely independent manner from the genes induced locally by a challenge. The
evolutionary impetus behind the remote response to a localised stimulus could be as a
priming mechanism to prepare organs for further systemic insult (Zhai, Futrell, &
Chen 1997) or as a protective downgrading response to avoid systemic organ-wide
inflammation with concomitant damage to host organs (Keyvani et al. 2000).
Brain
A major source of evidence for remote genotypic responses following local challenge
is the rat brain. A 1997 study by Zhai et al found significant increases in expression of
inflammatory cytokine genes (TNFa and ILip) in the contra-lateral brain and remote
ipsilateral tissue following middle cerebral artery occlusion (MCAO) in rats (Zhai,
Futrell, & Chen 1997). In a similar study using quantitative RT-PCR Jander et al
(2000) demonstrated up-regulation of IL1|3 and TNFa in the remote ipsilateral
sections of the brain following MCAO, though not in tissue from contra-lateral sites
(Jander, Schroeter, & Stoll 2000). A number of studies in the rat brain have shown
remote regulation of neurotrophic factors following traumatic brain injury (Truettner
et al. 1999; Oyesiku et al. 1999; Hicks et al. 1999). These studies used fluid
percussion (Hicks et al. 1999; Truettner et al. 1999) or impact trauma (Oyesiku et al.
1999) in order to injure the brain. Various molecular detection methods were
employed to detect changes in neurotrophic factor expression in the brain. All three
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studies showed remote contra lateral up-regulation of brain-derived neurotrophic
factor (BDNF). Oyesiku et al (1999) also found significant changes in expression of
neural growth factor (NGF), cerebral neurotrophic factor (CNTF) and its receptor as
well as tyrosine kinases A and B (trkA, trkB) (Oyesiku et al. 1999) in the absence of
any detectable phenotypic change. Truettner et al (1999), using non-quantitative
methodology, demonstrated similar changes in BDNF and NGF (Truettner et al.
1999). Flicks' study found no remote change in trkB expression (Hicks et al. 1999).
Kinouchi et al published two studies in 1994 investigating expression of immediate
early genes following MCAO in the rat. The first study found increased expression of
NGFI-A remote from the infarcted region (Kinouchi et al. 1994b) using in situ
hybridisation (ISH), whilst the second found induction of c-fos, c-jun, junB and hsp70
in various regions remote from the site of infarction (Kinouchi et al. 1994a). This
expression of immediate early genes appeared to be a 'spreading' response to the
infarction, with expression peaking first in the infarcted region, and then increasing at
later time points in the remote regions. These studies are supported by findings in the
mouse brain by Liu et al (2000) in which increased expression of c-jun was
demonstrated in the remote contra lateral regions of the brain (Liu et al. 2000).
Keyvani et al (2000) demonstrated significant two-fold reduction in expression of
proteosome C2 in contra lateral rat brain following focal brain ischemia (Keyvani et
al. 2000). Proteosome C2 is involved in protein turnover in the brain and the authors
postulated that the reduction in remote sections of the brain represents a protective
reaction following localised ischemia. Similarly, increased expression of COX-2
bilaterally from ischemic lesions was demonstrated in human cadaver brain specimens
using immunohistochemistry and northern blotting techniques (Sairanen et al. 1998).
Heart
A number of studies in the heart have found remote responses post-myocardial
infarction. Increased level of messenger RNA for P-MHC, a-skeletal actin and
sodium-potassium exchanger genes occur in remote, non-infarcted myocardium
(Yoshiyama et al. 1997). The pattern of gene expression differed to that occurring in
the infarcted tissue and adjacent non-infarcted tissue, suggesting discrete regulatory
patterns in spatially disparate areas of the organ. In 1998 the same group reported
altered expression of a-skeletal actin, atrial natriuretic peptide (ANP) and collagen I
and III in remote non-infarcted heart tissue, a pattern of gene expression that differed
from that seen in the infarcted areas (Hanatani et al. 1998). Long-term (4 months post
infarction) alterations in gene expression in non-infarcted myocardium of ATPase and
sodium-potassium exchanger genes were also highlighted by this group with the
authors suggesting that these genes are expressed remote from the site of infarction as
a compensatory reaction to tissue damage, or as a result of tissue remodelling
throughout the organ (Omura et al. 2000). These studies also demonstrated that a
remote response can occur at the molecular level with no concurrent phenotypic
change, and that the characteristics of the remote response can be separate and distinct
from that seen at the site of injury or stimulus. Further, remote expression of
endothelin-1, ANP and insulin-like growth factor-1 (IGF-1) was demonstrated in
post-infarction rat hearts by RT-PCR with the expression patterns linked to the size of
the infarcted area (Loennechen et al. 2001). A further experiment in rats by Sun et al
(1998) demonstrated remote expression of angiotensin II and its receptor (ACE) as
well as transforming growth factor Pi (TGFP) following myocardial infarction(Sun et
al. 1998). This remote expression was associated with low levels of fibrosis, and was
thus implicated in the repair process in the heart. These studies indicate that, in the
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heart, there is clear evidence for a molecular response to injury, which is independent
of the response in the directly challenged area of the organ.
Joints
Various studies in rats have demonstrated that an induced monoarthritis generates an
inflammatory response in the bilateral joint without involvement of the inducing
factor or concurrent inflammation in ipsilateral joints (Kidd et al. 1995; Decaris et al.
1999; Lombard et al. 1999). Various mechanisms have been suggested. The
predominant theory regarding induction of a bilateral inflammatory response to
unilateral stimulus is that the immune and inflammatory cascade is mediated via
neurogenic signalling in a symmetrical fashion (Tseng et al. 2001; Decaris et al. 1999;
Kidd et al. 1995; Tsuruoka et al. 2003; Lombard et al. 1999) with further evidence
suggesting that this is mediated by the NF-kB cascade (Miagkov et al. 1998). It is of
note that, in rabbits, adenovirus-mediated gene transfer of IL 1 and TNFa receptors to
knee joints with experimentally induced arthritis resulted in decreased inflammation
in both the directly treated joint and in the bilateral knee joint, with this effect
appearing to be independent of direct infiltration of the adenovirus vector (Ghivizzani
1998). These results were at the phenotypic level and did not include molecular
characterisation.
Kidneys
A further study involving gene delivery and expression was conducted by Kluth et al
(2001) in rats with experimentally induced glomerulonephritis (Kluth et al. 2001).
Following unilateral injection of macrophages transfected with adenovirus expressing
IL 4, inflammation was attenuated in both the treated kidney and the bilateral kidney.
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The mechanism by which organs respond in a bi-lateral or stimulus-remote manner is
unknown; however a number of reviews and research publications have hypothesised
possible mechanisms. Review articles by Downing (Downing & Miyan 2000), Barnes
(Barnes 1996) and Scott (Scott, Lam, & Ferrell 1994) have all postulated that the
immune system communicates with the neural network via a number of neuroeffector
mechanisms. In particular the neurogenic pathways have been implicated in the
regulation of inflammatory and immune responses via effector molecules such as
substance P. This network has been shown to be active in the lungs as well as a
number of other organs and systems (Barnes 1996) and direct disruption of the action
of substance P in the lung has been shown to attenuate immune complex deposition in
the mouse (Bozic et al. 1996). Reviews of lung innervation have also noted the links
between neuronal pathways in the lung and inflammatory responses (Belvisi 2003),
and have postulated that a bilateral response to stimuli would be consistent with the
known models of neurogenic injury (Perez Fontan 2002).
The Hypothesis
That the lung will mount a sub-phenotypic response remote to the site of local lung
injury and that this response will be amenable to characterisation at the molecular
level.
In order to challenge the hypothesis sensitive tools to characterise any induced
response are required. In the sheep such analysis currently founders on a relative
dearth of species-specific probes and reagents. The combined uses of microarray and
suppression subtraction hybridisation library techniques have already been shown to
be effective as tools for analysis of lung disease in rodent models (Dougherty &
Geschwind 2002) and human cell line models (Yang et al. 1999). Both of these




The robustness of the proposed ovine model of local lung segmental challenge with
LPS in eliciting a focally discrete inflammatory response, at least at the phenotypic
level, requires initial validation.
Addressing the hypothesis at the single gene level
A conventional 'single-gene' approach to characterising the inflammatory response in
directly challenged and remote lung segments will provide the means to address the
hypothesis using a limited number of currently available and well-characterised
species-specific molecular probes.
Gene discovery and microarray development
Conventional molecular analysis is necessarily limited to those genes that have
already been characterised in the ovine genome and as a consequence effectively
narrows the window on events. In the absence of tools to examine global responses in
ovine gene expression a process of gene discovery and array assembly is required to
fully characterise the nature and extent of a remote response in the lung.
Addressing the hypothesis using microarray gene profiling
The output from the array will furnish a snapshot of global transcriptional activity in
epithelial cells derived from the directly challenged and remote lung segments.
A central component to challenging the hypothesis in the above manner is the
development of a cDNA microarray platform that will combine currently available
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cDNA resources with respect to a closely homologous species (bovine) with an organ-
specific selection of clones from the species in question.
The combined uses of microarray and suppression subtraction hybridisation library
techniques have already been shown to be effective as tools for analysis of diverse
diseases and models including retinal disease in cattle (Schulz et al. 2004),
paramyxovirus infection in vitro (Munir et al. 2004), nasopharyngeal carcinoma in
humans (Zhang et al. 2003) and breast cancer in human cell line models (Yang et al.
1999). Both the SSH and microarray techniques are reviewed below.
Microarrays
Overview
Microarrays are a miniaturised format in which multiple array elements
(cDNA, oligonucleotides, proteins etc.) are bound as 'probes' to a solid substrate and
interrogated with a labelled target. Microarray technology has its basis in solution
hybridisation methods in which kinetic studies of the hybridisation of mRNA pools
with radioactively labelled cDNA were undertaken (Bishop & Smith 1974). These
solution hybridisation methods were superseded by hybridisations based on filter
blotting techniques, defined first as Southern blots (Southern 1975). The theory
underpinning these techniques is that a labelled probe will bind to a target (in nucleic
acid probes this target would be a homologous sequence to the probe), allowing the
target to be detected. DNA microarrays work by binding a nucleic acid probe to a
solid support, such as glass slides or nylon filters, and labelling the target DNA or
RNA. The labelled nucleic acid is then hybridised to the probe, stringency washes
used to remove excess and the label detected in order to determine which probes have
been bound and to what extent (Southern, Mir, & Shchepinov 1999).
DNA microarrays have become increasingly miniaturised due to the use of
robotic printing methods. Nucleic acid spots of 100 - 300 pm diameter are deposited
onto the solid array supports (Cheung et al. 1999). The support substrates themselves
have also aided greater miniaturisation with early nylon filters giving way to coated
glass slides (Lander 1999). The direct deposition method of printing microarrays
using high precision robots can be divided into two categories: the more widely used
cDNA microarrays in which fairly long (0.6 - 2.4 kilobases in length (Duggan et al.
1999)) PCR products are deposited onto slides (Schena et al. 1995); and
oligonucleotide microarrays in which much shorter (25-100 bases (Hacia et al. 1999))
single-stranded sequences are attached to a prepared glass surface. These direct
printing methods were pioneered by Patrick Brown at Stanford University (Schena et
al. 1995) and function by using robots to acquire the nucleic acids in nanolitre -
microlitre quantities, transferring the sample to pre-designated co-ordinates on the
slide and depositing them using miniaturised pins (Cheung et al. 1999).
Both of these techniques use labelled nucleic acids as a target, the label
usually being a nucleic acid-linked fluorochrome, though others, including radioactive
labels, are also used. The labelled target is hybridised to the microarray for between 8
and 24 hours (Cheung et al. 1999) after which the array is washed and then scanned to
detect the level of signal from each gene or control 'spot.' The scanned image is
processed electronically to determine the signal and background intensities for each
spot. Once the image data has been acquired the results are scaled and normalised
prior to analysis.
Microarray technology allows for the analysis of expression of many
thousands of genes simultaneously, providing a 'snapshot' of a cell's transcriptome at
any given point in time. This massively parallel investigation technique is potentially
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very powerful and is ideally suited to analysis of complex interlinked or cascade
effects within tissues. The technique is also highly applicable to situations in which
little is known concerning the effects of given treatments or procedures as these can
be screened and further investigated should they be found to be of significant import.
Microarrays therefore appear to be an ideal method for investigating remote response
genetic effects, as these are likely to be sub-phenotypic and complex in nature.
Gene Discovery
Overview
The total number of sequenced and characterised genes in sheep is under 4000,
representing approximately 1% of the total genome. There is only one large scale
genome mapping project currently identified for sheep in the Genomes Online
Database (GOLD) (Bernal, Ear, & Kyrpides 2001; Kyrpides 1999), and this project is
concerned with identification of quantitative trait loci in contrast to the full-length
sequencing and characterisation projects undertaken in bovine, human and rodent
species.. This lack of available genetic data hinders research into sheep genomics, and
particularly microarrays, as there are far fewer targets available for investigation. This
deficiency is exacerbated by the fact that a large proportion of the genes that are
available are commonly expressed maintenance (or housekeeping) genes that are
unlikely to be significant interest in a disease model. In order to successfully construct
an ovine microarray for use in the lung it is therefore necessary to generate a number
of 'new' ovine sequences that are known to be expressed in lung tissue. Various
methods of gene discovery are available ranging from genome sequencing to tissue-
specific library construction.
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It is preferable to utilise gene discovery techniques that both produce lung specific
results and encompass genes that are expressed at all levels. In order to find genes
expressed at low levels in the lung a suppressed subtracted library approach is
appropriate, whilst finding the more highly expressed genes in lungs requires a
broader screening process. Various screens are of potential use in discovering medium
to high expression genes, including genomic library screening and heterologous
screens against well characterised and closely related species to sheep - in particular
cattle. Heterologous screening carries the advantage that the selected heterologous
genes are more likely to be well annotated and characterised than the clones available
in a genomic library.
Review of SSH
Subtractive Suppressive Hybridisation (SSH) is a PCR-based technique that allows
RNA messages present in a tester population but absent in a driver population to be
isolated whilst at the same time normalising the quantities of the final sequences in
order to make less abundant species more accessible (Diatchenko et al. 1996). The
method works by taking two RNA populations termed 'tester' and 'driver' and
reverse transcribing these to cDNA. The cDNA populations are then restriction
digested and the tester population is adaptor ligated using two adaptors. A first
hybridisation is used with excess driver cDNA in order to equalise the populations
and enrich for differentially expressed genes, followed by a second hybridisation
which generates PCR templates from the differentially expressed sequences. Two
rounds of PCR are used to amplify the templates and reduce background, the first
with adaptor primers and the second with nested primers to further eliminate non-
differentially expressed sequences (Diatchenko et al. 1996). The procedure is outlined
diagrammatically in Figure 2.1.
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After the SSH, the resulting PCR products are cloned into E. coli and grown in 96-
well plates. This library can then be used to generate PCR products directly from the
clones, and these are then ready to be printed onto microarray slides. This method has
been used in order to generate subtracted libraries in humans for testis (Diatchenko et
al. 1996) colorectal cancer (Bustin et al. 2001), gastric cancer (Carvalho et al. 2002)
and cell lines including colon cancer (Bertram et al. 1998), haematopoietic (Beyer-
Sehlmeyer et al. 1999) and cervical and prostate lines (Endege et al. 1999). It has also
been used in strains of E. coli bacteria (Janke et al. 2001). The SSH technique has also
been used to generate a microarray for ER-negative breast cancer cell lines (Yang et
al. 1999) which clearly demonstrated that the sequences isolated by SSH were highly
differentially expressed in the tester population demonstrating the techniques
suitability for use in generating novel microarrays.
Clearly the idea of organ-wide genotypic change is one that requires further
investigation in order to fully characterise the responses to insult and their effects. A
quantitative, structured and parallel investigation of remote responses is desirable not
only in relation to inflammatory lung diseases such as ARDS but also to analyse the
possible effects that such responses may have on segmental studies that rely on the
assumption that there is little or no general effect resulting from local insult. In
systems used to model disease, particularly inflammatory disease, these regional
effects could potentially highlight novel avenues of intervention or prophylaxis.
Summary
It is clear from the published body of literature that a number of organs demonstrate a
remote response to localised inflammatory stimulus. It is also clear that the existence
of a remote response in lungs needs to be evaluated both in order to establish the
biological basis of pulmonary inflammation and to address a number of practical
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issues in pulmonary medicine such as the potential mechanism of ARDS pathology
and the validation of the segmental challenge model of lung inflammation. The ideal
platform for the investigation of subtle molecular regulation in the lung is the
microarray, and the lack of available ovine microarrays requires the generation of
novel array elements. The experimental plan is to produce a subtracted, suppressed
library representing gene sequences unique to or differentially expressed in lung
tissue. Additionally a homology search of publicly available cattle libraries for clones
with high levels of homology with known ovine sequences will be made and those
clones showing high levels of homology (>70%) selected and combined with the SSH
library clones. PCR products will be amplified from the combined clone set and
printed as a microarray. This array will be used to probe the expression of genes from
a remote segment of ovine lung compared with a segment directly subjected to a
significant inflammation with bacterial LPS, and the differences in expression
analysed between the segments in a group of out bred sheep (n=12). In addition to
answering the hypothesis this experiment will also characterise the inflammatory
response to bacterial LPS at the molecular level.
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Chapter 2 Materials and methods
Overview
One lung segment from both the right and left lung of each animal was selected on
bronchoscopic examination and its position carefully mapped. One segment,
designated 'direct', was selected for LPS instillation and the segment from the contra
lateral lung, designated 'remote', used to assess the whole organ response. 1 mg E.
coli OLB6 LPS (Sigma-Aldrich; Dorset, UK) in 5ml normal saline was used, selected
on the basis on phenotypic changes seen in previous ovine model investigations by
members of the laboratory team (personal communication, S.Tait). Bronchial
epithelial cells and BAL fluid were collected from each segment by bronchial
brushing and then bronchoalveolar lavage not less than two weeks prior to instillation
of LPS and at 6 hrs post instillation. Following this collection the sheep were killed
and necropsy samples taken for histopathological analysis.
The BAL fluid (BALF) samples were analysed for total and differential cellular
content in order to quantify the level of phenotypic change as a consequence of
instillation. Haematological profiles were assessed in blood samples collected prior to
and subsequent to instillation and, in conjunction with rectal temperature
measurements, as indices of systemic effect of the LPS instillation. Lung samples
taken at necropsy were assessed by veterinary pathologists in order to provide a
qualitative index of the gross and histopathological changes in lung segments
occurring as a consequence of instillation. The results from the phenotypic analysis of
the samples are presented in chapter 3.
The brushed epithelial cells were visualised by microscopy to analyse content, lysed,
total RNA extracted and the sample divided into two aliquots. The cellular content of
the brushing samples were uniformly over 90% epithelial cells, with the remainder
almost entirely consisting of monocytic cells, approximately 35% of samples
contained significant numbers of erythrocytes in addition. Half of each sample was
used for real-time quantitative RT-PCR analysis (chapter 4) and half used for
amplification and labelling prior to hybridisation to custom-made ovine lung
microarrays (chapter 6).
The requirement for a novel microarray to profile transcriptional activity in response
to LPS instillation necessitated a process of gene discovery and selection. The gene
discovery effort was focussed around the identification and selection of homologous
bovine genes in a commercially available cattle library and the creation of a novel
lung-specific library. The lung specific library was constructed using a commercial
technique called Suppressive Subtractive Hybridisation (SSH), and resulted in a
collection of clones representing a normalised and subtracted ovine lung population.
These two collections of clones were combined and their inserts used to produce
amplified PCR products that were, in turn, printed onto slides to make a new cDNA
microarray. The details of the homology searching, gene discovery and SSH library
construction are presented in chapter 5.
Gene discovery
BLAST
Homology searches were performed to find homologs between known ovine gene
sequences and the clones in the cattle libraries MARC 1, 2, 3 and 4 and BARC 5
(http://www.ark-genomics.org/resources/cattle.php). Searches were conducted using
the Basic Local Alignment Search Tool ( BLAST ), a public access program from the
National Centre for Biotechnology Information in Bethesda, MD, USA. (Altschul et
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al. 1990). This program uses a statistical algorithm to find homologies within genes
stored in the GenBank database. The searches were carried out using an expect value
of IxlO"7 and taking positive results as those with a bit score over 100 that showed




Tissue samples from heart, lung, liver, kidney, brain and skeletal muscle were taken at
necropsy from ex-sanguinated sheep, stored in 5 volumes of RNAlater at 4°C
overnight and then at -20°C long-term. Six crossbred sheep were used (2 male and 4
female; mean age 3.8 years [range 1-6]). Samples were taken from multiple sites
throughout the various tissues.
cDNA subtraction
The SSH was completed using the PCR-Select cDNA subtraction kit (Clontech, Palo
Alto, USA) according to the manufacturer's instructions. Each experimental
subtraction used 2 pg mRNA from lung as tester and 2 pg mRNA from the pooled
heart, muscle, liver, kidney and brain samples as driver. Positive controls comprised
the RNA provided in the kit and negative controls used water as tester and pooled
RNA as driver. The cDNA subtraction was divided into four main parts, double
stranded (ds) cDNA preparation, digestion and ligation, hybridisation and finally
amplification.
The production of ds cDNA began by incubating 2 pg mRNA with 1 pi cDNA
synthesis primer (10 pM) at 70°C for 2 minutes, and then on ice for two minutes - to
this were added 2 pi 5 X first-strand buffer, 1 pi dNTP mix (10 mM) and 20 units
AMV reverse transcriptase to a total volume of 10 pi. This was incubated at 42°C for
90 minutes in an air incubator and the reaction terminated by placing it on ice. Second
strand synthesis was achieved by adding 16 pi 5 X second strand buffer, 1.6 pi dNTP
mix (10 mM) and 4 pi 20 X second strand enzyme cocktail to the first strand mixture
in a total volume of 80 pi. The solution was incubated at 16°C for 2 hours after which
2 |ul (6 units) T4 DNA polymerase was added and the reaction incubated at 16°C for a
further 30 minutes. The reaction was terminated by adding 4 pi 20 X EDTA/glycogen
mix. The cDNA was isolated by adding 100 pi phenol:chloroform:isoamyl alcohol
(25:24:1) and then centrifuging. The aqueous layer was taken and 100 pi
chloroform:isoamyl alcohol (24:1) added. This was centrifuged and the aqueous layer
taken. DNA, precipitated by adding 40 pi NH4OAc (4 M) and 300 pi ethanol (95%),
was pelleted in a centrifuge and dissolved in 50 pi water. 6 pi of this was stored for
analysis at -20°C.
The remaining ds cDNA was Rsa 1 digested by adding 5 pi 10 X Rsa I restriction
buffer and 1.5 pi Rsa 1(10 U/pl) and incubating at 37°C for 90 minutes. 5 pi was
stored at -20°C for later analysis, the remaining reaction was terminated and DNA
purified as before, though at half the volumes previously stated. The final pellet was
dissolved in 5.5 pi water, stored at -20°C and used as the driver cDNA. 1 pi of the
driver cDNA was diluted with 5 pi water. Adaptor ligation proceeded as follows: 2 pi
of the diluted driver cDNA were put in 2 separate tubes (1-1 and 1-2) and 2 pi 5 X
ligation buffer and 400 units T4 ligase added to each sample. After adding 2 pi
adapter 1 (10 pM) to tube 1-1 and 2pl adapter 2R (10 pM) to tube 1-2, water was
added to a final volumes of 10 pi. 2 pi of each of 1-1 and 1-2 were mixed to make an
unsubtracted tester control tube labelled 1-c. All three solutions were incubated at
16°C overnight and ligation terminated by adding 1 pi EDTA/glycogen mix. Heating
at 72°C for 5 minutes inactivated the ligase. 1 pi of the unsubtracted tester control
was diluted into 1 ml water and stored at -20°C.
For the first hybridisation reaction 2 mixtures were made. Mix one contained 1.5 pi
Rsa I digested driver cDNA, 1.5 pi adapter 1 -ligated tester cDNA and 4 pi 4 X
hybridisation buffer. In mix two the adapter 1-ligated tester was replaced with adapter
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Fig. 1. Scheme of the SSII method. Solid lines represents the Rsal
digested tester or driver cDNA. Solid boxes represent the outer part
of the adaptor f longer strand and corresponding PC'R primer Pf
sequence. Shaded boxes represent the outer part of the adaptor 2
longer strand and corresponding PC'R primer P2 sequence. Clear
boxes represent the inner part of the adaptors and corresponding
nested PC'R primers PN1 and PN2. Note that after filling in the
recessed 3' ends with DNA polymerase, types a, b. and c molecules
having adapter 2 are also present but are not shown.
Figure 2.1: This diagram is taken directly from the original paper describing the
SSHprocedure by Diatchenko et al. It graphically illustrates the SSHprocedure,
and includes the summary accompanying the diagram from the original
publication {Diatchenko, 1996 DIATCHENKO1996/id}. The procedure described
is exactly as presented in the manufacturer's protocol and was followed in this
study.
2R-ligated tester. The reactions were incubated at 98°C for 90 seconds and then at
68°C for 8 hours. The second hybridisation step began by incubating 1 pi driver
cDNA with 1 pi 4 X hybridisation buffer in 4 pi at 98°C. This solution was then
mixed with hybridisation samples 1 and 2 from the first hybridisation step and the
mixed samples incubated at 68°C overnight. 200 pi dilution buffer was added and the
sample heated at 68°C for 7 minutes before storing at -20°C prior to the PCR step.
To 1 pi of each diluted cDNA (hybridised, control or unsubtracted control) the
following were added: 2.5 pi 10 X PCR reaction buffer, 0.5 pi dNTP mix (10 mM), 1
pi PCR primer 1 (10 pM) and 0.5 pi 50 X Advantage cDNA polymerase mix
(Clontech, Palo Alto, USA) to a total volume of 25 pi. The mixtures were incubated
at 75°C for 5 minutes and then subjected to 30 cycles of 94°C for 30 seconds, 66°C
for 30 seconds and 72°C for 90 seconds. 8 pi of each reaction was analysed on 2%
agarose gel run in TAE buffer for 1 hour at 60V with crystal violet. The part of each
lane of the gel corresponding to DNA over 200 base pairs in length was excised and
DNA purified from it using the S.N.A.P. UV-free gel purification kit (Invitrogen Ltd.;
Paisley, UK). 1 pi of the purified product was added to the following mixture: 2.5 pi
10 X PCR reaction buffer, 1 pi nested PCR primer 1(10 pM), 1 pi nested PCR primer
2R (10 pM), 0.5 pi dNTP mix (10 mM) and 0.5 pi 50 X Advantage cDNA
polymerase mix to a final volume of 25 pi. This mixture was subjected to 15 cycles of
94°C for 30 seconds, 66°C for 30 seconds and 72°C for 90 seconds. 8 pi of each
product was analysed on a 2% agarose gel in TAE buffer (1 hour at 60V with crystal
violet). The part of each lane of the gel corresponding to DNA over 200 base pairs in
length was excised and DNA purified from it using the S.N.A.P. UV-free gel
purification kit (Invitrogen Ltd.; Paisley, UK) and then stored at -20°C in preparation
for cloning. This process is illustrated graphically in Figure 2.1 (Diatchenko et al.
1996).
Cloning
PCR products were cloned into chemically competent TOPIOF' Escherichia coli
using the TOPO TA cloning kit (Invitrogen Ltd.; Paisley, UK) according to
manufacturer's instructions. Briefly the PCR products were incubated with the TOPO
TA vector and salt solution for 20 minutes at room temperature and then on ice. The
vector was then incubated with the E. co/i for 30 minutes on ice and heat shocked for
30 seconds at 42°C. 250 pi SOC medium was added to the cells, which were then
shaken at 37°C for 1 hour. The transformed cells were plated onto ImMedia
(Invitrogen Ltd.; Paisley, UK) agar plates (commercially prepared with kanamycin
and IPTG) and incubated overnight at 37°C. The remainder was grown overnight in 5
ml sterilised and fdtered LB broth (Invitrogen Ltd.; Paisley, UK) in 50 ml falcon
tubes until cultures were confluent. Blue vs. white colony counts were made to
analyse cloning efficiency. This screen sensitively and specifically analyses both
insertion of a DNA fragment into the plasmid, and transformation of the plasmid into
the E. Coli bacterial cell. Each plasmid contains a polylinker site located at the
beginning of the coding sequence of the gene coding for (3-galactosidase. The
polylinker site contains a variety of restriction sites, and is 54 bases in length (and
thus in-frame), and code for 18 amino acids that do not affect the enzyme's activity.
Insertion of a DNA fragment into this polylinker site disrupts the expression of the P-
galactosidase thus preventing its expression when a DNA fragment is successfully
inserted into the plasmid loop. B-galactosidase hydrolyzes IPTG (present in the
growth medium) and releases an insoluble blue dye, thus disruption of this gene
causes the colonies to be white, whilst those with plasmids containing no insert
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present as blue, allowing selection of bacterial colonies containing inserts. The
presence of a kanamycin resistance gene in the plasmid used allows selection of
bacteria which have been successfully transformed due to the presence of kanamycin
in the growth medium. Thus any bacteria growing on this medium have a plasmid
transformed into them, and those that are white have a DNA fragment inserted into
that plasmid.
Cultures were stabilised by addition of 15% sterile glycerol and stored at -80°C.
Cultured libraries were titrated by serially diluting aliquots of stored library and
growing on ImMedia (Invitrogen Ltd.; Paisley, UK) agar plates containing kanamycin
and IPTG overnight at 37°C and then counting the numbers of colonies present at
each dilution to determine the titre.
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Clone Screening
PCR reactions from the colonies were prepared by picking colonies directly from the
agar plate into PCR solution. PCR was performed using 0.5 pi Taq polymerase, 2 pi
10X PCR buffer, 0.5 pi 10mM dNTP mix (all Sigma-Aldrich; Dorset, UK) and 0.5 pi
of each forward and reverse Ml3 primers (MWG-Biotech, Ebersberg, Germany) in
total volumes of 20 pi. The solutions were incubated at 94°C for 2 minutes, subjected
to 30 cycles of 1 minute at each of 94°C, 55°C and 72°C, and finally incubated for 7
minutes at 72°C. All PCR products were visualised on 2% agarose gels mil in TAE
buffer for 1 hour at 60V. Products were stored at -20°C.
Sequencing
Plasmid inserts were sequenced using an ABI 3700 sequencer. Plasmids were purified
using the Qiagen MagAttract kit (Qiagen; Sussex, UK) according to the
manufacturer's protocol. Plasmid inserts were PCR amplified using primers
corresponding to the pCRII plasmid from the Invitrogen TOPO TA cloning kit
(Invitrogen Ltd.; Paisley, UK) and reagents supplied in the sequencing master mix
from the Packard MultiProbe II robotic dispenser. PCR was carried out using the
following temperature cycles:
96°C - three minutes} One cycle
96°C - 30s, 50°C - 30s } 35 cycles
60°C - four minutes } One cycle
Following amplification, the PCR product was cleaned using an ethanol precipitation
method. The PCR products were incubated with 10 pi water (Millipore; Livingstone,
UK), 5 pi 125 mM EDTA and 60 pi 100% ethanol for 30 minutes at room
temperature and then the precipitate collected by centrifugation at 2500 g for thirty
4-1
minutes. The pellets were rinsed by adding 150 pi 70% ethanol, mixing and then
centrifuging at 2500 g for ten minutes and removing the ethanol. Dried pellets were
resuspended in 20 pi water (Millipore; Livingstone, UK) and the DNA sequenced by
the Big Dye method on an ABI 3700 sequencer. Sequence trace files were analysed to
remove contaminant vector sequences using the VecScreen database and the BLAST
program (Altschul et al. 1990), and then further trimmed to account for low quality
sequencing. Sequences were assembled into contiguous alignment groups (contigs)
using the LaserGene SeqMan program (DNAStar; Madison, USA). Consensus
sequences from each contig alignment were analysed to determine nearest homology
with known characterised sequences from the NCBI nr and est databases, TIGR
sequence database and EMBL nucleotide and protein databases using various BLAST
sub-programs (Altschul et al. 1990). Tentative functional activity was attributed to
sequences where possible through literature revision or theoretical protein sequence
translation and analysis.
Microarray production
Microarray printing, clone preparation, insert sequencing, RNA amplification,
microarray hybridisation and microarray scanning were performed by ARK Genomic,
Roslin, UK according to the following methods.
Amplified PCR product derived from the clones selected from the SSH library and
MARC/BARC bovine libraries were robotically re-arrayed into 384 well microplates.
The PCR products were purified and normalised to a standard concentration. Each
product was deposited by a BioRobotics MicroGrid II robot (5/oRobotics;
Cambridge, UK) onto amino silane coated glass CMT-GAPS slides (Corning
International; London, UK) where they were bound by natural cross-linkage
(hydrogen bonding occurred between amine groups coated on the slide and phosphate
5V
groups in the DNA backbone.) After printing, the slides were baked to allow covalent
bonds to form, fixing the cDNA to the slide. All products were spotted in duplicate in
a grid pattern. The layout of the arrays and the sequences and clones that they
represent are detailed in Appendix III.
Animals
Twelve commercially sourced crossbred adult sheep were used. The sheep were
clinically examined by a veterinary surgeon prior to entering the protocol and
declared to be free from significant disease. Anthelminthic treatment was undertaken
as part of the pre-screening process to ensure the absence of patent lungworm
infection {D. fillaria and M. capillaris). These sheep comprised a representative cross-
section of animals, unselected in terms of their biology or underlying pathology. The
detailed characteristics of each sheep within the sample are given in table 2.1.
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Table 2.1: Characteristics of each sheep used in the study. All male sheep were
castrated. All sheep were out-bred, commercially sourced and housed indoors in
standard pens in groups. Prior to experimental use the animals were assessed for
clinical disease by a veterinarian. Overall sex ratio: 5 female: 7 male, mean age: 3.8
years [range 1-7], mean weight: 52.6 kg [range: 36 - 78]
Table 2.1
Animal Sex Age Weight (kg) Breed
S41 Female 7 70 Greyface
S46 Female 7 69 Greyface
451 Male 1 41 Texel cross
X26 Female 7 70 Greyface
S9 Female 7 78 Greyface
S12 Female 5 64 Greyface
0631 Male 2 42 Blackface
0681 Male 2 36 Blackface
0687 Male 2 44 Blackface
0693 Male 2 39 Blackface
0757 Male 2 38 Blackface
0861 Male 2 38 Blackface
Anaesthesia
Food was withheld for 12 hours prior to anaesthesia, which was achieved by
intravenous administration of a single bolus of thiopentone sodium (Thiovet;
Novartis) at a dose rate of 20 mg / kg bodyweight. Thereafter sheep were intubated
and anaesthesia maintained using gaseous halothane (2-3 per cent) in oxygen and
nitrous oxide (50:50). The sheep were placed in sternal recumbency in a large
Plexiglas whole body respirator (internal volume: 388 litres). The proximal end of the
endotracheal tube was connected to the anaesthetic circuit through a connector in the
wall of the box. Pressure in the box was varied by appropriate connection to a large
bellows pump (Cuirass; Cape Warwick, Warwick, U.K.) which induced a sinusoidal
tidal respiratory pattern, the rate and magnitude of which could be controlled by
adjustment of the pump itself. The magnitudes of pressure fluctuations were adjusted
to maintain a tidal volume of 10 ml / kg bodyweight. Respiratory rate was adjusted to
maintain end-tidal CO2 measurements in the range 4.5-5.5% (Oxicap Monitor Model
4700; Ohmeda, Louisville, CO, USA). 1 mg E. coli 026:B6 LPS (Sigma-Aldritch;




A flexible fibre optic bronchoscope (5.3mm OD) (Model FG-16X; Pentax U.K. Ltd.)
was advanced and wedged in selected segmental bronchi. The subtended segments
were lavaged by installation and withdrawal of two, 20 ml aliquots of normal saline
(0.9% NaCl solution). BALF was immediately placed on ice until subsequent
analysis. Lavage fluid from each lung lobe was separated into supernatant and cells by
si
centrifugation at 400 g for 7 min and the resultant cell pellets were washed twice in
phosphate buffered saline (PBS).
Brushing
After the bronchoalveolar lavage (BAL) a sheathed biopsy brush (Olympus BC-
202D-2010; Keymed, Livingstone, UK) was introduced through the bronchoscope,
and the surface of the bronchus entering the segment of interest was brushed
vigorously. A movie clip of the brushing procedure is included in appendix II. The
brush was re-sheathed and withdrawn. After removal from the bronchoscope, the
brush was unsheathed and passed repeatedly through the end of a modified disposable
pipette tip into a sterile 1.5-ml centrifuge tube containing 1 ml of RNAlater (Ambion;
Huntingdon, UK). The solution was agitated, the brush removed and the cells stored
at -80°C in RNAlater (Ambion; Huntingdon, UK) until the RNA purification step.
Systemic monitoring
Prior to each anaesthetic induction rectal temperatures were recorded and venous
blood samples (2x7 ml) collected into heparinised vacutainer (Fisher Scientific;
Loughborough, UK) tubes. One blood sample was submitted to the Veterinary
Pathology Unit Clinical Laboratories, Easter Bush Veterinary Centre (EBVC) for
routine haematological analysis and the second sample was centrifuged at 2000 g for
20 minutes to separate the blood fractions (red blood cells, white blood cells and
plasma). The Buffy coat layer was removed and stored in RNAlater (Ambion;
Huntingdon, UK) at 4°C overnight and thereafter at -20°C as archival material for
future study.
Histopathology
Lungs were instilled via the airway with 50% neutral buffered formalin (pH 7.0) at an
inflation pressure of 2.5 to 3.0 kPa until fixed. 3 tissue blocks were sampled from
each lung segment and routinely processed and embedded in paraffin. 4-5 pm sections
were cut from the tissue blocks, and mounted and stained with haematoxylin and
eosin for histopathological assessment by a veterinary pathologist.
Cell counts
Total cell counts
Cells were counted using a Neubauer haemocytometer and values expressed per
millilitre BALF. lxlO5 cells were used in the preparation of cytospin slides. The
remaining cells were stored in RNAlater (Ambion; Huntingdon, UK) at 4°C
overnight, and thereafter at -20°C. Aliquots of supernatant were stored at -80°C.
Differential cell counts
The BAL cell pellet was re-suspended in PBS to a cellular concentration of 105 cells /
ml. 100 pi of the suspension (104 cells) was placed in a cytospin (Thermo Shandon;
Runcorn, UK) collection funnel and centrifuged at 300 rpm for 3 minutes. Two slides
were prepared for each sample of BALF. Cytospin slides were air-dried and stained in
100% Leishmann's stain for 3 minutes. Slides were then stained in 50% Leishmann's
stain for 6 minutes prior to washing and air-drying. The dried and stained slides were
cover-slipped using DPX mounting agent. The mean of two differential cell counts
was established on the basis of counting 500 cells from each slide. Cells were
classified as neutrophils, macrophages, eosinophils, lymphocytes or mast cells
according to standard morphological criteria. Cells not classified in the
aforementioned groups were recorded as 'other' cells.
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RNA purification
Epithelial cells from bronchial brushings were stored in RNAlater (Ambion;
Huntingdon, UK) at -20°C. Prior to processing the samples were diluted 1:1 with
sterile PBS and centrifuged for 15 minutes at maximum speed (13,000 g) in a
microcentrifuge to pellet the cells. The GenElute Mammalian total RNA kit (Sigma-
Aldrich; Dorset, UK) was used to extract total RNA from the cell pellet according to
the manufacturer's protocol provided. Briefly, supernatant was removed and the cells
re-suspended in lysis buffer. The cells were lysed and solubulised by mechanical
shearing and vortexing. The lysate was filtered and mixed with 70% ethanol in a 1:1
ratio. This solution was passed through a binding column, which was then washed
twice with each of two wash solutions before being eluted from the column using the
elution buffer provided. The RNA was then treated with DNAfree DNAse in buffer
(Ambion; Huntingdon, UK) for 15 minutes at 37°C to remove remaining DNA
contamination; the reaction was stopped by addition of buffer and heating at 70°C for
5 minutes. RNA was precipitated using 0.1 volumes 8M LiCl and 2 volumes 100%
ethanol and snap-frozen. The RNA precipitate was stored at -80°C.
RNA quality analysis
RNA quality analyses (both pre- and post-amplification) were performed using the
Agilent 2100 bioanalyzer (Agilent Technologies; South Queensferry, UK) (Mueller et
al. 2000). The bioanalyzer performs gel electrophoresis in the confines of a micro
fabricated chip. Electrical voltages are applied to fluid reservoirs by means of
individual electrodes, each of which is connected to a separate high voltage power
supply. Samples are separated electrophoretically in an entangled polymer solution,
similar to capillary electrophoresis. The instrument allows for highly sensitive laser
induced fluorescence detection using an intercalating dye, which is added to the
polymer. The bioanalyzer software automatically calculates size and concentration of
each separated band and displays the results in real-time.
All chips were prepared according to the manufacturer's instructions. In brief: gel
matrix was prepared by adding 25 pi of dye to a gel vial. The gel/dye mixture was
filtered through a spin filter. The chip was filled with the gel/dye mixture and 9 pi of
gel/dye mixture were filled into the buffer wells. Sample and ladder wells were filled
with 5 pi of RNA marker solution before adding 1 pi of ladder and sample in the
respective wells. The chip was vortexed and placed in the bioanalyzer for analysis.
Fluorescent trace images were translated by the software to provide a numerical RNA
integrity score, and a 'gel-like' image indicating RNA integrity in an extrapolated
standard RNA denaturing gel format. RNA exclusion was based on visual analysis of
the peaks present on the fluorescence electropherogram. Samples which lacked peaks
corresponding to the ribosomal RNA content of the sample were considered of
insufficient quality for amplification.
RT-PCR
Reverse transcription
The RNA was pelleted from the ethanol solution by centrifugation at maximum speed
for 20 minutes and re-suspended in PCR grade water (Sigma-Aldrich; Dorset, UK).
The RNA was reverse transcribed using the Superscript II kit (Invitrogen Ltd.;
Paisley, UK) according to the protocol provided. Briefly, 10 pi RNA was incubated at
65°C with 1 pi oligo-dT primers and lpl 10 mM dNTP mix for 5 minutes, and then at
42°C for 2 minutes with 4 pi 5X RT buffer, 1 pi RNAseout RNase inhibitor (Sigma-
Aldrich; Dorset, UK) and 2 pi dithiothreotol (DTT). 1 pi Superscript II reverse
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transcriptase was added and the reaction incubated at 42°C for 50 minutes. The
reaction was stopped by heating to 70°C for 15 minutes and the cDNA stored at -
20°C.
Quantitative real-time PCR
Each real-time PCR reaction was performed in triplicate in white, hard-shell, skirted
96-well miniplates with optically clear strip-caps (Genetic Research Instrumentation
Ltd.; Braintree, UK). Each reaction consisted of 1 pi template cDNA, 0.5 pi forward
primer (5 pmol), 0.5 pi reverse primer (5 pmol), 8 pi PCR water (Qiagen; Sussex,
UK) and 10 pi 2X SYBR green master mix (Qiagen; Sussex, UK). Primer sequences
for each cytokine and the housekeeping gene are shown in Table 2.2. These were
selected from published literature based on the similarity of their annealing
temperatures. Primers were HPLC purified and produced by MWG Biotech (MWG
Biotech; Ebersberg, Germany). Each reaction was performed in a total volume of 20
pi in an Opticon Lightcycler (MJ Research; Reno, USA) using the following cycling
parameters: 95°C - 15min, 50 x (94°C - 15s, 52°C - 30s, read, 72°C - 30s, read, 80°C
- 5s, read), melting curve (40°C-95°C, read every 0.1 °C, 0.2s hold), 72°C - 10 min.
These parameters were selected following optimisation reactions in which serial
dilutions of primer and template were compared, along with temperatures and
durations of the cycling parameters. These optimisation reactions were guided by both
published literature in which the primers used were successfully employed, and
standard practice. Analysis of the results from these reactions indicated that the
parameters used were those that uniformly demonstrated high levels of product
formation with minimal contaminant or background interference.
Table 2.2: Details of the primer sequences used in the real-time quantitative RT-PCR





ILip (-) CTAGGGAGAGAGGGTTTCCA (Gohin et al. 1997)
IL6 (+) GCTTCCAATCTGGGTTCA
IL6 (-) CCACAATCATGCGAGCCG (Egan et al. 1996)
IL8 (+) GAGTTATTGAGAGTGGGCC
IL8 (-) AGCAGTCTAGGGTTGGAAG (Legastelois et al. 1994)
IL10 (+) TGTTGCCTGGTCTTCCTG
ILIO(-) TCTCTTCACCTGCTCCAC (Gohin et al. 1997)
TNFa (+) GAGCACAGAAAGCATGATCC
TNFa (-) AAAGTAGACCTGCCCAGACT (Gohin et al. 1997)
ATPase (+) GCTGACTTGGTCATCTGC
ATPase (-) CAGGTAGGTTTGAGGGGATAC (Woodall, Maclaren, & Watt
1997)
Data analysis
Fluorescence intensity at each cycle was recorded by the proprietary Opticon Monitor
(MJ Research; Reno, USA) software as a graph of intensity vs. cycle number, a
representative example is shown in figure 2.2. The method used to extrapolate
quantitative information from this data was as described by Higuchi et al (Higuchi et
al. 1992;Higuchi et al. 1993). Briefly, PGR product from samples with more abundant
template will start to exponentially accumulate following fewer reaction cycles, and
the fluorescence intensity of the intercalated SYBR green dye rises proportionally
with it (Lekanne Deprez et al. 2002). In order to analyse the quantity of starting
template of each target gene, the earliest point at which it detectably enters the
exponential amplification phase is determined. Subsequently this point is related to
the equivalent point for the reaction product from one or more housekeeping gene (s)
from the same experimental sample.
The suitability of ATPase as a housekeeping gene was assessed in short optimisation
test prior to analysis of the experimental samples. Briefly, primers corresponding to
three potential housekeeping genes - ATPase, GAPDH and P-actin were used for
PCR fragment amplification. These were inserted into TOPO plasmids which were
transformed into E. coli, which was grown to confluent culture. Colonies with verified
plasmid inserts were selected and the plasmids purified, quantified and serially
diluted. The serial dilutions of plasmids were used as the templates in real-time PCR
reactions as previously described, and a standard curve derived for each gene.
Bronchial epithelial brushing samples were then taken from experimental animals
before and after LPS treatment, the RNA was purified and reverse transcribed to
cDNA. These samples were then used as templates for each housekeeping gene and
the results compared to the standard curves acquired previously. The results were
analysed by comparing the expression of each gene before and after LPS
administration. The post-LPS sample results were divided by the baseline sample
results to find a fold-change for each primer and the results compared using a student
t-test to assess the significance of the results.
Both GAPDH and P-actin showed significant up-regulation (GAPDH 1.9 fold up
regulated, p=0.001; P-actin 2.6 fold upregulated, p=0.003) following LPS exposure in
the lung, and were therefore considered unsuitable for use as consistent housekeeping
genes in this experiment. ATPase showed no significant change between samples (0.9
fold change, p=0.897), and was therefore considered to be suitable for use as an
internal reference control for relative real-time PCR analysis. These results are
concurrent with published data showing alterations in expression of both P-actin and
GAPDH in lung disease (Glare et al. 2002).
In order to determine the point at which fluorescence rose above baseline and entered
the exponential (quantitative) phase, the intensity background was subtracted from the
overall totals at each point. Baseline threshold was set as two standard deviations
above the minimum fluorescence over the total cycle range. The point at which
fluorescence intensity crossed the threshold (C (t) value) was calculated, and this value
was exported to a Microsoft Excel (Microsoft Corporation; Seattle, USA) worksheet
for further analysis. The melting curve for each cytokine was analysed in order to
ensure that fluorescence readings were due to genuine products of the appropriate size
as opposed to non-specific amplification or primer-dimer formation. Any samples that
did not conform to the standard shape of the melting curve were excluded from
further analysis. An example of the melting curve graph obtained is given in figure
2.3.
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areal-timePCRmelting curvegraphas producedbytheOpticor Monitorsoftware.Each colouredlinerepresents aPCRsample.The integraloffluor scence intensity(yaxis)s measureda temperatureincreases(x axis).Atthemelting temperatureofany stableDNAproduct, sharppeakidetected. Eachpeakrepresents DNAfragment.Asharp, narrowpeakrepresents amorestablnd uniformDNAfragment. Higherpeak temperaturesrepresent longerDNAstretches. Thistechniqueisusedo evaluatethequalityof thePCRproductwithin eachsamplereplacing thegelinstandardPCR.
The triplicate C (t) values for each sample were averaged to give an individual C (t)
value for each sample. Each cytokine value was normalised to the corresponding
ATPase value in order to give a relative expression value (R) using the formula:
R = 2 A ^Pase C(t) value) / 2 A (cytokine C (t) value) (pfaffl? Rorga^ & Dempfle 2002)
Outliers were identified using the Grubb outlier identification rule, and the remaining
relative expression values were compared using a Wilcoxon signed rank test to
identify significant changes in expression between samples at 0 hours and at 6 hours
after LPS challenge. Significance was taken as p < 0.05. Fold changes in the
expression level of each cytokine were calculated by dividing the 6 hour post-LPS
value by the 0 hour baseline value.
Microarray processing
RNA amplification
The MessageAmp aRNA Kit (Ambion; Huntingdon, UK) is based on the RNA
amplification protocol developed in the laboratory of Dr James Eberwine (Eberwine
1996). The procedure consists of reverse transcription with an oligo-dT primer
bearing a T7 promoter and in vitro transcription of the resulting DNA with T7
polymerase to generate hundreds to thousands of antisense RNA copies of each
mRNA in a sample. The antisense RNA is referred to as aRNA and the amplification
method is referred to as the aRNA amplification procedure.
Prior to amplification 11.2 ml of ACS grade 100% ethanol was added to the cDNA
wash and mixed well and 20 ml of ACS grade 100% ethanol was added to the bottle
of aRNA wash and mixed well. Between 100 - 1000 ng of total RNA was placed into
a sterile, RNase free 0.2ml PCR tube. The volume of this sample was 11 pi or below.
To each PCR tube containing total RNA 1 pi Oligo-dT Primer was added along with
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nuclease free water to give a final volume of 12ul. The mixture was incubated at 70°C
for 10 minutes. The following were then added to each reaction: lOx First Strand
Buffer (2 jul), Ribonuclease Inhibitor (1 pi), dNTP mix (4 pi). The samples were
mixed by pipetting, centrifuged to collect the sample and placed on ice prior to
incubation at 42°C with 1 pi of Reverse Transcriptase for 2 hours. Samples were
centrifuged at <5000 rpm for 5 seconds to collect the reaction in the bottom of the
tube and placed on ice. Second strand cDNA synthesis reagents were then added in
the following order: nuclease free water (63 pi), lOx second strand buffer (10 pi),
dNTP mix (4 pi), DNA Polymerase (2 pi), RNase H (1 pi). The reaction was pipetted
to mix and incubated at 16°C for 2 hours.
cDNA was transferred to a clean, sterile, RNase free tube and 250 pi of cDNA.
Binding Buffer added to each cDNA sample the sample was mixed thoroughly by
repeated pipetting. The reaction was fdtered through an equilibrated filter cartridge in
a centrifuge at 10,000 g for 1 minute. 650 pi of cDNA Wash Buffer was added to
each filter cartridge and the cartridge centrifuged for 1 minute at 10000 g. The filter
cartridge was then centrifuged for a further minute at 10000 g to remove trace
amounts of ethanol. cDNA was eluted by applying 10 pi nuclease-free water at 50°C,
incubated at room temperature for 2 minutes, and then the cartridge was centrifuged at
10000 g for 90 seconds, this step was performed twice, and the purified cDNA stored
at -20°C.
16 pi cDNA solution was transferred to a 0.2 ml sterile, RNase free PGR tube. To the
16 pi of double stranded cDNA, 4 pi of each of the following components were added
in order, at room temperature (final volume = 40 pi). T7 ATP Solution (75 mM), T7
CTP Solution (75 mM), T7 GTP Solution (75 mM), T7 UTP Solution (75 mM), T7
lOx Reaction Buffer and T7 Enzyme Mix. The reaction was incubated for 24 hours at
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37°C. After the incubation 2 pi DNasel was added to the reaction and the reaction
incubated for 30 minutes at 37°C. 60 jul of elution solution was added to each sample
and mixed thoroughly by repeated pipetting. Each sample was transferred to a fresh
nuclease free 1.5 ml microfuge tube. 350 pi of aRNA Binding Buffer was added to
each aRNA sample and mixed. 250 pi of ACS grade 100% ethanol was then added to
each aRNA sample and mixed. Each aRNA/Binding Buffer/ethanol mix was then
placed onto the center of an equilibrated filter cartridge and centrifuged for 1 minute
at 10000 g. 650 pi of aRNA Wash Buffer was then applied to each filter cartridge and
the cartridge centrifuged for 1 minute at 10000 g. The filter Cartridge was transferred
to a fresh aRNA collection tube and 50 pi of Nuclease-free water at 50°C added. The
solution was incubated at room temperature for 2 minutes and then centrifuged for 1.5
minutes at 10000 g. Elution was repeated with a second 50 pi of preheated Nuclease-
free water. aRNA was stored at -80°C.
cDNA labelling
1.2 pg aRNA was diluted in 20 pi MilliQ water (Millipore; Livingstone, UK) in an
RNase free microfuge tube. This was dried down in a SpeedVac centrifuge until the
liquid had been removed from the tube. RNA was resuspended in 5 pi coupling buffer
from the Stratagene Fairplay kit (Stratagene; Amsterdam, The Netherlands). The
reaction was vortexed and spun briefly to collect the contents. Following incubation at
37°C for 15 minutes the tubes were vortexed and centrifuged briefly to return the
contents. RNA was reverse transcribed as described above, with the inclusion of
amino-allyl linked dCTP in the dNTP mix. 5 pi of Cy dye coupled to amino-allyl
groups (Amersham pic.; Buckinghamshire, UK) was added to the cDNA and
incubated for one hour at room temperature in the dark. This process linked the allyl
groups and resulted in labelled cDNA. Labelled cDNA was purified using the DyeEx
2.0 spin kit (Qiagen; Sussex, UK) according to manufacturer's instructions. Briefly,
the tubes were prepared by adding 300 pi MilliQ water (Millipore; Livingstone, UK)
to the resin bed to resuspend the resin. The tubes were centrifuged at 3000 rpm for
one minute in an Eppendorf microcentrifuge 5415D (Eppendorf UK Ltd; Cambridge,
UK) before adding a further 300 pi MilliQ water and centrifuging the tubes at 3000
rpm for 3 minutes. Sample was added to the top of the suspended resin bed of the spin
column, and the tubes centrifuged at 3000 rpm as before for 3 minutes. The eluate
was then stored and used in the microarray hybridisation reactions.
Hybridisation
Cy labelled cDNA target was hybridized to DNA probes immobilized on a glass slide,
using the Genomic Solutions GeneTAC automated hybridisation station (Genomic
Solutions; Huntingdon, UK) according to manufacturer's instructions. This procedure
was carried out in a clean room. Briefly, each array slide was placed within a
GeneTAC cassette and heated to 75°C. The appropriate labeled cDNA solutions were
then added to the cassette along with ULTRAHyb hybridization buffer (Ambion;
Huntingdon, UK). The solutions were then agitated, hybridized and washed in a
strictly controlled manner as part of the operation of the hybridization station,
utilising proprietary hybridization solutions (Genomic Solutions; Huntingdon, UK).
Once this process was complete the slides were immersed in low stringency buffer
(Genomic Solutions; Huntingdon, UK) for approximately 1 minute followed by
isopropanol for 1 minute. The slides were then dried by centrifuging (Beckman GS-3)
at 1200 rpm for six minutes in preparation for scanning.
Scanning
Hybridised arrays were scanned using a ScanArray 5000XL (Perkin Elmer;
Weybridge, UK) confocal laser microarray scanner according to the manufacturer's
protocol. Arrays were scanned at 10 pm resolution for analysis. The laser intensity
varied from 73-78% for the Cy3 and 75 and 78% for the Cy5 dye as appropriate for
the intensity of fluorescence on each slide. Array scans for each dye were saved as
.TIFF extension image fdes and stored for data acquisition.
Data acquisition
Data was acquired from the fluorescence intensity scan images using the BlueFuse
data capture software package (BlueGnome; Cambridge, UK). BlueFuse measures
signal intensity from each array spot present in the scanned image and corresponds
each spot to its relevant data (name, position etc) using a pre-prepared procedure file
designed around the .GAL file structure. The procedure file informs the program as to
the layout of the printed slide and the relevant processing instructions. The acquired
data is exported to an Excel spreadsheet'(Microsoft Corporation; Seattle, USA) for
analysis.
Data analysis
Data were analysed using the GeneSpring analysis software package (Silicon
Genetics; Redwood, USA). Data were imported from excel files containing raw
fluorescence intensity, background readings and array composition data. The software
package transformed these raw intensities into relative values, and adjusted values
according to background signal fluorescence, spot conformation and dye type. The
transformed data were then analysed for dye-swap variance and normalized to the
global mean of data as standard. Normalized data were plotted as scatter plots, and
analysed for significant changes using the segmental locations as replicates in a
standard student t-test. The Benjamini and Hochberg False Discovery Rate method
(Benjamini 1995) was used as a multiple testing correction where appropriate.
Chapter 3 Direct, remote and systemic effects associated
with local lung instillation of LPS in sheep
Aims and objectives
• To define the nature of cellular events in the bronchoalveolar space following
local lung instillation of lipopolysaccharide in sheep.
• To determine whether such local events are associated with concomitant
systemic or 'lung-wide' changes.
Introduction
Acute local gram-negative sepsis is recognised as a predisposing factor in the
development of acute lung injury (ALI) and the acute respiratory distress syndrome
(ARDS) (Pelosi et al. 2003). Direct airway instillation of bacterial lipopolysaccharide
(LPS) is a well-recognised rodent model of acute lung inflammation and ARDS
(Holub & Lawrence 2003). LPS-induced airway inflammation is associated with a
pronounced neutrophil (PMN) infiltrate (Wesselius et al. 1997), with attendant release
of pro-inflammatory cytokines, proteases and free radicals leading to acute lung
injury. This local inflammatory response is preceded by a systemic circulating
neutrophilia (O'Grady et al. 2001), and the release of chemotactic factors at the site of
stimulus resulting in the localisation of the circulating PMNs (Toews 2001). As only a
proportion of individuals go on to develop ALI and ARDS it is conceivable that this
variable susceptibility reflects a difference in the manner in which the lung responds
as a whole organ to local insult. Indeed, whether such local insult acts to increase or
decrease the sensitivity of the lung to further challenge is unclear, with conflicting
reports in the literature (Miyazaki et al. 1999; Yamada et al. 2000).
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Previous rodent model studies examining local and remote lung responses to acute
bacterial sepsis reveal important limitations in study design. In a study by Terashima
et al direct instillation of bacteria to one lung in order to study the contra-lateral
response resulted in almost 20% of the instilled bacteria spilling over into the 'nai've'
lung (Terashima et al. 1996). Further limitations relate to the close spatial relationship
of individual lung lobes in rodent models with greater potential for crossover of
inflammatory cells and mediators into contra lateral lungs and lung segments as a
consequence of breakdown of compartmental barriers. This clearly confounds
attempts to differentiate local and remote lung responses (Terashima et al. 1996).
Large animals are less limiting in this respect and as such are a preferable model for
segmental lung studies (Ferrari et al. 2003).
The sheep offers particular advantage as a model to study such responses. Sheep are
tolerant of routine procedures such as blood sampling and do not constitute a
particular anaesthetic risk (Borrie & Mitchell 1960). With specific respect to the
respiratory system, sheep lungs are anatomically closer to those ofman than are dog,
cat or monkey lungs (McLaughlin et al. 1994) and when compared to dogs, sheep
appear to be better suited as models for human gas exchange (Werlen, Py, & Haab
1984).
Previous studies have also demonstrate that the airway epithelium in sheep is highly
analogous to human airway epithelium (Mariassy et al. 1988a; Mariassy et al. 1988b).
Previous lung function analyses in the sheep include analysis of airway responses
(Wagner & Mitzner 1990), lung inflammatory responses (Wheeler, Hardie, & Bernard
1992; Wheeler, Hardie, & Bernard 1990), lung function during anaesthesia , gas
exchange of the lung (McNeil et al. 1991; McNeil et al. 1989) and physiological
responses to exercise (Mundie et al. 1991). Sheep also benefit from ease of handling
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and availability. Ovine immune and inflammatory responses appear analogous to
those seen in human subjects responding to acute bacterial infection in the lung (Redl
et al. 1993). The work detailed in this chapter characterises at a cellular level the




The total number of cells present in BALF (cells x 106/ml) was significantly
(p=0.001, n=12) up-regulated six hours post-LPS challenge in the direct segment (Oh
median count: 2.04 xlO6 cells/ml [range: 0.69-6.94] vs. 6h median count: 9.28 xlO6
cells/ml [range: 2.37-23.86]). In BALF taken from the remote segment there was no
significant change (p=0.078, n=12) in the total number of cells. Figure 3.1 shows, for
each animal, the change in total cell numbers in BALF (cells x 106/ml) in the directly
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intotalcelnumbers(x 106cells)inBALFthe directlychallengedand remotes gmentspri r totreatment,andt6 hoursafterLPS challenge.Totall countwassignificantly (p=0.001)increasedsix hourspost-LPS challengeintdirect segment.Cellstake fromthere otes gment werenotsignificantly changed(p=0.078) followingcontralateral challenge.
Differential cell counts
Absolute differential cell counts in BALF (cells x 106/ml) derived from challenged
(Direct) and contra-lateral (Remote) lung segments prior to treatment (Oh) and 6 hours
after LPS challenge (6h) are shown in table 3.1.
The total number of neutrophils present in BALF was significantly (p=0.001, n=12)
increased six hours post-LPS challenge in BALF taken from the direct segment (Oh
median count: 0.03 xlO6 cells/ml [range: 0.002-0.76] vs. 6h median count: 5.89 xlO6
cells/ml [range: 0.23-18.08]). This represented the major part of the increase in the
total cell numbers. Figure 3.2 shows, for each animal, the change in PMN numbers in
BALF in the directly challenged and remote segments prior to treatment (Oh), and at 6
hours after LPS challenge (6h). In BALF taken from the remote segment there was no
significant change (p=0.784, n=12) in the number of neutrophils. No significant




The total number of neutrophils present in blood was significantly (p=0.002, n=12)
increased six hours post-LPS challenge (Oh median count: 0.88x106 cells/ml [range:
0-3.44] vs. 6h median count: 3.75 xlO6 cells/ml [range: 0.6-8.05]). The total number
of lymphocytes present in blood was significantly (p=0.008, n=12) decreased six
hours post-LPS challenge (Oh median count: 4.8 xlO6 cells/ml [range: 1.59-11.13] vs.
6h median count: 2.44 xlO6 cells/ml [range: 1.15-5.48]). There were no significant
changes in either total cell counts in blood or in any other specific cell types in blood
Table 3.1: Median total cell counts (x 10 cells) in bronchoalveolar lavage samples
taken at baseline (Oh) and 6 hours post-LPS challenge (6h). Segments used were
labelled 'direct ' for the segment into which LPS was instilled, and 'remote 'for the
contra-lateral segment sampled. Macrophage, lymphocyte and eosinophil numbers
were not significantly altered in any segments following local LPS challenge.
Neutrophil numbers were significantly higher in the directly challenged segment 6
hours post-LPS challenge than at baseline (* p = 0.001).
Oh Direct 6h Direct Oh Remote 6h Remote
Macrophage 1.50 1.81 1.38 1.17
Neutrophil 0.03 7.68* 0.04 0.03
Lymphocyte 0.05 0.16 0.04 0.03
Eosinophil 0 0 0 0
Figure3.2:PMNcellounts
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Figure3.2:shows,fo eachanimal,thechange
inPMNnumbers(x106 cells)inBALFthe directlychallengedand remotes gmentspri r totreatment,andt6 hoursafterLPS challenge.Total neutrophilumbers weresignificantly increased(p-0.001)six hourspost-LPS challengeinBALFtak n fromthedirects g ent. Thisrepresentedt majorp rtofthe increasetot lel numbers.IBALFtaken fromthere otes g ent therewasnosignificant change(p=0.784)inthe numberofeutrophils.
6 hours following LPS challenge. The systemic haematological effects of local lung
administration of lipopolysaccharide are depicted in table 1 (Appendix I).
Rectal Temperature
A slight (+0.8 °C) but significant (p<0.005) pyrexia developed as a consequence of
the procedure (Table 2; Appendix I). This mild pyrexia was not associated with any
clinical signs of systemic disease.
Histopathology
Figure 3.3 shows a section of lung from a healthy, untreated animal at x 40 (i) and x
400 (ii) magnification and represents the normal histology of the ovine lung. In
sections from the directly challenged segments there was clearly defined pathological
change. The predominant pathological change observed were a moderate to severe
infiltration of neutrophils into the lumena of small (terminal) bronchioles and
particularly the alveolar air spaces. In the most severely affected areas there were also
varying degrees of intra-alveolar oedema and occasionally mild haemorrhage. These
acute inflammatory changes are within discrete, although poorly defined foci,
adjacent to unaffected areas; this may be due to uneven distribution of LPS within the
lung segment.
Figure 3.4 is a digital image of a section taken from a directly challenged segment at x
40 (i) and x 400 (ii) magnification and is representative of these changes. These
changes are consistent with acute, neutrophil mediated inflammation seen in clinically
and experimentally inflamed sheep lungs (R. Blundell; personal communication,
2004). The histopathological features of sections derived from adjacent and remote
segments were consistent with those seen in untreated control animals managed under
identical conditions. These data, particularly the example from the adjacent section,
n
illustrate the highly localised and site-specific effects of local LPS deposition by
bronchoscopy.
Figure 3.5 shows a representative section from a segment adjacent to the challenged
segment at x 40 (i) and x 400 (ii) magnification and figure 3.6 shows a representative
section from a segment contra lateral to the challenged segment at x 40 (i) and x 400
(ii) magnification. Neither section shows any detectable histological abnormalities.
Figure3.3.i:D italimagofformalin-fixed,p raffin embeddedtissusectionak nfronaivgme t(x40 magnification).Thetissueectiohowsorph logya d histologyconsistentwithealthy,un-infamedlu g.Thelveolar spacesarclearofinfilt atingimmunell ,thi wayw l intactandtheepith liallayersundamaged.Re i encellsr atnormallevelsndth reisoevidencefhaemorrhag oedema.Ths ctionwasassessedbyv t ri aiypathologistt confirmtheseobservations.
Figure3.3.H:Di italimagofformalin-fix d,p ra fin embeddedtissuectionak nfronaivs gme t(x400 magnification).Thetissueectiohowsmorph logya d histologyconsistentwithealthy,un-inflamedlu g.The epitheliumcontainsn rmalquantit efr sid timmuncel s, theairwaywallisntactndepith lialayerundamaged, withcleari ia edepithelialellsv sib .Th rinovidenceof haemorrhagerdeformationfai waycells.Thesectionw assessedbyveterinaiypatholog sttconfirmh se observations.
Figure3.4.i:Di italimagofformalin-f xed,p raffin embeddedtissuectionak nfromlungg e tdir ctly challengedwithLPS(x40magnification).Ttissuectio demonstratessignificantpathologicalchan .Amoder tet severeinfiltrationofn utrophilstthluminamall (terminal)bronchiolesandparticularlythelveolarrspaci apparent.Theislsontra-alveolaro d mandmil haemorrhageapparent.Thsectionw sassessedby veterinarypathologisttconfi mh seobservatio s.
Figure3.4.ii:Di italmagofformalin-fixed,p ra fin embeddedtissuectionak nfrolungsegme tdir ctly challengedwithLPS(x400magnification).Ttissueectio demonstratessignificantpathologicalchan .T eti u containsincreasednumb rfimmuneellsalthoughthe airwaywallndepitheliallayerintact,thciliat dit lial cellsshowalteredmorphology.Th rrneutr phil aggregationsvisibleinthirwayndalveolarspaces.T sectionwasassessedbyv teri arypathologisttconfirmh observations.
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Figure3.5.i:D italimagoffor alin-fixed,p raffin embeddedtissuectionak nfrolunggme tdjac theLPS-c allengedsegment(x40magnificatio ).Tti su sectionhowsmorphologyandhist l gyconsiste twi healthy,un-inflamedlu gdsimilartohatfenaiv segment.Thislidehighli htstlocalnaturoft inflammatoryresponsetos gmentalLPSinstillatio .Th sectionwasassessedbyv teri arypathologisttconf m theseobservations.






Figure3.6.i:D italimagoffor alin-fixed,p raffin embeddedtissuectionak nfrolungs gmentcontra lateralotheLPS-c allengeds gment(x40magnificatio ).T tissuesectionhowshistol gyconsiste twi healthy,u - inflamedlungdsi ilartohatfnaivedj c nt segments.Thislideindicattlo lnatureoft inflammatoryresponsetos gmentalLPSi stillationnd confirmsthetackfgrosshangeiremotlu gfoll wing localLPShallenge.Tsectionw sassessedbyv t ri ary pathologisttoc nfirmheseobservation .
Figure3.6.H:Di italimagoffor alin-fix d,para fin embeddedtissuectionak nfrolungs gme tcon ra lateralotheLPS-c allengeds gment(x400magnificatio ). Thesectionhowshistol gyconsistentwi heal ylung . Residentcellsaretnormallev sndthesobservatio s consistentwiththfromena va ddjacentsegments. Thereisnochanget eneutrophilcont ntfts gment, confirmingthetackfgrossimpactlo lLPSc allengeo thecontra-laterallung.Tsectionw sassessedbyv t rin ry pathologisttconfirmheseobservat ons.
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Discussion
Segmental approaches have been extensively utilised in the characterisation of the
functional, cellular, and immune nature of the local lung response to antigen challenge
in both experimental animals and humans. Published studies have included allergen
challenge in dogs (Out et al. 2002; Bice & Muggenburg 1996; Bice, Jones, &
Muggenburg 1993; Jones et al. 1993; Weissman et al. 1992), horses (Yoshikawa et al.
2003; Hoffman et al. 1993), pigs (Goodman et al. 1991) and human subjects (Sur et
al. 1996; Shaver et al. 1995; Hunt et al. 2002). Sheep have been used in a similar
manner to model a number of human lung diseases including emphysema (Susskind et
al. 1985; Peterson et al. 1992; Janoff et al. 1983) and allergic lung disease (Collie et
al. 2001).
This study indicates that local lung instillation of LPS in sheep elicits an
inflammatory response at 6h after instillation. The inflammation remains confined to
the challenged segment and there is no evidence of cellular change in contra lateral
segments. The discrete and focal nature of the inflammatory response is supported by
histopathological analysis of the tissues where contra lateral and indeed adjacent
segments show no evidence of an inflammatory response. However, instillation was
associated with systemic changes in the form of a pyrexia and blood neutrophilia.
Overall the model appears to offer the facility to determine whether apparently
discrete events at a local lung level can modify gene expression throughout the lung
as a whole.
Bacterial sepsis involving the lung is associated with increased numbers of PMN in
the circulation with a concomitant local increase in PMN airway infiltrates in the
absence of involvement of the contra lateral lung (Monton & Torres 1998). Bacterial
sepsis and associated inflammation has been shown to be a contributory factor in the
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development of ARDS (Pelosi et al. 2003). The results of this study indicate that the
response to endobronchial LPS instillation to local lung segments closely mirrors the
accepted model of Gram negative bacterial inflammation (Moore & Standiford 1998).
The response in the direct segment is as described for acute bacterial infection in both
sheep (Brogden, Cutlip, & Lehmkuhl 1984) and humans (O'Grady et al. 2001).
Cellular content of BALF from the directly challenge segment consisted of increased
neutrophil numbers.
In contrast, the contra-lateral lung showed no change from baseline following LPS
challenge. Brogden et al (1995) highlighted, in sheep and cattle, a localised,
neutrophil-mediated inflammatory response to LPS instillation consistent with that
seen in this study (Brogden, Ackermann, & Debey 1995). A study in human lungs by
O'Grady et al (2001) in which local LPS deposition elicited an inflammation at the
cellular and cytokine level showed considerable similarity with the results seen in this
experiment(0'Grady et al. 2001). Haematological analysis indicated the presence of a
systemic neutrophilia with a reduction in total lymphocyte numbers.
These data, consistent with the reactions seen in previously described models of lung
endotoxaemia (Toews 2001; Xing et al. 1999), were not associated with any clinical
evidence of disease. Histopathological analysis of the segments directly challenged
with LPS showed damage consistent with neutrophil mediated damage associated
with bacterial infection whilst the contra-lateral segment indicated no damage remote
from the site of inflammation. The mild systemic pyrexia seen in this study was not of
clinical significance and was consistent with sham procedures seen in previous studies
(Collie; personal communication, 2004).
There are a number of possible mechanisms for the systemic production of
neutrophils following exposure to endotoxin. It is conceivable that these cells are
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produced in response to endotoxin reaching the systemic circulation across the airway
barriers. Indeed tight junction perturbation may presumably occur prior to or in the
absence of significant evidence of epithelial damage. A further possibility, supported
by in vitro investigations (Ahmad et al. 2003; Fujii et al. 2001) is that the LPS
initiates immune mediator production from resident cells lining the airspaces and/or
the mobile cell population in the epithelial lining fluid and that raised local and/or
systemic levels of these factors, which may include cytokines, chemokines or
chemotactic factors, initiate the production of PMNs and facilitate the localisation of
the PMNs to the site of inflammation.
The preferential influx of the PMNs to the inflamed lung may also be facilitated by
the increased expression of adhesion molecules and localisation signals such as
selectins and ICAM molecules as a direct result of LPS treatment (Kuo et al. 2000;
Wright et al. 1991) as well as indirectly via the action of mediator cells such as
alveolar macrophages etc (Blahnik et al. 2001). The exposure of PMNs to LPS,
known as priming of the cells, has been shown to result in a reduction of the PMNs
ability to deform (Lawrence et al. 1996;Sato et al. 1999), and hence they become
more 'rigid' and less able to transfer across barriers from the circulation. Priming may
help to explain the localised nature of the PMN response as the primed, less
deformable cells do not readily cross barriers such as airway epithelium, and will thus
be less likely to transfer without additional chemotactic signalling.
Once located in the lung airspaces the neutrophils will be preferentially retained due
to the lack of deformability acquired through the priming of the cells by LPS
exposure. In conclusion, available literature suggests that the combination of priming
and adhesion molecule expression would contribute to the observed highly focal
infiltration of PMNs in the lung following localised deposition of LPS.
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An emerging hypothesis concerning the advancement of lung inflammation from a
localised and relatively minor inflammatory response to the destructive and highly
lethal ARDS syndrome concerns the balance between pro- and anti-inflammatory
reactions in the lung following exposure to infectious agents.
The previously accepted paradigm of this evolution of inflammation held that the
progression to ARDS was due to a loss of anti-inflammatory capacity in the lung and
excessive pro-inflammatory reaction (Bone et al. 1992) and that this resulted in the
inflammatory reaction overwhelming the organ and consequently causing tissue
damage and organ failure leading to death in many cases (Bone, Sibbald, & Sprung
1992). This hypothesis was supported by evidence of therapeutic benefit following
systemic delivery of the anti-inflammatory cytokine IL 10 in animal models of tissue
infection and sepsis, but was confounded by research indicating that if the IL 10 was
administered at the site of bacterial infection there was a delay in clearing bacteria and
an increase in mortality.
These studies indicated that a systemic anti-inflammatory reaction was highly
protective, however a local, tissue based, anti-inflammatory reaction resulted in
greater susceptibility to adverse effects from infection and increased mortality
following infection. Suggested mechanisms for this enhanced susceptibility include
impairment of macrophage and monocyte recognition of, and response to, bacterial
molecules (such as LPS), impaired neutrophil function and reduced levels of
surfactant proteins in the airway space (Munford & Pugin 2001).
The macrophage has been established as a playing a crucial role in the resolution of
bacterial infection and loss of function in macrophages has been shown to
compromise the response to bacterial challenge to the lung. It has been clearly
demonstrated that macrophage functions are severely reduced following direct
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exposure to LPS, and also that this exposure consequently renders the macrophages
less effective in terms of response to bacterial challenge (Dobrovolskaia & Vogel
2002; West & Heagy 2002). It has also been noted that macrophage function is
impaired following exposure to IL 10, with a similarly compromised response to
bacteria. An interesting additional observation was made by Dehoux who
demonstrated that, following unilateral pneumonia involving localised inflammatory
responses and no gross involvement of the contra lateral lung, macrophages isolated
from the contra lateral lung segments were hyporeactive to LPS treatment (Dehoux et
al. 1994).
The importance of the neutrophil in resolving bacterial lung infection is also well
established (Aldridge 2002; Chollet-Martin et al. 1996), though it is clear that PMNs
can also mediate considerable tissue damage, and have been implicated in the hyper
responsive inflammatory effect seen in some lung diseases. Impairment of neutrophil
function is known to exacerbate the negative effects of bacterial colonisation of the
lung and loss of function in neutrophils correlates strongly with morbidity and
mortality following endotoxin administration to the lung (Frevert, Warner, & Kobzik
1994; Rehm, Gross, & Pierce 1980; White et al. 1986).
Patients with sepsis have been shown to have impaired PMN function, showing
reduced chemotaxis towards endogenous and exogenous factors in vitro. PMNs have
also been shown to exhibit reduced migration to secondary sites of inflammation in
septic patients (Ahmed et al. 1999). This impairment of function suggests that patients
with sepsis are at increased risk of secondary infection due to loss of PMN
antibacterial properties, as has also been reported in animal models of sepsis.
The phenotypic characteristics of the direct response to LPS at 6 hours post-challenge
are consistent with activation of the innate acute inflammatory arm of the immune
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system and prior literature suggests that such responses are likely to be accompanied
by a characteristic profile of cytokine production from the resident immune and
epithelial cells in the airways and alveoli. Such cytokines are likely to include TNFa,
IL 1, IL 6, IL 8 and IFNy (Toews 2001).
That no remote responses were detected, either at the level of the bronchoalveolar
cellular profile or following histological examination, is consistent with previous
studies (Monton & Torres 1998). The lack of organ-wide phenotypic change in this
model supports the contention that local lung responses remain discrete. Whilst such
an observation makes intuitive sense in that local restriction of an inflammatory focus
would be desirable it does raise the question as to whether mechanisms exist at an
organ level to limit progression, and indeed whether progression to fulminant
inflammatory lung disease - as seen in ARDS - represents a failure of such
mechanisms, and thus supports the hypothesis that lung failure is a consequence of
disruption in the balance of pro- and anti-inflammatory responses. Resolution of this
question would lead to a deeper understanding of the mechanisms of pathogenesis of
sepsis in the lung and consequently widen the available options for therapeutic
strategies or interventions in the treatment of lung infection.
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Chapter 4 Direct, and remote cytokine expression
associated with local lung instillation of LPS in sheep
Aims and objectives
• To validate the process of deriving quantitative information relating to
endogenous gene expression from samples of bronchial epithelial cells
obtained by bronchoscope cytology brush in vivo.
• To characterise the molecular profile of cytokine gene expression in bronchial
epithelial cells in response to direct lung challenge with LPS.
• To characterise the concomitant response in terms of cytokine gene expression
in lung segments remote to the sites of direct challenge.
Introduction
Over the last 30 years flexible bronchoscopy has become established as a routine
clinical diagnostic procedure (Mitchell et al. 1980a; Mitchell et al. 1980b). However it
is only relatively recently that the potential of this technique to furnish specimens
appropriate for molecular analysis has become apparent (Eissa & Erzurum 2001). The
majority of recent studies have utilised biopsy material in this regard. However,
although cytological brushing is a method that can be employed to harvest viable
tracheobronchial epithelial cells for similar analyses (Kelsen et al. 1992), relatively
few studies have capitalised on this technique in a clinical research context (Trapnell
1993; Becker et al. 1999; Penn et al. 1996; Riise et al. 1996; Bhathena et al. 2000;
Joseph et al. 2001; Takizawa et al. 2000; Takizawa et al. 2001; Hackett et al. 2003).
As such, the practical aspects in relation to sampling and processing for molecular
analysis are not sufficiently well described or widely validated to be considered a
routine adoption in any experimental protocol. It is for this reason that the first
objective is stated.
The second and third objectives, aimed specifically at the underlying hypothesis, are a
natural progression from chapter 3. Primer pairs were synthesised in order to detect
transcripts pertaining to the expression of IL lp, IL 6, IL 8, TNFa and IL 10 in
epithelial cells sampled before, and 6h after local lung instillation of LPS in the ovine
model and to quantify this expression in relation to the housekeeping gene ATPase.
Results
RNA quality and quantity
Table 4.1 lists the quantity of RNA from each sample derived from the lung segments
in this study. Figure 5.3.A is a representative example of the 'false gel' image
acquired by the Agilent Bioanalyzer chip analysis platform. Full trace scans of all
samples are shown in Appendix II. A number of the PCR data show numbers used in
statistical tests less than 12. Samples were excluded from the data analyses due to
PCR contamination or error established by analysis of melting curve data for each
sample as detailed in the materials and methods chapter.
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Table 4.1: This table details the quantity of total RNA (jug) extractedfrom the brushed
epithelial cells derivedfrom each sheep lung sample. Samples labelled 'direct' were
taken from the LPS-cha/lenged segment, samples labelled 'remote 'from the contra
lateral lung segment at baseline (0 hours) andpost-LPS challenge (6 hours). The
quantification of the RNA was performed using the Agilent Bioanalyzer platform
which calculates RNA concentration using fluorescence-based detection technology.
The RNA was purified and divided into two. Thefirst halfofeach sample was usedfor
real-time quantitative RT-PCR analysis ofcytokines. The second halfwas usedfor
amplification and labelling prior to microarray hybridisation (see chapter 6). The
RNA analysis was performed on the second halfofeach sample after thefirst halfhad
been reverse-transcribedfor the RT-PCR reactions. Due to a technical error the
second halfof 13 RNA samples were destroyed (marked as * in the table). Samples
labelled ** were not amplified or used in the microarray analysis due to quantity
and/or quality considerations.
Sheep Direct (Oh) Direct (6h) Remote (Oh) Remote (6h)
0687P 199.5 362.5 251.5 308.5
0693P zj.** 161.5** 420.5 208
086 IP 0.5** 18.5** 190 108.5
068 IP 262 56 177 217.5
063 IP 276.5 11 144.5 264.5
0757P 180.5 70 147 165
451 * 2** 213.5 173
S12 * * * *
S46 118.5 117.5 106.5 142.5
X26 * * 81.5 34.5
S9 * * * *
S41 * * 106.5 142.5
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Real-time PCR analysis of cytokine expression
The raw data obtained from the real-time PCR analysis are included in Appendix II.
Interleukin ip
The relative expression of interleukin ip mRNA as measured by qRT-PCR was
significantly (p=0.002, n=T 1) up-regulated six hours post-LPS challenge in epithelial
brushings taken from the direct segment (median fold difference relative to baseline:
248.9; range: 1.1-30829.5). In epithelial brushings taken from the remote segment
there was no significant change (p=0.919, n=10) in the level of IL ip expression.
Figure 4.1 shows, for each animal, the change in relative expression of IL lp in
epithelial brushings in the directly challenged and remote segments both prior to (Oh)
and 6 hours after LPS challenge (6h).
Interleukin 6
The relative expression of interleukin 6 mRNA was significantly (p=0.01, n=12) up-
regulated six hours post-LPS challenge in epithelial brushings taken from the direct
segment (median fold difference relative to baseline: 4.6; range: 0.04-48.6). In
epithelial brushings taken from the remote segment there was no significant change
(p=0.505, n=l 1) in the level of IL 6 expression. Figure 4.2 shows, for each animal, the
change in relative expression of IL 6 in epithelial brushings in the directly challenged
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Figure.;4.2:Expression levelofinterleukin(IL)6 assse sedbyreal-time RT-PCRanalysisofNA frombrushedepith lial cellsinhallenged (direct)andco tralateral (remote)segmen sat baseline(0hours)and post-LPS(6hours). Expressionlevellative
toATPasehouseke ping geneexpressionishown onthey-axisn logarithmicscale.IL6 wassignificantly(p=0.01) increased(4.6foldmean change)sixhourpost- LPSchallengein epithelialcellstakenfrom thedirects gment.In epithelialcellstakenfrom theremotes gmenter wasnosignificantchange (p=0.505)inthe expressionifIL6.
Tumour necrosis factor a
The relative expression of tumour necrosis factor a mRNA was significantly
(p=0.023, n=12) up-regulated six hours post-LPS challenge in epithelial brushings
taken from the direct segment (median fold difference relative to baseline: 4.2; range:
0.08-422.4). In epithelial brushings taken from the remote segment there was no
significant change (p=0.756, n= 11) in the level of TNFa expression. Figure 4.3
shows, for each animal, the change in relative expression of TNFa in epithelial
brushings in the directly challenged and remote segments both prior to (Oh) and 6
hours after LPS challenge (6h).
Interleukin 8
Interleukin 8 expression was not significantly altered in either the direct (p=1.00,
n=12) or remote (p=0.894, n=ll) segments six hours after LPS challenge. Figure 4.4
shows, for each animal, the change in relative expression of IL 8 in epithelial
brushings in the directly challenged and remote segments both prior to (Oh) and 6
hours after LPS challenge (6h).
Interleukin 10
The relative expression of interleukin 10 mRNA in epithelial brushings taken from the
direct segment showed no significant change following challenge (p=0.784, n=12). In
epithelial brushings taken from the remote segment there was a significant increase
(p=0.003, n=10) in the level of IL 10 expression (median fold difference relative to
baseline: 10.4; range: 3.3-90.9). Figure 4.5 shows, for each animal, the change in
relative expression of IL 10 in epithelial brushings in the directly challenged and
remote segments both prior to (Oh) and 6 hours after LPS challenge (6h). The overall
levels of IL-10 found at Oh in the remote and directly challenged segments show
considerable differences. This overall difference in baseline levels of IL-10 would
appear to have no physiological basis, and did not affect the analysis of the cytokine
changes in either segment. As the segments chosen were heterogeneous there can be
no suggestion of a spatial bias in levels of IL-10 expression at baseline, and there is
no correlation with age or sex either, the observation was therefore determined to be
artefactual and of no functional or analytical consequence.
The fold changes in relative cytokine expression as a consequence of LPS-instillation
are depicted in figure 4.6. Cytokine gene expression at Oh and at 6h was assessed in
samples derived from both directly instilled segments (Direct) and contra-lateral
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Figure4.4:Expression levelofinterleukin(IL)8 asssessedbyreal-time RT-PCRanalysisofRNA fromb ushedepith lial cellsinchallenged (direct)andco tralateral (remote)segmentsa baseline(0hours)and post-LPS(6hours). Expressionlevellat ve
toATPasehouseke ping geneexpressionishown onthey-axis logarithmicscale.IL8 expressionwasnot significantlychanged (p=1.0)sixhourspost- LPSchallengein epithelialcellstakenfrom thedirects gmen .In epithelialcellstakenfrom theremotes gmenth r wasnosignificantchange (p=0.894)inthe expressionifIL8.
—0—639 -■-689 —A—693 -*-687 -*-757 -•—861 —I—S9
S12





Figure4.5:Expression levelsofinterl ukin(IL) 10assse sedbyreal¬ timeRT-PCRanalysisof RNAfromb ushed epithelialcellsin challenged(dir ct)and contralateral(remote) segmentsatbas line(0 hours)andpost-LPS(6 hours).Expres ionlevel relativetoATPase housekeepinggene expressionishownont y-axisonlogarithmic scale.IL10w s significantly(p=0.003) increased(10.4foldmean change)sixhourpost- LPSchallengein epithelialcellstak nfrom theremotes gment.In epithelialcellstakenfrom thedirects gmentr wasnosignificantchange (p=0.784)inthe expressionofIL10.
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Discussion
The described method of brushing the airway wall to obtain epithelial cells suitable
for use in molecular assays such as RT-PCR has been reported in humans (Trapnell
1993; Reynolds, Scicchitano, & Holmes 2001; Soria et al. 2002; Muhlebach, Reed, &
Noah 2004) but not in the sheep. It is prudent to consider the likely cellular
composition ofmaterial obtained by this method in sheep. In a study involving human
subjects the percentage of ciliated, secretory, and basal-like cells was 24 +/- 2%, 11
+/- 1%, 29 +/- 1%, respectively, while the remaining 36% were difficult to type
(Kelsen et al. 1992). This data is consistent with experience in our own laboratory
with brushings obtained from sheep (D Collie; personal communication) and is
substantiated by a body of literature indicating that the composition of the ovine
respiratory epithelium is comparable with that of human subjects (Mariassy &
Plopper 1983; Plopper, Mariassy, & Hill 1980).
The quantities of RNA obtained were sufficient to enable samples to be split and half
of each used for real-time RT-PCR and the remainder stored for subsequent
amplification and use in microarray analyses. Although the limited quantities of
sample obtainable by this method precluded standard quality analyses such as the use
of denaturing gel electrophoresis the Agilent Bioanalyzer system offers improved
resolution of mRNA separation relative to native agarose gels and as such was
considered a superior method of analysis of both quality and quantity of RNA
samples.
The classic method for determining the quality of RNA is to estimate the ratio of 28S
to 18S ribosomal RNA, with a ratio of 2 expected for good quality RNA. Using this
criterion the RNA obtained would not have been considered of adequate quality for
RT-PCR, however recent publications have made clear that this method does not
101
correlate in any way with genuine mRNA quality in terms of its suitability for RT-
PCR (Miller et al. 2004; Skrypina et al. 2003). That the samples obtained in this study
were sufficient in terms of both quality and quantity was evidenced by the
consistently early threshold crossing values of the housekeeping genes in the samples
used, each ofwhich represented 5% of the total RNA sample collected.
Several reviews indicate that bronchial epithelial cells respond in a predictable
fashion to LPS. Following binding of LPS to the phospholipid binding protein, LPS
binding protein (LBP), and interaction with soluble or membrane associated LPS
pattern-recognition receptors (mannose receptor, the macrophage scavenger receptor
(SR-A), collectins, integrins and CD 14) a predictable pattern of cellular activation
occurs as the innate immune system is triggered (Martin 2000; Toews 2001; Monton
& Torres 1998; Takizawa 1998; Levine 1995). Both bronchial epithelial cells and
alveolar macrophages contribute to this early innate response through release of pro¬
inflammatory cytokines, in particular interleukins 1(3, 6 and 8 and TNFa(Takizawa
1998). These cytokines activate the resident alveolar macrophages in a positive
feedback loop, initiate neutrophil haematopoiesis and release from bone marrow
reserves and act, through up regulated expression of adhesion molecules, to localise
neutrophils to the challenged area resulting in a rapid and significant localised
neutrophilic response (Levine 1995).
At the peak of this T cell independent phase of the innate inflammatory response IL
10, released by epithelial cells, macrophages and other cells, inhibits production of
pro-inflammatory cytokines and causes the immune system to switch to the adaptive
stage with activation of T-cells and down regulation of the inflammatory response
(Toews 2001) This central role for IL 10 in the regulation of the inflammatory
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response to LPS and its reported role in the development of ARDS marks it as an
important factor to evaluate in terms of any potential remote response.
Whilst the integral role played by IL 12 in the initiation of inflammation is well
established in rodent models (Toews 2001) its role in the sheep is poorly
characterised. Ovine lung models have demonstrated that the pro-inflammatory
cytokines IL ip, TNFa and IL 6 are consistent markers of gram-negative bacteria-
induced inflammation (Murtaugh et al. 1996). Regulation of these cytokines in
epithelial cells in primary culture (Crestani et al. 1994) and transformed epithelial cell
lines (Koyama et al. 2000) have been characterised in sheep and humans, showing
highly analogous regulatory profiles in response to LPS/bacterial challenge whilst
epithelial cells from bronchial brushings have been used to quantify cytokine
regulation in human subjects following grain dust exposure (Becker et al. 1999).
In the present study real-time RT-PCR (Giulietti et al. 2001) was selected as a
quantitative and highly sensitive technique for the measurement of such mRNA
transcripts in bronchial epithelial cells. The quantitative measurement of transcript
within a cellular sample relies on the quantification of each target relative to an
endogenous reference gene that remains unchanged or affected by the experimental
challenge, and thus acts as an internal standard (Pfaffl, Horgan, & Dempfle 2002).
The method is derived from the original polymerase chain reaction. A standard
reverse transcription of RNA to cDNA is followed by an amplification of specific
DNA via the use of primer sequences that act to specifically amplify segments of
genes or transcripts of interest.
This method is commonly used and accepted as a standard method of transcript
detection. The real-time technique adds to this method by measuring the quantity of
amplified DNA throughout the reaction. This allows measurement of the level of
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DNA to be made specifically at the point of exponential amplification, yielding fully
quantifiable information (Schmittgen 2001; Pfaffl, Horgan, & Dempfle 2002).
Previous studies examining the inflammatory responses to bacterial endotoxin and
gram-negative bacterial infection in humans (Wesselius et al. 1997), mice (Hirano
1997;Vernooy et al. 2001) and rats (Xing et al. 1994) have shown patterns of cytokine
regulation consistent with those seen in the directly challenged segment of the sheep
lung in this experiment. The pro-inflammatory effects of interleukin 1 (3, interleukin 6
and TNFa are recognised (Xing et al. 1999) and accepted as hallmarks of a
neutrophil-mediated acute inflammation (Wesselius et al. 1997). In contrast to their
well-characterised and familiar roles as macrophage-generated mediators (Mantovani
et al. 2001) the roles of these three pro-inflammatory cytokines in the pulmonary
epithelium have been relatively poorly documented (Levine 1995).
The pattern of up-regulation of IL ip, IL 6 and TNFa in ovine lung epithelial cells
suggests an important role for epithelial-derived cytokines within the innate immune
response to acute bacterial challenge in the lung. Indeed the present findings concur
with the wider perception that these cytokines play a central role in mediating
inflammatory processes following acute bacterial or endotoxin challenge (Moore &
Standiford 1998; Toews 2001). The unknown correlation between mRNA expression
and protein production limits any interpretation regarding the physiological effect of
the cytokine regulation seen in this investigation, however previous studies in mice
(Hirano 1997; Vernooy et al. 2001) and rats (Haddad et al. 2002) have shown strong
correlations between cytokine mRNA levels and quantity of protein produced.
Interleukin 1(3
Interleukin ip is one of the two subunits of interleukin 1. IL 1 is a potent pro¬
inflammatory cytokine that has been implicated in numerous physiological processes
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as well as inflammatory diseases (Dinarello 1994). IL 1 is an important mediator of
pulmonary inflammation induced by bacteria and bacterial products produced in lungs
after administration of LPS, and inhibition of IL 1 activity attenuates lung
inflammation caused by LPS (Jordan et al. 2001). Additionally, recombinant IL 1
causes neutrophilic infiltration in the lung comparable to LPS (Ulich et al. 1991).
Elevated IL 1 levels have been found in pleural fluids of patients with unilateral
community-acquired pneumonia, significantly higher IL 1 concentrations have been
measured in bronchoalveolar lavage fluids (BALF) from infected lungs, compared
with BALF from uninfected lungs or serum (Crestani et al. 1994).
Clinical investigations into IL ip expression specifically have indicated significant
increases in levels of this cytokine in the tissue compartment and in the BALF of
patients with pneumonia compared with control patients (Millo et al. 2004; Wu,
Herndon, & Wolf 2003). Moreover, alveolar macrophages recovered from infected
lungs spontaneously release more IL 1 into cell culture supernatants than
macrophages isolated from the uninfected lung (Dehoux et al. 1994). Evidence from
knockout mouse studies and antibody blockade of IL 1 in the mouse have
demonstrated that IL 1 is important as a positive mediator of inflammation, however,
somewhat in contradiction, its absence results in an increased clearance of bacteria in
murine pneumonia models (Rijneveld et al. 2002; Schultz et al. 2002).
Interleukin 6
IL 6 is a pleiotropic cytokine produced locally in the lung tissue and released into the
circulation in many situations of immune challenge including endotoxaemia, LPS
instillation to the lung, and acute infections (Kishimoto, Akira, & Taga 1992). As well
as its role in the immune response to bacterial infections, circulating IL 6, together
with pro-inflammatory cytokines TNFa and IL 1, has been shown to be necessary for
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the induction of innate immune reactions such as pyrexia, corticorsterone release, and
production of acute phase proteins from the liver, including a number of protease
inhibitors (Baumann & Gauldie 1994).
This role is usually seen as a homeostatic maintenance mechanism however, it is
unclear whether IL 6 is also directly involved in the modulation of inflammation
during local or systemic acute inflammatory responses, particularly in relation to
modulating cytokine responses and tissue inflammatory infiltration. In a clinical
setting serum IL 6 levels appear to correlate with mortality of patients with endotoxic
syndrome or trauma and has been considered a marker of severity in bacterial
infection (Dehoux et al. 1994; Hack et al. 1989). IL 6 is likely to be produced locally
in the lung in response to bacterial products such as LPS, as evidenced by the pattern
of localized expression seen in this study which corresponds well with the local
regulation observed in unilateral pneumonia (Dehoux et al. 1994).
The difficulty in separating the biologic effect of IL 6 from an ongoing process of
tissue injury renders establishing the role of IL 6 as a central factor difficult, and
consequently it remains unclear whether it acts as a beneficial or detrimental
modulator in an infectious scenario (DiCosmo et al. 1994). Blockade of IL 6 by use of
antibodies in LPS models has yielded conflicting information (Barton & Jackson
1993; Heremans et al. 1992; Starnes, Jr. et al. 1990) and although studies in knockout
mice have also been contradictory, the balance of evidence appears to suggest a pro¬
inflammatory role for IL 6 in acute inflammation.
This observation is based on original work by Kopf et al who reported increased
susceptibility to infection in IL 6 knockout mice (Kopf et al. 1994). Further
investigation by Dalrymple et al (1995) extended this observation by establishing a
central role for IL 6 in the rapid initiation of a systemic neutrophilia. Later studies
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demonstrated increased susceptibility to E. coli infection with concomitant failure to
establish blood neutrophilia in mice with otherwise broadly normal expression of
other innate immune effectors such as interferon gamma and nitric oxide, and
unaffected macrophage and natural killer cell activation (Dalrymple et al. 1995).
Establishing the functional role of 1L 6 in bacterial inflammation remains a key target
in inflammatory studies, however it is known to exert both pro-inflammatory effect in
acute inflammation, and anti-inflammatory effects in chronic models (Xing et al.
1998) and to be an important balancing cytokine in inflammatory disease models
(Aderka, Le, & Vilcek 1989; Appelberg 1994; Chen et al. 1993; Schindler et al.
1990).
Tumour necrosis factor a
Tumour necrosis factor a is mostly produced by macrophages and monocytes though
other cell types in the airway have the ability to generate TNFa including eosinophils
(Costa et al. 1993; Finotto et al. 1994) epithelial cells (Khair et al. 1994) and mast
cells (Thomas 2001). TNFa activates neutrophils and macrophages leading to
production of cytokines and immune mediators, as well as directly enhancing
bactericidal activity and phagocytosis (Strieter, Kunkel, & Bone 1993; Le & Vilcek
1987). TNFa is also a chemotactic cytokine for granulocytes including eosinophils
and neutrophils (Ming, Bersani, & Mantovani 1987) this is achieved through up-
regulation of cellular adhesion molecules such as E-selectin, vascular cell adhesion
molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-lor CD54)
(Gamble et al. 1985; Pober et al. 1986).
Tumour necrosis factor a induction of adhesion molecules on pulmonary endothelium
has been demonstrated as an important factor in the recruitment of granulocytes
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(Yamamoto, Sedgwick, & Busse 1998). TNFa has been found to be expressed in
lungs of clinical patients with bacterial pneumonia (Nohynek et al. 1991) as well as
having been reported to play a critical role in clearance of streptococcal pneumonia in
a mouse model (van der et al. 1997). Other murine models of gram negative
pneumonia have also demonstrated the central role of TNFa in bacterial clearance
from the lungs, and blockade of TNFa in these models has resulted in increased
mortality and impairment of bacterial clearance (van der et al. 1997; Takashima et al.
1997; Laichalk et al. 1996; Gosselin et al. 1995).
Interleukin 8
In contrast to the significant up regulation of IL 1(3, IL 6 and TNFa in direct
segments, no significant change in the expression of IL 8 occurred following
challenge with LPS. . Several studies have examined the cytokine response of the
A549 transformed human type Il-like bronchial epithelial cell line to challenge with
pure LPS (Ahmad et al. 2003; Palmberg et al. 1998), grain dust (Palmberg et al. 1998;
Jagielo et al. 1996), swine dust (Palmberg et al. 1998) or immune modulators or
cytokines (Ahmad et al. 2003; Standiford et al. 1996). The role of IL 8 in such
systems is not clearly defined in that Standiford (Standiford et al. 1990) demonstrated
that the A549 cell line does not produce IL 8 directly as a response to LPS challenge
whereas Ahmad (Ahmad et al. 2003) concluded that, in the presence of immune
serum, IL 8 is indeed produced.
Primary cell culture experiments using LPS challenge are similarly contradictory with
one study showing no change in IL 8 mRNA levels (Pechkovsky et al. 2000) and
another indicating significant up-regulation (Palmberg et al. 1998) following
challenge with both LPS and swine dust respectively. Nevertheless the literature
indicates that levels of IL 8 protein in BALF (Jagielo et al. 1996) and IL 8 mRNA
levels in epithelial cells (Jagielo et al. 1996) are both raised following instillation of
LPS to the lungs of rodents.
The time-course of this response is unclear, and no assessment of IL 8 mRNA in
ovine bronchial epithelial cells has been previously reported in vivo. The stimulatory
effect of LPS on alveolar macrophages to produce IL 8 along with other pro¬
inflammatory cytokines is clear from published studies (Standiford et al. 1990;
Strieter et al. 1990), and authors have proposed that the production of IL 8 from
epithelial cells may be as a result of this production, a hypothesis supported by the
lack of appropriate receptors for LPS-stimulated IL 8 production on epithelial cell
surfaces in comparative species (Wright et al. 1991; Wright et al. 1990b; Wright et al.
1990a).
Interleukin 10
Interleukin 10 is released from alveolar macrophages and epithelial cells as part of the
late phase acute inflammatory response (Standiford et al. 1995). Its role relates to the
down-regulation of inflammation by inhibition of pro-inflammatory cytokine release
(Thomassen, Divis, & Fisher 1996) through blockade of the phospholipase C signal
pathways (Lo, Fu, & Cryer 1998) and NF-kB transcriptional pathway (Raychaudhuri
et al. 2000). IL 10 has been shown to inhibit endotoxin-mediated TNFa, IL ip, IL 6
and IL 8 release from alveolar macrophages (Thomassen, Divis, & Fisher 1996) as
well as neutrophil chemotaxis (Dokka et al. 2000) and mortality due to LPS sepsis
(Inoue 2000).
Abrogation of the IL 10 response has been implicated in the development of acute
respiratory distress syndrome (Standiford et al. 1995) and has been shown to cause
systemic LPS induced shock (Ishida et al. 1994), enterocolitis (Kuhn et al. 1993) and
increased lethality in endotoxaemia (Standiford et al. 1995). A significant ten-fold
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increase in IL 10 gene expression occurred in the remote segment six hours after LPS
challenge. This anti-inflammatory response remote from local endotoxin challenge
has not been reported in any tissue or in any species. Indeed remote responses of any
character have yet to be reported in lung tissue at the molecular level.
It could be speculated that the role of remotely produced IL 10 may be a protective
response against systemic, lung-wide inflammation. Results from previous studies
(Raychaudhuri et al. 2000) would suggest that the increased expression of IL 10
would serve to down-regulate any inflammatory mediators and inactivate any immune
cells that were to infiltrate the pulmonary space.
The systemic neutrophilic leukocytosis that occurs as a consequence of local lung
instillation of LPS could conceivably lead to an increase in the number of primed
and/or activated granulocytes trafficking through lung tissues remote from the site of
inflammation. Remote up-regulation of IL 10 could potentially serve as a mechanism
for limiting damage to the organ as a whole.
Overview
Overall this study confirmed the expression profile of the 'classical' inflammatory
cytokines IL 1(3, IL 6 and TNFa in unilateral LPS instillation after 6 hours post-
instillation. There are no previously published examples of this model of
inflammatory lung disease, and the profile of cytokine expression in the affected
segment is closely analogous to that seen in unilateral pneumonia both clinically and
in other animal (particularly rodent) models of acute lung injury, pulmonary
endotoxaemia and pneumonia. The remote expression of IL 10 in the lung is a novel
observation. Previous studies including investigation of the contra lateral lung have
been limited to phenotypic and cellular changes, with some including measurements
of the protein levels of classical pro-inflammatory markers in bronchoalveolar lavage
HO
fluid. The observed increase in IL 10 also provides a mechanism for the observed
hyporeactivity of alveolar macrophages isolated from bronchoalveolar lavages
derived from patients with unilateral pneumonia as this cytokine has been
demonstrated to be a potent suppressor of macrophage function in vitro (Lo, Fu, &
Cryer 1998; Raychaudhuri et al. 2000).
The consequences of the observed anti-inflammatory gene expression in remotely
situated lung tissue following unilateral localised LPS inflammation may relate to the
balance of inflammatory regulators present in the systemic circulation and tissue
compartments, and this balance may play an important role in subsequent infection.
This is of particular note with regard to potential impact on the development of
diffuse lung injury, further bacterial colonisation of the lung and the progression to
ARDS. IL 10 has been shown to impair PMN function both in vivo and in vitro, as
well as playing a role in the blockade of PMN infiltration and sequestration in the
tissue compartment (Dokka et al. 2000; Inoue 2000; Quinn et al. 2000).
IL 10 expression in tissue has been implicated in increasing the vulnerability of the
lung to bacterial colonisation and bacterial outgrowth in pulmonary infection
(Greenberger et al. 1995; Reddy et al. 2001; Steinhauser et al. 1999). The effects of IL
10 in the tissue compartment have been detrimental in terms of clearance of infectious
organisms and in terms of survival following infection (Sewnath et al. 2001; van der
et al. 1996). These effects in tissue are in contrast to the documented effects of IL 10
in the systemic circulation where its impact is largely protective (van der et al. 1995).
Studies in IL 10 knockout mice showed improved clearance of bacteria from the lung
- presumably due to improved inflammatory ability within the pulmonary space - but
reduced survival indicating a central protective role in the resolution of infection for
systemic IL 10.
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During primary pneumonia with no subsequent or prior inflammatory stimulus the
balance between pro- and anti-inflammatory responses in the lung functions as a
highly effective mechanism to clear bacteria whilst protecting the lung from
subsequent tissue destruction by over-production and tissue sequestration of PMNs.
However in the unusual situation where this primary inflammatory stimulus is
followed by a secondary infection the anti-inflammatory response may become a
liability and a potential window of innate immuno suppression may then allow
colonisation and outgrowth of bacterial pathogens and consequent morbidity and
mortality. This window of vulnerability would be particularly important if the levels
of remote IL 10 in tissue stayed high whilst the systemic IL 10 levels dropped back to
baseline levels, and it is conceivable that this set of circumstances predisposes for
ARDS in the clinical setting. Indeed such a notion correlates well with observations in
pulmonary ARDS patients linking secondary infection with development of the
syndrome.
As there has been no study revealing this remote anti-inflammatory response
previously, this hypothesis has yet to be challenged, however it concurs with a study
involving trauma patients in which systemic and alveolar IL 10 levels were
investigated (Muehlstedt, Lyte, & Rodriguez 2002). In this study patients admitted
with traumatic injury were assessed for susceptibility to nosocomial pneumonia.
Levels of IL 10 were measured systemically and in alveolar spaces both at admission
(pre-infection) and at later time-points. Systemic IL 10 levels in patients who acquired
pneumonia and those who remained free from pneumonia followed similar temporal
profdes, whilst those that developed pneumonia showed significantly higher alveolar
levels of IL 10 than those that did not.
m
The implication of this study closely mirrors the assertion above that the systemic:
tissue balance in anti-inflammatory (IL 10) expression is a critical factor in the
susceptibility of the lung to bacterial invasion. In addition to the potential for
identification of potential avenues of intervention in the development of ALI/ARDS,
it is also conceivable that this window of opportunity could be manipulated in
unrelated pulmonary applications such as gene therapy as a means of circumventing
the negative effects of immune reactions to applied treatments.
This investigation establishes for the first time the validity of a real-time PCR
approach to investigating cytokine responses to segmental LPS challenge in the ovine
lung. A number of variants of the real-time technique exist, with probe-based and
intercalating dye-based methods predominant. Probe based techniques use a labelled
probe specific to a portion of the amplified section of DNA. When bound as double
stranded DNA the probe fluoresces. This method is highly specific due to the
combined specificity of the primer pair and the labelled probe however it suffers from
disadvantages, particularly related to high cost, time delays and poor sensitivity
(Bustin 2002).
The intercalating dye method uses a usually inert dye (e.g. SYBR green) that, when
bound to double stranded DNA, fluoresces at a known wavelength (Lekanne Deprez
et al. 2002). An important advantage of this more sensitive technique is that the dye
can be used for detection of any amplified transcript with no need for probe design or
purchase. However, a major disadvantage of the technique is the loss of sensitivity as
the dye can bind to any non-specifically amplified DNA as well as any primer-dimers
that form through normal molecular interactions (Vandesompele, De Paepe, &
Speleman 2002). As a result this latter method requires considerable optimisation
compared with probe-based techniques.
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The characterisation of this remote response due to LPS inflammation confirms the
hypothesis that the ovine lung will respond on a whole-lung basis to local
inflammation. Further investigation to fully characterise the nature of this remote
response may potentially lead to novel avenues of investigation and even prophylaxis
in terms of the manipulation of whole organ responses to acute onset localised gram-
negative sepsis in the lung.
The immediate investigation into the remote response will concentrate on the
expression profiles of a large cohort of sequences in the lung in order to assess the
extent of the anti-inflammatory reaction in this segment as well as to fully
characterise the networks of genetic changes that underlie this event. This
characterisation may provide clues as to a potential mechanism that drive the remote
changes in response to LPS inflammation and thus expose avenues of intervention and
further investigation. At this preliminary stage it is unlikely that large-scale genomic
analysis will provide complete answers to the questions concerning the fundamental
nature of the remote response to local inflammatory stimulus, but is instead a
springboard toward further investigative directions in that regard.
Additional investigation will seek to establish the effect of the identified response at 6
hours through a secondary challenge in the contra-lateral lung. This investigation may
give an indication of any overt alteration in the ability of the lung to initiate
inflammatory responses at the phenotypic level following pre-conditioning of a
contra-lateral segment. A logical working hypothesis would be that this pre¬
conditioning would result in attenuation of the response to LPS, and may induce a
form of endotoxin tolerance similar to that seen in vitro following both pro- and anti¬
inflammatory stimulus.
//*
In conclusion, the assessment of cytokine gene expression profiles described has
shown, for the first time that the lung responds in a whole organ manner to localised
LPS-induced inflammation. Further it has shown that the lung promotes an anti¬
inflammatory reaction remote from the focus of inflammation, which significantly
expands upon the available body of knowledge as concerns the inflammatory
response to bacterial infection in the lung.
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Chapter 5 Gene discovery and microarray production
Aims and Objectives
• To assemble an array of cDNA elements comprising those ovine genes that are
preferentially expressed in the lungs and a selection ofmore widely expressed
highly homologous bovine genes.
• To fabricate a microarray of these elements capable of profding the expression
of gene transcripts expressed in bronchial epithelial cells in response to LPS
instillation in the ovine lung.
Introduction
With the objective of characterising the molecular response of the ovine lung to an
inflammatory stimulus and no a priori assumption as to the characteristics of that
response it was assumed that the novel cDNA microarray should ideally be capable of
analysing gene expression from as wide a pool of genes as possible. Indeed the
elements on the array should represent commonly expressed and highly abundant
gene products as well as lung specific, differentially expressed and rare transcripts.
In order to generate a set of elements representing the high abundance and more
commonly found gene products, an approach involving the use of bovine clones was
devised. Known and characterised ovine sequences from the NCBI database were
used to query the collected sequences from an available bovine genomic library, with
clones showing suitably high homology with ovine sequences then being used to
represent those ovine products on a microarray.
In order to discover elements representing lung specific transcripts, including those
expressed at low levels, a subtractive suppressive hybridisation (SSH) library
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technique was employed. The SSH technique involved subtracting pooled mRNA
from heart, brain, liver, kidney and skeletal muscle tissues from lung-derived mRNA
and then normalising the abundance of the sequences in the subtracted population to
enrich for rare transcripts. The two populations of clones (SSH and bovine) were then
printed onto prepared glass slides and these microarrays were used to probe the
differential expression pattern between bronchial brushing RNA samples in the
directly challenged and contra lateral lung segments. These hybridisations were also
analysed to assess both the functionality of the array and the success of the SSH
experiment.
Results
Identification of ovine homologs to bovine clones.
The BLAST searches of ovine genes against the MARC bovine library clone set
yielded a total of 4,952 clones with a greater than 70% homology with their respective
ovine sequences. There was considerable redundancy within these clones, with a total
of 524 unique ovine sequences represented (mean 9.5 times redundancy). Clones
showing significant overlap within each sequence were assessed and those showing
greater overall homology retained for inclusion. The final list of clones selected for
inclusion comprised 1,694 clones (mean 3.2 fold redundancy). The mean homology in
this set was 90.75% (S.D. 7%). The lists of all homologs identified and the final
clones used in the array are detailed in appendix III.
Suppressive subtractive hybridisation library
Subtraction
2 pg mRNA was purified from pooled tissue samples of lung, heart, brain, liver,
kidney and skeletal muscle from six adult sheep, this quantity was derived from large
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samples of total RNA and diluted to generate a representative mRNA sample
conforming to the quantity required by the SSH experimental process. The RNA was
reverse transcribed to cDNA and digested with Rsa 1 resulting in smaller fragments as
shown in Figure 5.1a. Following Rsa I digestion the cDNA was ligated to adaptors 1
and 2R the results of which are shown in a gel image in Figure 5.1b.
The adaptor-ligated sequences were hybridised twice and then underwent two rounds
of nested PCR. After each round of PCR the population of cDNA was size selected
for sequences greater than 200bp length. Figure 5.1c-d shows the results of these PCR
rounds. It can be seen that the subtracted lanes contain lower molecular weight bands
than in the unsubtracted lanes. The second round of PCR also accentuated the bands
standing out from the general smear. The control lanes clearly show that human
skeletal muscle control samples have also been subtracted as intended indicating the
success of the process.
Cloning
The pool of subtracted cDNA was cloned into pCRU vector using the TOPO TA
cloning kit, and then transformed into TOPI OF E. co/i bacteria. These were grown
overnight on Kanamycin LB agar plates and in LB broth with kanamycin. Table 5.1
lists the numbers of clones counted at the various dilutions of sample. The cloning
appeared to be initially successful and the confluent liquid cultures of bacteria were
then serially diluted and grown on LB Kan' plates, the results of this are shown in
table 5.2. From these counts a titre of 1.66 x 106 c.f.u. / pi was obtained. An aliquot of
this library was sent to ARK genomics for colony picking and sequencing.
In addition to the aliquot sent for sequencing, an initial screen was performed on 40 of
the clones obtained from the initial growth of the library. This screen involved picking
II s
Table 5.1: Details ofthe numbers ofwhite (positivej and blue (negative) clones
appearing on the agar plates after the cloned SSH library was spread at various
concentrations. Positive controls were a previously assessedplasmid transformed into
the same bacteria and using the same method asfor the experimental SSH clones.
Negative controls were reactions using empty plasmid. The plates used contained
IPTG allowing blue /white screening to differentiate between clones carrying insert-
bearing plasmids (white) and those not (blue). Control reactions resulted in the
expectedpercentages ofpositive clones. The SSH reaction had a higher proportion of
negative (blue) clones than had been expected according to the manufacturer's
claims, and this was initially considered to be due to a lower efficiency caused by the
use ofa mixedDNA population in the cloning reaction. Subsequent screening
indicated that a number ofblue clones in fact contained inserts and this therefore
impliedfailure of the blue / white screen in this experiment. Samples labelled * were
extrapolatedfrom counts ofquarter sections of the plate.
Sample White colonies Blue colonies Positive %
Control - (lOOpl) 5 60 8
Control - (50jnl) 0 54 -
Control + (l OOjnl) 500* 50 91
Control + (50/j.I) 300* 24 93
SSH (lOOpl) 280 140 67
SSH (50p.l) 73 61 55
SSH (25jLrl) 40 26 61
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Table 5.2: Details ofwhite (positive) and blue (negative) clones appearing on the
agar plates after 100 pi ofeach serially diluted concentration ofcells from the cloned
SSH library was spread. Negative controls were reactions using untransformed
bacteria. The plates used contained IPTG allowing blue /white screening to
differentiate between clones cartying insert-bearing plasmids (white due to disruption
ofX-gal gene) and those not (blue due to hydrolysis ofIPTG to blue dye). Control
reactions resulted in a higher than expectedpercentage ofpositive clones. The SSH
reaction had a slightly higher proportion ofnegative (blue) clones than had been
expectedfrom the manufacturer's claims, and this was initially considered to be due
to a lower efficiency caused by the use ofa mixed DNA population in the cloning
reaction. Subsequent screening indicated that a number ofblue clones in fact
contained inserts and this impliedfailure of the blue / white screen in this experiment.
Sampled labelled * were extrapolated from counts ofquarter sections of the plate.
The sample labelled ** was uncountable as the clones present were so numerous as to
form a continuous lawn.
Dilution White colonies Blue colonies Positive %
1 / 1 x 1010 0 2 0
1 /1 x 108 4 6 40
1 / 1 x 106 53 30 64
1 / 1 x 104 300* 200* 60
1 / 1 x 102 ** ** **
Control (0 cells) 22 131 14
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Figure 5.1.A.: Gel electrophoresis
analysis of the Rsal digestion stage
ofthe SSHprocedure. From left to
right - Lanes:
1: Molecular weight marker(MWM).
2: Undigested driver (pooled organs).
3: Digested driver (pooled organs).
4: Undigested tester (lung).
5: Undigested tester (lung).
6: Digested control (human muscle).
7: Undigested control (human muscle).
Figure 5.1.B.: Gel analysis of the
adaptor ligation step of the SSH
procedure. From left to right -
Lanes: 2: MWM.
3-6: GAPDH driver assessment, (human
GAPDHprimers, pooled sheep organs)
7-10: GAPDH tester assessment (human
GAPDHprimers, sheep lung).
11-14: GAPDH control assessment
(human GAPDHprimershuman muscle).
Figure 5.I.C.: Gel analysis ofthe
first PCR subtraction stage ofthe
SSHprocedure. From left to right -
Lane 1: MWM.
2: Unsubtractedforward (total sheep lung)
3: Subtractedforward (pooledfrom lung)
4: Unsubtracted reverse (totalpooled)
5: Subtracted tester (lungfrom pooled)
6: Unsubtracted control (human muscle)
7: Subtracted control (subtracted muscle)
8: Positive control (subtracted muscle)
Figure 5.I.D.: Gel analysis of the
second PCR subtraction stage of
the SSHprocedure. From left to
right - Lane 1: MWM.
2: Unsubtractedforward (total sheep lung)
3: Subtractedforward (pooledfrom lung)
4: Unsubtracted reverse (totalpooled)
5: Subtracted tester (lungfrom pooled)
6: Unsubtracted control (human muscle)
7: Subtracted control (subtractedmuscle)
8: Positive control (subtracted muscle)
Figure 5.1: Fig A shows the change in size between the digested and undigested
samples, demonstrating successful digestion. This was true across the samples,
though the concentration difference between samples rendered visualisation ofall
samples simultaneously impossible. Fig B shows the amplification ofa
housekeeping gene in each samplefollowing adaptor ligation. The primers used
were human, resulting in poorer amplification from the ovine samples. Figs C and
D are the analyses of the subtraction hybridisations. The clearer bands in the
subtracted samples indicate the successful elimination ofcommon fragments.
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Figure 5.2i: Gel electrophoresis
analysis ofthe PCR products
derivedfrom the screening ofSSH
clones. Lanes from left to right.
1+14: molecular weight markers;
2: plasmid only negative control; 3:
previously screenedpositive control
colony; 4: colonyfrom negative






Figure 5.2U: This is an image ofgel
electrophoresis analysis of the PCR
products derivedfrom the
screening ofSSH clones. Lanes
from left to right. 1 + 14: molecular
weight markers; 2: plasmid only
negative control; 3: previously
screenedpositive control colony; 4:
colonyfrom negative control plate;
5-13: white SSH colonies.
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Figure 5.2iii: This is an image of
gel electrophoresis analysis ofthe
PCR products derivedfrom the
screening ofSSH clones. Lanes
from left to right. 1+14: molecular
weight markers; 2: plasmid only
negative control; 3: previously
screenedpositive control colony; 4:
colonyfrom negative control plate;
5-13: white SSH colonies.
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Figure 5.2iv: This is an image of
gel electrophoresis analysis of the
PCR products derivedfrom the
screening ofSSH clones. Lanes
from left to right. 1 +8: molecular
weight markers; 2: plasmid only
negative control; 3: colonyfrom
negative control plate; 4-7: blue
SSH colonies.
Figure 5.2: The PCR screening ofthe colonies grown from the SSH library
cloning procedure established that the overall SSHprocess was a success. The
screened white colonies displayed a variety ofproduct sizes demonstrating
insertion ofmultiplefragments ofdifferent sizes. This resulted in a cloned library
representing many varied sequences in the plasmids. Control samples amplified
successfully, though more weakly than experimental ones. Blue colonies were also
shown to contain inserts (Figure 5.2.iv), implying underestimation ofthe positive
clone numbers.
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clones directly into a PCR mix using the sequencing primers corresponding to the
appropriate part of the cloning vector. The results were run on agarose gels, which are
shown in Figure 5.2. This initial screen indicated that approximately 80% of the white
colonies obtained were positive for inserts with approximately 33% variation in size
between the positive clones. It also indicated that around 20% of the blue colonies
were false negatives.
Sequencing
The library sent to ARK was plated onto multi-well bio-plates and the clones that
were grown were picked to select white colonies. These were then subjected to a
preliminary screen in order to select clones with a genuine insert. 238 of the positive
clones from the initial screen were sequenced using an ABI robotic scanner and the
results returned for analysis. The sequences were trimmed to remove vector sequences
flanking the insert, and the trimmed sequences assembled into the contig groups
shown in Table 5.3.
These groups were clusters of similar sequences, with an 80% minimum homology
threshold for inclusion, from which a consensus sequence was derived for each group.
As the majority of the contig groups contained only a single sequence or pair of
similar sequences it is likely that the number of sequences obtained has not identified
each of the individual sequences present within the population and that there are
therefore likely to be a number of additional sequences within the library yet to be
discovered. The 100 consensus sequences were assessed for any remaining vector
contamination and then run through an initial BLAST search against the NCBI EST
database.
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Table 5.3: Representative SSH sequences aligned into contig groups along with the
length ofthe consensus sequence derivedfrom each contig alignment. 234 sequences
were aligned in total in two batches. Thefirst batch (table 5.3.A) yielded 25 contig
groups from 96 original sequences, representing approximately 3.8-fold redundancy.
The second batch (table 5.3.B), selectedfrom significantly regulated sequences
identifiedfrom microarray analysis, yielded 75 contig alignments from 138 original
sequences, representing approximately 1.8-fold redundancy. The different amounts of
overlap in the two batches was probably due to the selection ofvariably expressed
sequences from the array data. Overall the redundancy within the evaluate SSH
library sequences was 2.34-fold. The lengths ofconsensus sequences are consistent
with those seen in publicly available EST libraries produced by various methods.
Table 5.3.A: First batch ofSSH contig alignment groups.



























Table 5.3.B: Second batch ofSSH contig alisnment groups.















































































Table 5.4: Homologsfound corresponding to each consensus sequence from batch I
(table 5.4.A) and batch 2 (table 5.4.B) representing the contig group listed. For each
sequence a general database search both against the NCBI database and the TIGR
cluster database was conducted in order to attempt a tentative identification of the
gene from which the sequence originally came. Clones which did not show homology
after this were translated to protein sequences and an identification attempted on that
basis. Those that could not be identified were labelled as unknown.
Table 5.4.A: First batch ofSSH contig alignment groups.
Contig EST hit Description Tentative ID
1 AW427705 64054 MARC 3BOV Bos taurus
cDNA 5'
Unknown
2 CB421002 593997 MARC 6BOV Bos taurus
cDNA 5'
Unknown
3 AW427705 64054 MARC 3BOV Bos taurus
cDNA 5'
Unknown
4 BI775330 467760 MARC 2BOV Bos taurus
cDNA 5'
Sorbin
5 CB419863 592757 MARC 6BOV Bos taurus
cDNA 3'
Gonadal PISRT1
6 CF117165 Fp290.z2 fp 73-75d foetal sheep
skin library Ovis aries cDNA
Ribosomal protein L23a
7 AW659822 97634 MARC 1BOV Bos taurus
cDNA 5'
Ribosomal protein












11 BM446397 11L7C3.ab1 Bos taurus Ileum #1 Ubiquinol-cytochrome c
m
library Bos taurus cDNA reductase binding protein










14 CB465370 726643 MARC 6BOV Bos taurus
cDNA 5'
Ubiquitin




16 None None Unknown
17 CB444746 695948 MARC 6BOV Bos taurus
cDNA 3'
Lactogen precursor (PL)







20 CB539079 777237 MARC 6BOV Bos taurus
cDNA 3'
Unknown protein
21 CB533000 757497 MARC 6BOV Bos taurus Elongation factor 1-alpha
1
cDNA 5'
22 CB421980 595044 MARC 6BOV Bos taurus
cDNA 3'
Unknown
23 CB226128 1RT28G05 Bos taurus Reticulum
#1 library Bos taurus cDNA
Restin
24 None None Unknown




Table 5.4.B: Second batch ofSSH contig alignment groups.
Contig EST hit Description Tentative ID
1 64054
MARC








































10 None None Unknown
11 467760
MARC










Brown rat DNA sequence from













Cattle homologue to RAD23B
protein
RAD23B protein





Bos taurus thymosin beta-10 Thymosin beta-10













22 None None Unknown
23 None Ovis aries chromosome X
centromeric satellite I DNA
sequence
centromeric satellite I






























31 1 RT28G0 Homo sapiens restin Restin
32 1 I15.abd
POE14J
Ovis aries beta-2 microglobulin Beta-2-microglobulin













Ovis aries ribosomal protein
S25 mRNA
Ribosomal protein S25
38 CR550390 Bos taurus cell division cycle
10 (CDC 10)
Cell division










































50 None None Unknown
51 PIR|I3735 Epithelial microtubule- Epithelial microtubule-
Ill
6|I37356 associated associated
52 W427705 >cattle AW427705 Unknown








55 None None Unknown
56 None None Unknown
















Ovis aries cytochrome c-








63 None None Unknown
64 fs485.zl
fs 103-





Homo sapiens cytochrome b-
245, beta polypeptide
Cytochrome b-245








Homo sapiens CD24 CD24
69 Oa splbn
07J07_M1
Ovis aries ferritin heavy-chain Ferritin
70 SP P0125
3 TYB4
Thymosin beta-4 (FX) Thymosin beta-4
im-
71 None None Unknown
72 961522
MARC
Homo sapiens solute carrier
family 39 (zinc transporter),
Solute Carrier
73 OB 142 Bos taurus thymosin beta 4 Thymosin beta-4
74 11 Jll.ab
d POE14









Table 5.4 lists the search results for each contig group. For each sequence a
general database search both against the NCBI database and the TIGR cluster
database was conducted in order to attempt to make a tentative identification of
the gene from which the sequence originally came. These suggested identities
are also listed in Table 5.4.
Microarray quality control
A list of all elements present on the microarray, and the information pertinent to each
is presented in Appendix II, table 1. The red and green dyes showed no significant
variability between them as assessed by the internal quality control used by the
microarray analysis software. The red vs. green dye swaps are plotted against each
other in Figure 5.3. In this figure the averaged and normalized values of each array
element are plotted on each axis with the result of the replicate slide in which baseline
cDNA was labelled with Cy3 (and experimental, post-LPS cDNA with Cy5) on the y
axis (green/red) and the replicate in which the samples were labelled the other way
around plotted on the x axis (red/green). The result is a figure illustrating the bias
across each slide resulting from differential fluorescence readings due to dye type
used. If no dye bias is present there will be no overall trend in the plotted points - and
this is the case in figure 5.3 indicating that there was no dye bias inherent in the array
results.
No slides showed significant within-slide variability was seen when assessed by the
analysis software. Bovine and SSH clones were printed at random on the microarray
in order to avoid any potential systematic bias across the slides. The analysis software
used was able to sort the expression data based on which group of clones each
element was derived from (bovine or SSH). This analysis found that bovine spots and
SSH clones showed no significant differences in their tendency to hybridise
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effectively. There were no systematic patterns of variable expression between SSH
and bovine clones - i.e. as many showed up as down regulation from each group, and
as many bovine as SSH clones were significantly changed in either segment.
Location of spot on the microarray slides appeared to play no part in expression level
by visual inspection. Examples of hybridised arrays are shown in figure 5.4.
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Figure5.3:Scatterplotofeach arrayelement'snor alised fluorescencevaluemeas r d whenthintercalatingdyes (Cy3=green,5=r d)we exchangedinachsampl . Eachpointothegraph representsanelem toth arraywithllofthedata obtainedf rth telementin eachofthewodyswap arrangementsplottedgainst theoth r.T isgraphthe efore representsallofthd ta collectedfromallfthrray hybridisations,andi indicationofanysystematic biastowardsnedyeh otheracrossthexperiment. Redpoints:significantlyaltered inthedirects gment,blu points:remoteandurple: both.Greyspotsdidn th w anysignificantv riatiointhe standardanalysis.Thepoint areclusteredrounthent al pointasexpected,ndthereis noevidenceofdye-basedbia .
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Figure 5.4.A: Scanned image of the
ovine lung microarrayfollowing
hybridisation to cDNA sample
labelled with Cy3 dye. Each spot is
clear and all but a very small
proportion show uniform
morphology. There is no evidence
ofsystematic spatial bias in
hybridisation efficiency across the
slide. Visual inspection reveals no
evidence ofsmeared elements, or
extrinsic interferencefrom
contaminants. The Cy3
hybridisation gave similar results
to the Cy5 hybridisation in terms of
pattern offluorescence and quality
of image. Overall the array
hybridised successfully and
consistently, and was of
appropriate qualityfor data
acquisition
Figure 5.4.B: Scanned image ofthe
ovine lung microarray following
hybridisation to cDNA sample
labelled with Cy5 dye. Each spot is
clear and has uniform morphology.
There is no evidence ofsystematic
spatial bias in hybridisation
efficiency across the slide. Visual
inspection reveals no evidence of
smeared elements, extrinsic
interferencefrom contaminants.
The Cy5 hybridisation gave similar
results to the Cy3 hybridisation in
terms ofpattern offluorescence and
quality of image. The image
intensity overall is marginally
higher than in the Cy3 array,
though this would be corrected
during the normalisation process.
Discussion
Identification of ovine homologs to bovine clones.
The MARC genomic cattle library had a considerable number of highly homologous
clones with the ovine genome, as expected from such closely related species. Due to
the bias inherent in the known and characterised ovine gene sequences there were
disproportionate numbers of homologous clones representing MHC genes,
housekeeping genes, immunoglobin genes and inflammatory mediator genes. These
categories are over-represented due to the prevalence of immunology-based research
in the sheep and as a result the set used on the microarray is suited to immune-
inflammatory research purposes such as the investigation of LPS-induced
inflammation.
The large set of housekeeping genes present within the bovine clones are also of
functional importance in terms of the data analysis arising from the microarray
investigation as they provide an alternate route to normalisation other than global
strategies. The clones found using this technique represent commonly expressed and
highly abundant mRNA species which complement the SSH strategy and allow for a
robust and representative microarray to be constructed.
Suppressive subtractive hybridisation library
The subtractive suppression library technique has proved in the past to be an
appropriate method of gene discovery in a specific and sensitive manner. The results
from this experiment have shown that the technique is also applicable to the ovine
lung, as it has isolated a number of sequences that are as yet unidentified within the
sheep genome. Of the 238 sequences analysed, ten were discarded due to the
sequence being empty, and a further two were eliminated as they represented stretches
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of cloning vector only, this left 226 fully representative transcript sequences which
fell naturally into 101 contig assemblies. Two of these contigs were identical
complements of each other and can therefore be considered as one group leaving 100
unique transcript sequences, thus within the 238 clones there is approximately 2.4-
fold redundancy.
A number of the sequences analysed showed homology with known sheep genes, with
greater then 70% of the remainder showing strong homology with clones derived
from other ovine or bovine EST libraries. Approximately 25% of the sequences
analysed showed no homology with any EST or annotated gene sequences - and this
could be due to a number of factors. It is possible that these sequences represent
"junk" DNA unrepresentative of any real expressed transcript or are a result of some
other artefact of the experimental process. The other possibility is that these
sequences are ovine specific and have thus not been detected in other species
(particularly bovine) library project, or that they are highly lung specific and
expressed at low level, and again never been detected previously.
The majority of the analysed sequences showed strong homologies with known
bovine EST sequences, mostly from the large scale MARC library bovine genome
sequencing project and this is a strong indication that they are "genuine" transcripts
representing - for the main part - uncharacterised gene products in the sheep. The
majority of the contig groups from the sequenced products contained one or two
sequences, indicating that the selection was still far from saturated and that there are
thus a number more sequences to be found.
1,200 SSH clones were PCR amplified and the products used in the manufacture of a
novel microarray. Were the percentage coverage within the SSH clones to remain
constant over this number of inserts it would be expected that they would represent
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between 400 and 500 unique transcripts. Even if this number is not achieved it seems
highly probable that fifty or more novel ovine ESTs will be represented. There are
currently approximately 4000 ovine sequences in the NCB1 gene database, so this
library represents anywhere from five to ten percent of the known ovine genome and
is therefore a significant resource in terms of gene discovery. Further characterisation
of the sequences obtained by this method also represents a new avenue into the
continued investigation of both the ovine transcriptome and the molecular nature of
the ovine lung.
Microarray Performance
The new array performed well overall as the images acquired looked clean, lacking
significant background interference and resolving clear, uniform spotted elements.
There appeared to be little if any smearing of the spotted cDNA and the grids were
uniformly distributed and positioned as intended - indicating that the mechanical
printing was a success. The quantified results appeared to be due to biological change
and not systematic bias within array as the red/green balance was even, and there was
no discernable spatial bias across any of the slides. The cDNA spots showed equal
effectiveness as probes when derived from either the bovine library clones or the
subtracted suppressed hybridisation generated library clones.
Overall the global normalisation approach used assigned the majority of housekeeping
and other elements that would not be expected to change to the 1-fold unchanged
region, and did not find them to be significantly altered. However actin, often used as
a housekeeping gene, was found to be significantly down regulated along with a
number of related cell structure genes, including actin binding and regulating
elements. This change is consistent with findings by previous studies (Glare et al.
2002) that suggest alterations in beta-actin during lung disease and challenge and
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which call into serious question the use of beta-actin as a reference or housekeeping
gene in the lung. These data indicate that the array worked as expected and strongly
suggest that the overall biological results from this platform are viable and genuine.
Meta-analysis of the results obtained from the array show that approximately 5% of
the elements present changed significantly in the directly challenged segment. This
figure is lower than has been reported in previous comparable studies, however this
was likely to be due to the nature of the statistical tests and low biological number of
replicates (n=5) which make statistical significance less likely. Similarly there were
approximately 5% of the elements altered significantly in the contra-lateral remote
segment - this result may be more as expected due to the subtlety of the remote
response, consequent to which the numbers of affected genes would perhaps be
expected to be lower than in a grossly affected tissue population.
Conclusions
The combination of SSH library construction and BLAST identification of
homologous genes is a rapid and efficient means of gene discovery of direct
application to the generation of a novel microarray. The gene sequences thus
discovered cover those products expressed at high levels and commonly throughout
the sheep, as well as rare transcripts specific to or differentially expressed in the ovine
lung. The microarray thus produced is therefore suited to a wide range of investigative
areas within ovine pulmonary biology and represents a considerable resource in that
regard.
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Chapter 6 Microarray analysis
Aims and objectives
• To determine the nature and extent of contra lateral remote lung responses
following local lung instillation of LPS
• To compare and contrast such responses to those occurring in response to
direct challenge with LPS
Introduction
The inflammatory and immune response of the lung to LPS has been shown to be
multi-faceted with the characterised aspects of the response involving large numbers
of disparate genes, gene products and pathways (Prince et al. 2001; Yamanaka et al.
2001; Moore & Standiford 1998). It is probable that such characterised elements
represent a fraction of the total change in gene expression involved in such a
response. Indeed the diversity of genes involved in response to LPS has been
previously highlighted in the context of murine lung in a whole lung in vivo study
(Katsuma et al. 2001) and human neutrophils (Malcolm et al. 2003), endothelial cells
(Zhao et al. 2001) and epithelial cells (Yamanaka et al. 2001; Ichikawa et al. 2000).
To emphasise the extent of this the study by Malcolm et al demonstrated significant
regulation of cytoskeletal genes and genes involved with cell cycle control. These
genes are not considered a usual part of the innate inflammatory response. These
studies have shown that the response to LPS is not confined to genes conventionally
held to be a part of the inflammatory or immune cascades. The contention held here is
that such diversity will also be reflected in the ovine lung response to LPS.
The power of the microarray as a molecular analysis platform is its ability to
simultaneously and quantitatively determine the expression levels of many genes in a
given RNA population (Duggan et al. 1999). This has been likened to providing a
'snapshot' of the transcriptional activity within the sample (Francois et al. 2003;
Neumann & Galvez 2002). Microarrays may therefore indicate the nature and extent
of genetic networks and offer particular advantage over more conventional molecular
techniques such as PCR or in situ hybridisation in providing insight into the overall
complexity of gene expression responses. These qualities render microarrays suitable
for detecting subtle changes in transcription between closely related samples in a
quantitative and robust manner. The assertion here is that a microarray platform is
ideally suited to detecting the nature and extent of hypothesised changes in gene
expression in ovine lung segments remote to the site of local LPS challenge.
An expanding literature base surrounds the use of microarray technology in defining
and dissecting lung responses. Indeed previous studies in the lung have investigated
changes in a number of cell and tissue types including neutrophils (Malcolm et al.
2003), endothelial cells (Zhao et al. 2001; Neilsen, Zimmerman, & Mclntyre 2001)
and epithelial cells (Ichikawa et al. 2000) in vitro, as well as whole lung, endothelium
and epithelial brushings in vivo in samples derived from mice (Katsuma et al. 2001)
rats (Wiethoff et al. 2003; Liu et al. 2003; Floshikawa et al. 2003) and
humans(Wolfgang et al. 2004; Laprise et al. 2004)..
One significant caveat in relation to the interpretation and implied value of microarray
data concerns the analysis of often very large data sets. As outlined by Stark et al
2003 devising methods that can extract useful information about biological function
from the vast amounts of data being generated by such technologies is a major
challenge. Conclusions drawn on the basis of current techniques are largely
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descriptive, without necessarily leading to deeper insights about how gene
interactions control cellular function. It is with this limitation in mind that the
objectives of the present chapter have been defined.
Results
Remote segment gene expression
Examples of the scanned microarrays in false colour images are shown in figure 6.1.
Figures 6.1a (Cy3) and b (Cy5) show arrays from the remote lung segments and 6.1c
(Cy3) and d (Cy5) from the directly challenged segments. The remaining images are
shown in Appendix III along with all raw data in Appendix IV. Figure 6.1.B shows an
example array slide in which the overall fluorescence intensity is higher on the left
than the right, probably due to a slight inaccuracy in the positioning f the slide in the
loading cartridge. This type of systematic bias across an array slide is accounted for
during the data capture and analysis processes. During data capture the image is
analysed in terms of each array spot individually, with total fluorescence information
for the spot, its immediate neighbours, its immediate block and the overall
fluorescence intensity of the array. Each spot is then normalized within and without
its near-neighbour spots and blocks, resulting in a spot value that is corrected for the
systematic bias across the slide as well as any local deviant areas or localised
artefactual anomalies.
The normalized results from the microarray analysis of gene expression in the remote
segment indicated a number of significantly regulated genes following LPS exposure.
The results of the overall changes in the remote segment are shown as a scatter
diagram in figure 6.2. The points plotted in figure 6.2 are coloured by significance of
expression change with increasing red colour intensity indicating more significant up
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regulation of the element and increasing green colour intensity indicating more
significant down regulation of the element. The majority of the array elements were
found to be at or around the 1-fold mark indicating no change from baseline following
LPS challenge. Overall there were fewer elements that were up than down regulated.
A number of control elements were included in the array design. These broadly
comprised three distinct subgroups - housekeeping gene controls, negative control
genes and negative spot controls. Negative control spots comprised spotted SSC (i.e. a
totally non-DNA spot). These spots allowed for assessment and control of non-DNA
binding to the slide substrate itself, and as such comprised the 'absolute baseline'
control. The analysis software used integrally analysed fluorescence from these spots
and adjusted all subsequently analysed spots based on the data acquired from them.
Negative control genes comprised genetic sequences from non-mammalian species
(i.e. plant, bacterial and synthetic 'nonsense' sequences) and controlled for non¬
specific DNA-DNA binding. These control sequences were analysed prior to printing
to ensure no sequence homology was found with any experimental genes, they
therefore provided a means of subtracting the non-specific binding on the array due to
DNA-DNA interactions that did not depend on homology for their strength. The
housekeeping gene controls used were those previously published as maintenance
genes or those often used in experimental settings. Those used included ATPase, (3-
actin and GAPDH. None of these showed significant deviation from baseline.
Figure 6. l.A: Scanned image ofthe
ovine lung microarrayfollowing
hybridisation to a cDNA sample
taken from the contra lateral lung
segment at baseline labelled with
Cy3 dye. Each spot is clear and all
but a very smallproportion show
uniform morphology. There is no
evidence ofsystematic spatial bias
in hybridisation efficiency across
the slide. Visual inspection reveals
no evidence ofsmeared elements or
extrinsic interferencefrom
contaminants. This sample is taken
from the same sheep as the image
from the Cy5 sample alongside.
Figure 6.1.B: Scanned image ofthe
ovine lung microarrayfollowing
hybridisation to a cDNA sample
taken from the contra lateral lung
segment at 6 hours post-LPS
labelled with Cy5 dye. Each spot is
clear and has all but a very small
proportion show uniform
morphology. There is some
evidence ofsystematic low
fluorescence bias in along the right
hand side of the slide. There is no
evidence ofsmeared elements or
extrinsic in terference from
contaminants.
Figure 6.1.C: Scanned image ofthe
ovine lung microarrayfollowing
hybridisation to a cDNA sample
taken from challenged lung
segment at baseline labelled with
Cy3 dye. Each spot is clear and has
all but a very small proportion
show uniform morphology. There is
no evidence ofsystematic spatial
bias in hybridisation efficiency
across the slide. Visual inspection
reveals no evidence ofsmeared
elements or extrinsic interference
from contaminants. This sample is
taken from the same sheep as the
image from the Cy5 sample
alongside.
Figure 6.1.D: Scanned image of the
ovine lung microarrayfollowing
hybridisation to a cDNA sample
taken from the challenged lung
segment at 6 hours post-LPS
labelled with Cy5 dye. Each spot is
clear and has all but a very small
proportion show uniform
morphology. There is some
evidence ofsystematic low
fluorescence bias in along the right
hand side ofthe slide. There is no
evidence ofsmeared elements or
extrinsic interference from
contaminants.
In order to assess the numbers of elements which showed significant changes in
expression in the remote segment genes were filtered to show those which passed a
student t-test with a score at p<0.05 (n=8) after a false positive reporting correction.
These data are illustrated in the scatter graph shown in figure 6.3. 170 elements were
found to have changed significantly. False positive correction was applied in order to
account for the relatively high number of chance positives acquired even at a 95%
significance level due to the high sample number. Prior to correction 382 elements
were found to have changed significantly.
One element showed greater than 2-fold significant up regulation and was assigned to
the 'high up' category (table 6.1). Fifteen elements showed greater than 2-fold
significant down regulation and were assigned to the 'high down' category (table 6.2).
Fifty-five elements showed between I and 2-fold significant up regulation and were
assigned to the 'low up' category (table 6.3). Ninety-nine elements showed between 1
and 2-fold significant down regulation and were assigned to the 'low down' category
(table 6.4).
Where possible each element showing significant regulation was assigned to a
predicted functional classification. The number of elements in each predicted
functional classification and expression category (high/low, up/down) are displayed as
a 3D bar chart in figure 6.4.
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Table 6.1: Details ofthe gene that was classified as highly (>2 fold) up regulated in
the remote segment at 6 hours post-LPS treatment. Thefold change represents the
mean value ofthe normalised fluorescence intensities ofthe labelled cDNA samples
derivedfrom the RNA taken from the post-LPS instillation (6 hours) brushed
epithelial cells divided by the normalisedfluorescence intensities of the labelled
cDNA samples derivedfrom the RNA takenfrom the baseline (0 hours) brushed
epithelial cells from the sheep analysed (n=8). Functional classification was based on
homology analysis ofthe probe sequence combined with literature searches.
Gene name Fold change Function
Em4b 2.152 Immune/Inflammatory
Table 6.2: Details ofthe genes that were classified as highly (<0.5 fold) down
regulated in the remote segment at 6 hours post-LPS treatment. The derivation of the
fold change and assignedfunctional classification was as described in Table 6.1.




Cell division 0.484 Cell cycle
Thymosin beta-10 0.392 Cell structure
Filensin 0.493 Cell structure
Centromeric satellite I 0.457 Centromere
Surfactant protein C 0.48 Membrane
Immunoglobulin mu heavy chain variable region 0.496 Membrane
Cytochrome b (Swissprot) 0.475 Metabolic
Cytochrome b (Swissprot) 0.479 Metabolic
Alpha-Si-casein 0.477 Milk
Ribosomal protein S27a 0.481 Ribosomal
Unidentified SSH clone insert 0.462 Unidentified
Unidentified SSH clone insert 0.473 Unidentified
Phospho-tyrosine 0.454 Transcription
Factor
RAD23B protein 0.467 Unknown
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Table 6.3: Details of the genes that were classified as showing low (<2fold) up
regulation in the remote segment at 6 hours post-LPS treatment. The derivation ofthe
fold change and assignedfunctional classification was as described in Table 6.1.
Gene name Fold change Function
Bcl2-associated protein Bax Bax 1.496 Cell cycle
Cathepsin D CTSD 1.585 Cell cycle
Hyal2 protein Hyal2 1.39 Cell structure
Growth hormone 1.616 Growth hormone
Growth hormone 1.647 Growth hormone
Complement component C3 C 1.433 Immune/Inflammatory
Prostaglandin endoperoxidase 1.872 Immune/Inflammatory
Interferon-gamma-inducible protein-10 1.923 Immune/Inflammatory
Kunitz domain protein 1.818 Kunitz
MHC class I protein 1.271 Membrane
Immunoglobulin mu heavy chain variable
region
1.413 Membrane
MHC class I protein 1.444 Membrane
MHC OVAR-DQ-ALPHA1 1.617 Membrane
CD3 gamma subunit 1.749 Membrane
Cystic fibrosis transmembrane conductance
regulator CFTR gene, intron 1
1.8 Membrane
Beta-casein 1.853 Membrane
T-cell receptor beta-chain 1.907 Membrane
Cytochrome c oxidase subunit III 1.262 Metabolic
Cytochrome b 1.357 Metabolic
Lipoprotein lipase 1.459 Metabolic
Muscle-type carnitine palmitoyltransferase I,
CPTIB gene
1.474 Metabolic
Cytochrome c-oxidase subunit three COIII 1.497 Metabolic
/5"?
gene, complete cds and tRNA-Gly
Mitochondrial cytochrome b 1.55 Metabolic
Cytochrome b 1.631 Metabolic
Cytochrome P450 steroid 17alpha-
hydroxylase /17,20 lyase CYP17
1.724 Metabolic










Ribosomal protein 23a 1.191 Ribosomal
Ribosomal protein 23a 1.228 Ribosomal
Ribosomal protein 23a 1.264 Ribosomal
MARC 9438-9439:991426302:1 Sheep
WBCOvis aries STS genomic, sequence
tagged site
1.403 Ribosomal
Ribosomal protein S25 1.438 Ribosomal
BI094681 et3-19 Sheep Lambda Zap II
Library Ovis aries cDNA clone et3-19 5'
1.469 Ribosomal
Ribosomal protein S16 1.503 Ribosomal
Ribosomal protein S25 1.553 Ribosomal
Ribosomal protein 1.579 Ribosomal
AF354168 Ovis aries chromosome 18clone
229G11; 359E3, WORKING DRAFT
SEQUENCE, 30 ordered pieces
1.527 Transcription factor
/Cf
AF354168 Ovis aries chromosome 18clone
229G11; 359E3, WORKING DRAFT
SEQUENCE, 30 ordered pieces
1.634 Transcription factor
Thyroid hormone receptor alpha 1 1.814 Transcription factor
Unidentified SSH clone insert 1.36 Unidentified
Unidentified SSF1 clone insert 1.41 Unidentified
Unidentified SSH clone insert 1.436 Unidentified
Unidentified SSH clone insert 1.498 Unidentified
Unidentified SSH clone insert 1.603 Unidentified




Table 6.4: Details ofthe genes that were classified as showing low (>0.5 fold) down
regulation in the remote segment at 6 hours post-LPS treatment. The derivation of the
fold change and assignedfunctional classification was as described in Table 6.1.




Plastin 3 0.507 Cel structure
Actin-depolymerizing factor 0.509 Cel structure
Beta actin 0.519 Cel structure
Thymosin beta-4 0.526 Cel structure
Thymosin beta-10 0.53 Cel structure
Epithelial microtubule-associated 0.583 Cel structure
Human beta-actin control 0.738 Cel structure
Thymosin beta-4 0.768 Cel structure
Thymosin beta-4 0.776 Cel structure
Thymosin beta-4 0.792 Cel structure
Centromeric satellite I 0.566 Centromere
Centromerically located satellite DNA 0.666 Centromere
Centromerically located satellite DNA 0.714 Centromere




Immunoglobulin mu heavy chain variable
region clone VRA17
0.561 Membrane
Surfactant protein C 0.569 Membrane
Solute Carrier 0.613 Membrane




6-pgdh mRNA for 6-phosphogluconate
dehydrogenase
0.509 Metabolic
Cytochrome b 0.513 Metabolic
Cytochrome b 0.529 Metabolic
Cytochrome b 0.531 Metabolic
Mannose/glucose-binding lectin precursor 0.531 Metabolic
Cytochrome b 0.535 Metabolic
Cytochrome b 0.553 Metabolic
Cytochrome b-245 0.557 Metabolic
Ferritin 0.593 Metabolic
Cytochrome b 0.595 Metabolic
Acetyl-CoA carboxylase alpha, 5' region 0.604 Metabolic
Cytochrome b 0.64 Metabolic
Cytochrome b 0.656 Metabolic
Cytochrome b 0.657 Metabolic
Cytochrome b 0.675 Metabolic
Cytochrome b 0.716 Metabolic
6-pgdh mRNA for 6-phosphogluconate
dehydrogenase
0.751 Metabolic
Cytochrome c oxidase subunit III 0.873 Metabolic







Ribosomal protein S7 0.513 Ribosomal
Ribosomal protein S16 0.52 Ribosomal
Ribosomal protein L35 0.524 Ribosomal
Ribosomal protein S25 0.551 Ribosomal
Ribosomal protein S12 0.563 Ribosomal
Ribosomal protein S27a 0.566 Ribosomal
Ribosomal protein 0.573 Ribosomal
Ribosomal protein S25 0.583 Ribosomal
Ribosomal protein S25 0.617 Ribosomal
Ribosomal protein S12 0.626 Ribosomal
Ribosomal protein S23 0.642 Ribosomal
Ribosomal protein L32 0.651 Ribosomal
Ribosomal protein S16 0.764 Ribosomal
Transcription factor Ets-2 0.539 Transcription factor
Unidentified SSH clone insert 0.501 Unidentified
Unidentified SSH clone insert 0.51 Unidentified
Unidentified SSH clone insert 0.521 Unidentified
Unidentified SSH clone insert 0.522 Unidentified
Unidentified SSH clone insert 0.523 Unidentified
Unidentified SSH clone insert 0.525 Unidentified
Unidentified SSH clone insert 0.529 Unidentified
Unidentified SSH clone insert 0.533 Unidentified
Unidentified SSH clone insert 0.533 Unidentified
Unidentified SSH clone insert 0.538 Unidentified
Unidentified SSH clone insert 0.559 Unidentified
Unidentified SSH clone insert 0.573 Unidentified
/T 5
Unidentified SSH clone insert 0.576 Unidentified
Unidentified SSH clone insert 0.578 Unidentified
Unidentified SSH clone insert 0.579 Unidentified
Unidentified SSH clone insert 0.58 Unidentified
Unidentified SSH clone insert 0.581 Unidentified
Unidentified SSH clone insert 0.582 Unidentified
Unidentified SSH clone insert 0.584 Unidentified
Unidentified SSH clone insert 0.59 Unidentified
Unidentified SSH clone insert 0.597 Unidentified
Unidentified SSH clone insert 0.617 Unidentified
Unidentified SSH clone insert 0.631 Unidentified
Unidentified SSH clone insert 0.645 Unidentified
Unidentified SSH clone insert 0.647 Unidentified
Unidentified SSH clone insert 0.65 Unidentified
Unidentified SSH clone insert 0.659 Unidentified
Unidentified SSH clone insert 0.663 Unidentified
Unidentified SSH clone insert 0.738 Unidentified
Unidentified SSH clone insert 0.764 Unidentified





RAD23B protein 0.608 Unknown
Unknown 0.632 Unknown
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Direct segment gene expression
The normalized results from the microarray analysis of gene expression in the direct
segment indicated a number of significantly regulated genes following LPS exposure.
The results of the overall changes in the direct segment are shown as a scatter diagram
in figure 6.5. As for figure 6.1 the colouring of points reflects the intensity of
expression. The majority of the array elements were found to be at or around the 1-
fold mark indicating no change from baseline following LPS challenge. Overall there
were very similar numbers of elements that were up and down regulated.
In order to assess the numbers of elements which showed significant changes in
expression in the direct segment genes were filtered to show those which passed a
student t-test with a score at p<0.05 (n=5) without false positive reporting correction.
These data are illustrated in the scatter graph shown in figure 6.6. A total of 153
elements were found to have changed significantly.
Two elements showed greater than 2-fold significant up regulation and were assigned
to the 'high up' category (table 6.5). Nine elements showed greater than 2-fold
significant down regulation and were assigned to the 'high down' category (table 6.6).
Seventy elements showed between 1 and 2-fold significant up regulation and were
assigned to the 'low up' category (table 6.7). Seventy-two elements showed between
1 and 2-fold significant down regulation and were assigned to the 'low down'
category (table 6.8).
Each element showing significant regulation was assigned to a functional
classification. The functional classification numbers in each category (high/low,
up/down) are displayed as a 3D bar chart in figure 6.7.
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Figure6.5:Scatterplotofeach microarrayelement's normalisedfluorescence intensityatbas line(xxis)vs. 6hourspost-LPSchallenge(y axis)inthechallengedsegm nt. Bluelines(fromefttright) representapproximately2,I, and0.5-folchange respectively.Eachpointoth graphrepresentsanelem to thearray,ndiscoloured accordingtosignificance,i.e. themoreintens lyredpoint, thehigh rsignificanceofup regulationis,whilstthemore intensethegre ncolour, higherthsignificanceofdow regulationis.Elementsthaare haveweakorinterm diate coloursh wlowevelsf statisticalsignif cance.The numberofsignificantly expressedgenesislow rthann thecontralateralsegment,and thespr adofex ression changesisgreat rwithmor biastowardsupregulation.
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Figure6.6:Scatterplotofth microarrayelements(bas li e
(xaxis)vs.6hourspost-LPS challenge(yaxis))th ts owed significantlyalteredexpression
inthechallengedlungsegment. Bluelines(fromefttight) representapproximately2,1 and0.5-folchange respectively.Eachpointothe graphrepresentsanelem to thearray,withredpo nts representingupgulat d elementsandgre npoints representingdowngulat d ones.Thmajorityft significantlycha gedelements fallbetweenthouterolu lines,indicatingesthan2-fold changeineitherdire tion.T spreadofgeneswithinth rangeisimilartohateenn theremotes gment.Tpoints onthischarts owledown regulatedgenesthanin remotes gment,andli ht biastowardsloexpres ion elements.
Table 6.5: Details ofthe genes that were classified as highly (>2 fold) up regulated in
the directly challenged segment at 6 hours post-LPS treatment. Thefold change
represents the mean value ofthe normalisedfluorescence intensity ofthe labelled
cDNA sample derivedfrom the RNA taken from the post-LPS instillation (6 hours)
brushed epithelial cells divided by the normalisedfluorescence intensity ofthe
labelled cDNA sample derivedfrom the RNA taken from the baseline (0 hours)
brushed epithelial cells from the sheep analysed (n=5). Functional classification was
based on homology analysis of the probe sequence combined with literature searches
and/or protein translation with predictedfunctional analysis.
Gene name Fold change Function
Cytochrome P-450 17-alpha-hydroxylase 2.526 Metabolic
Unidentified SSH clone insert 2.064 Unidentified
Table 6.6: Details ofthe genes that were classified as highly (<0.5 fold) down
regulated in the directly challenged segment at 6 hours post-LPS treatment. The
derivation ofthe fold change and assignedfunctional classification was as described
in Table 6.5.
Gene name Fold change Function
Thymosin beta-10 0.344 Cell Structure
centromeric satellite I 0.46 Centromere
Endothelial nitric oxide synthase 23B 0.491 Immune/Inflammatory
TIMP-l=metalloproteinase tissue inhibitor 0.476 Immune/Inflammatory
Unidentified SSH clone insert 0.498 Unidentified
Unidentified SSH clone insert 0.48 Unidentified
Unidentified SSH clone insert 0.464 Unidentified
RAD23B protein 0.468 Unknown
Phototyrosine 0.41 Unknown
Thymosin beta-10 0.344 Cell Structure
centromeric satellite I 0.46 Centromere
Endothelial nitric oxide synthase 23B 0.491 Immune/Inflammatory
Ik#
Table 6.7: Details of the genes that were classified as weakly (<2 fold) tip regulated
in the directly challenged segment at 6 hours post-LPS treatment. The derivation of
the fold change and assignedfunctional classification was as described in Table 6.5.
Gene name Fold change Function
Smooth muscle myosin light chain kinase 1.706 Cell Structure
Prostaglandin H synthase-2 1.433 COX
Immunoglobulin mu chain secreted form 1.77 Ig
Ig rearranged mu-chain 1.509 Ig
Gamma-globin gene, exon 2 1.507 Ig
Serum albumin 1.581 Immune/Inflammatory
Serum albumin 1.408 Immune/Inflammatory
Fetuin 1.388 Immune/Inflammatory
Complement component C3 1.339 Immune/Inflammatory
Kunitz domain protein 1.734 Kunitz
Beta-casein 1.675 Membrane
Uterine IEL TCR delta 5 1.652 Membrane
CFTR gene, intron 1 1.386 Membrane
Aldehyde dehydrogenase 1.865 Metabolic
Aldehyde dehydrogenase 1.839 Metabolic
Aldehyde dehydrogenase 1.812 Metabolic
Cytochrome P-450 17-alpha-hydroxylase 1.587 Metabolic
Aldehyde dehydrogenase 1.552 Metabolic
Aldehyde dehydrogenase 1.521 Metabolic
Aldehyde dehydrogenase 1.49 Metabolic
Cytochrome P-450 17-alpha-hydroxylase 1.453 Metabolic
Aldehyde dehydrogenase 1.434 Metabolic
MHC class 1 protein 1.971 MHC
JfcS"
MHC OVAR-DQ-ALPHA1 1.721 MHC
MHC OVAR-DQ-ALPHA-2.1 1.692 MHC
MHC class II OVAR-DQB1 1.633 MHC
MHC Ovar-DR-alpha 1.558 MHC
MHC OVAR-DQ-ALPHA-2.1 1.529 MHC
DR beta-chain antigen binding domain 1.478 MHC
MHC Ovar-DRBl 1.385 MHC












prion protein 1.372 Prion
prion protein 1.233 Prion
Cytochrome c-oxidase subunit three COIII 1.53 Respiratory
Unidentified SSH clone insert 1.923 Unidentified
Unidentified SSH clone insert 1.9 Unidentified
Unidentified SSH clone insert 1.881 Unidentified
Unidentified SSH clone insert 1.736 Unidentified
Unidentified SSH clone insert 1.644 Unidentified
Unidentified SSH clone insert 1.631 Unidentified
Ibio
Unidentified SSH clone insert 1.499 Unidentified
Unidentified SSH clone insert 1.489 Unidentified
Unidentified SSH clone insert 1.473 Unidentified
Unidentified SSH clone insert 1.468 Unidentified
Unidentified SSH clone insert 1.436 Unidentified
Unidentified SSH clone insert 1.412 Unidentified
Unidentified SSH clone insert 1.395 Unidentified
Unidentified SSH clone insert 1.381 Unidentified
Unidentified SSH clone insert 1.353 Unidentified
Unidentified SSH clone insert 1.276 Unidentified
Unidentified SSH clone insert 1.234 Unidentified
Unidentified SSH clone insert 1.198 Unidentified
Unidentified SSH clone insert 1.171 Unidentified
Unidentified SSH clone insert 1.155 Unidentified
Unidentified SSH clone insert 1.135 Unidentified
Unidentified SSH clone insert 1.095 Unidentified
Mariner related transposon Hsmarl 1.615 Transposon





Table 6.8: Details ofthe genes that were classified as weakly (>0.5 fold) down
regulated in the directly challenged segment at 6 hours post-LPS treatment. The
derivation of the fold change and assignedfunctional classification was as described
in Table 6.5.
Gene name Fold change Function
Beta actin 0.737 Cell Structure
Actin 0.735 Cell Structure
Beta-actin 0.735 Cell Structure
Activin receptor type IIB 0.559 Cell Structure
centromeric satellite I 0.574 Centromere
Placental lactogen precursor PL, exon 1 0.781 Growth Hormone
Placental lactogen precursor PL, exon 1 0.722 Growth Hormone
Immunoglobulin alpha heavy chain IgA 0.717 Ig
Immunoglobulin mu chain secreted form 0.623 Ig
Immunoglobulin gamma 1 chain secreted
form
0.618 Ig
Ig gamma 2 constant region heavy chain 0.558 Ig
Ferritin heavy-chain 0.786 Immune/Inflammatory
Endothelin receptor A precursor 0.722 Immune/Inflammatory
Ferritin heavy-chain 0.704 Immune/Inflammatory
Skeletal muscle-specific calpain 0.699 Immune/Inflammatory
Intercellular adhesion molecule-1 precursor
ICAM-1
0.69 Immune/Inflammatory
Ferritin heavy-chain 0.672 Immune/Inflammatory
TIMP-l=metalloproteinase tissue inhibitor 0.655 Immune/Inflammatory
Interferon regulatory factor 1 0.632 Immune/1n flammatory
DAP 12 protein 0.629 Immune/Inflammatory
Interleukin 6 0.622 Immune/Inflammatory
Retinol-binding protein 0.596 Immune/Inflammatory
I(J>
Ferritin heavy-chain 0.589 Immune/Inflammatory




Flistone H2A.Z 0.531 Immune/Inflammatory
CFTR gene, intron 1 0.761 Membrane
ATP 7B protein 0.703 Membrane
T-cell receptor beta-chain 0.689 Membrane
Glucose transportertype 3 GLUT-3 0.605 Membrane
Decorin 0.591 Membrane













6-phosphogluconate dehydrogenase 0.68 Respiratory
6-phosphogluconate dehydrogenase 0.633 Respiratory
6-phosphogluconate dehydrogenase 0.517 Respiratory
Unidentified SSH clone insert 0.768 Unidentified
Unidentified SSH clone insert 0.742 Unidentified
lb°j
Unidentified SSH clone insert 0.722 Unidentified
Unidentified SSH clone insert 0.719 Unidentified
Unidentified SSH clone insert 0.7 Unidentified
Unidentified SSH clone insert 0.695 Unidentified
Unidentified SSH clone insert 0.64 Unidentified
Unidentified SSH clone insert 0.638 Unidentified
Unidentified SSH clone insert 0.63 Unidentified
Unidentified SSH clone insert 0.616 Unidentified
Unidentified SSH clone insert 0.611 Unidentified
Unidentified SSH clone insert 0.605 Unidentified
Unidentified SSH clone insert 0.604 Unidentified
Unidentified SSH clone insert 0.591 Unidentified
Unidentified SSH clone insert 0.588 Unidentified
Unidentified SSH clone insert 0.577 Unidentified
Unidentified SSH clone insert 0.573 Unidentified
Unidentified SSH clone insert 0.56 Unidentified
Unidentified SSH clone insert 0.555 Unidentified
Unidentified SSH clone insert 0.542 Unidentified
Unidentified SSH clone insert 0.537 Unidentified
Unidentified SSH clone insert 0.526 Unidentified
Unidentified SSH clone insert 0.521 Unidentified
Unidentified SSH clone insert 0.51 Unidentified
Unidentified SSH clone insert 0.501 Unidentified
Oligodendrocyte GTP-binding protein 0.524 Transcription factor
WBC STS genomic, sequence tagged site 0.613 Unknown
Ifo
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Direct vs. Remote comparison
The different expression levels of each element present in the normalised data
between the direct and remote segments were plotted against each other and are
shown as a scatter graph in figure 6.8. The majority of elements are found around the
1-fold mark, indicating similar expression between the direct and remote segments.
There were more genes altered in the remote segment than in the direct segment.
RNA quality and amplification
Table 6.9 details the quantity of amplified RNA obtained from each sample taken
from the brushed epithelial cells. Figure 6.9 displays representative 'false gel' images
that were used to distinguish poor quality RNA for exclusion. Unfortunately a
mechanical fault destroyed a proportion of the RNA samples prior to amplification,
and consequently fewer hybridisations were achieved than were planned. There were
8 sheep samples used from the remote segment, and 5 from the directly challenged
segment. Each sample was hybridised in duplicate with the dyes swapped to avoid
any errors based on differential dye fluorescence. Full analysis of the amplified RNA
is presented in Appendix III.
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Table 6.9: Quantities ofamplified RNA (pg) producedfrom the original total RNA
samples extractedfrom brushed epithelial cells derivedfrom each sheep lung sample.
Direct samples were taken from the LPS-challenged segment, remote from the contra
lateral lung segment at baseline (0 hours) or post-LPS challenge (6 hours). The
quantification of the RNA was performed using the Agilent Bioanalyzer platform
which calculates RNA concentration using fluorescence-based detection technology.
The original RNA was purified and divided into two. Thefirst halfofeach sample was
usedfor real-time quantitative RT-PCR analysis ofcytokines. The second halfwas
used for amplification and labelling prior to microarray hybridisation. Samples
labelled * were in a pair ofsamples not sufficient for microarray hybridisations, those
spaces labelled ** were samples which were excluded through technical error or
insufficient quality of total RNA.
Sheep Direct (Oh) Direct (6h) Remote (Oh) Remote (6h)
0687P 50.09 28.42 ** **
0693P ** ** 22.15 16.42
0861P 11.13* 1.41* 15 15
068 IP 31.79 1 1.02 16.2 15.8
063 IP 26.86 4.14 18.6 18.6
0757P 15 15 14.2 24.2
S46 52.16 27.18 39.6 32.6
X26 ** ** 14.8 9
S41 ** ** 30 30
m-
Figure 6.9.A: A 'false gel image' representing total RNA samples purifiedfrom
brushed epithelial cells from lung segments. The image was derivedfrom the
fluorescence trace data acquired by the Agilent Bioanalyzer chip platform. The
analysis software extrapolated bands from corresponding peaks in the fluorescence
trace data. RNA quality was assessed visually using both these gel impressions and
the trace data in order to exclude poor quality RNA samples. The presence ofclear
ribosomal peaks indicates intact RNA is present.
Figure 6.9. B: A false gel image' representing amplified aRNA samplesfrom original
RNA purified from brushed epithelial cells from lung segments. The image was
derivedfrom the fluorescence trace data acquired by the Agilent Bioanalyzer chip
platform. The analysis software extrapolated bands from corresponding peaks in the
fluorescence trace data. RNA quality was assessed visually using both these gel
impressions and the trace data in order to exclude poor quality RNA samples. The
lack ofribosomal peaks indicate that there was no ribosomal RNA contamination of
the samples after amplification.
Discussion
Remote segment gene expression
There appear to be a number of gene networks active in the contra lateral segment
following local LPS challenge. These networks are associated with a number of
functions, some apparently unrelated to inflammation or immune responses.
There were changes in the regulation of a considerable number of ribosomal proteins,
which divide relatively evenly between low levels of up and down regulation.
Elements corresponding to the small ribosomal subunit proteins S23a and S25 exhibit
increased expression in the remote segment following LPS, whilst those
corresponding to the large ribosomal subunit proteins L30, L32 and L35 and the small
ribosomal subunit proteins SI6, SI2, S23, S25, S27a and S7 exhibit decreased
expression following LPS challenge.
Ribosomal proteins are major constituents of ribosomes that catalyse protein
synthesis in the cytoplasm (Mager 1988). The catalytic functions specific to
individual ribosomal proteins are largely unknown (Wool 1996; Wool, Chan, & Gluck
1995). Under normal conditions, ribosomal proteins are synthesized with rRNA to
produce RNA and protein. Under altered conditions, including events surrounding
cellular growth and proliferation, the expression levels of ribosomal proteins are
altered. For instance, both the large and small ribosomal subunit proteins 7, 23a and
27a exhibited decreased expression in a study of neuronal differentiation of human
embryonic carcinoma cells (Chester et al. 1989), this correlated well for levels of the
small ribosomal subunit proteins in a further study (Bevort & Leffers 2000). These
alterations appear to be restricted to specific ribosomal proteins, because some
ribosomal protein levels are altered, whereas others remain constant (Frigerio et al.
IU
1995). The contradictory evidence for ribosomal subunit protein S25 demonstrating
both increased and decreased regulation may be due to very similar transcripts being
differentially regulated and cross-hybridising to both elements.
Independent alterations in ribosomal protein synthesis suggest that individual
ribosomal proteins have functions beyond the simple structural makeup of the
ribosome or protein synthesis. For example, PO and S3 possess endonuclease activity,
suggesting that they may have DNA repair functions (Grabowski et al. 1991; Kim et
al. 1995), and subunit 7 can function as a co activator of nuclear receptors (Berghofer-
Hochheimer et al. 1998) and has been implicated in apoptosis (Goldstone & Lavin
1993; Naora et al. 1998; Neumann & Krawinkel 1997). Altered ratios of ribosomal
subunits are also associated with stage-specific tissue development (Mazuruk et al.
1996).
The present data provide evidence that the levels of specific ribosomal transcripts are
altered in the contra-lateral lung following local LPS challenge. The results suggest
that regulation of protein synthesis and/or other functions mediated by ribosomes are
associatedwith the remote response in the lung.
This could potentially indicate that the cells were in the process of closing down non¬
essential functions - possibly in preparation for a rapid response to any incipient
exposure to a stimulus, whilst boosting functions that may be needed to respond to a
challenge. Another possibility raised by the regulation of ribosomal proteins is that
the cells were preparing for apoptosis (Goldstone & Lavin 1993; Naora et al. 1998;
Neumann & Krawinkel 1997).
Cell structure genes, including actin binding genes, actin itself and actin regulator
genes such as filensin and thymosin beta, appeared to be down regulated in contra¬
lateral sites. Actin-based structures participate in the regulation of cell motility,
growth and differentiation, not only by altering cell morphology, but also by acting as
active components of the signalling complexes transmitting signals to the nucleus and
thereby regulating gene activation (Vicente-Manzanares et al. 2002; Bamburg &
Wiggan 2002).
The role of actin and associated cytoskeletal genes and gene products has not been
extensively investigated in the context of pulmonary inflammation. Studies
specifically investigating the expression of this category of molecule have
demonstrated involvement in the migration of neutrophils in a rabbit model of
bacterial pneumonia (Mueller et al. 1994). In this model, the inhibition of actin de-
polymerisation resulted in reduced trafficking of neutrophils from the circulation into
the lung tissue following bacterial challenge, and that this was due to actin
rearrangement in the lung cells and not the neutrophils themselves.
Relatedly McClenahan et al investigated the expression of filamentous actin in bovine
neutrophils in response to a variety of stimuli including LPS (McClenahan et al.
2000). This study concluded that filamentous actin played a critical role in altering the
deformability of neutrophils in vitro, though there was no significant alteration in
actin expression as a result of bacterial products. Lim et al also demonstrated that
actin plays a role in the reaction to inflammatory stimulus in pulmonary
microvasculature (Lim et al. 2001). This study concluded that inflammation results in
considerable actin rearrangement associated with alterations in expression and spatial
localisation of other cytoskeletal factors.
These studies support the assertion that observed down-regulation may relate to a
change in cellular morphology within the airway epithelium associated with
neutrophil trafficking and sequestration. Whilst the mechanism of action and biologic
consequences of these alterations remain unclear, the central role of neutrophil
in
movement in the inflamed lung in terms of bacterial clearance and tissue damage
together with the data from this study warrant further investigation into the role of the
cytoskeleton in pulmonary inflammation.
A large number of mitochondrial genes were significantly regulated in the remote
segment in response to local lung administration of LPS, though their pattern of
regulation was unclear as similar numbers of elements were increased and decreased.
ATPase 6 in particular represents a large proportion of the elements altered and,
though it is unclear whether it is up or down regulated, the regulation is at very low
levels. This observation is of particular note as this gene has been implicated in the
inflammatory response to Pneumocystis carinii infection in the rat lung (Asnicar et al.
2001). This study demonstrated up regulation of a fragment of the ATPase 6 gene in
whole lung compared with control lung by differential display, and also localised the
expression to Clara cells and type II pneumocytes.
Diubiquitin was also regulated significantly, this protein consists of two ubiquitin-
like molecules arranged in a head to tail formation and its expression has been shown
to be induced synergistically by a combination of interferon y and TNFa (Raasi et al.
1999), both of which are generally accepted mediators of the acute inflammatory
response in the lung. Although the functional role of this molecule has yet to be
elucidated, structurally similar molecules have been implicated in the inhibition of the
ubiquitin/proteosome pathway (Swinney et al. 2002). This latter pathway is involved
in initiating NFkB transcription which in turn leads to cytokine production in
response to LPS signalling. These results may suggest that the epithelial cells were
altering the mitochondrial output as a part of the inflammatory cascade, though the
means and ends of these expression changes are unknown.
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Genes expressed in membranes were also significantly affected. These included MHC
molecules, cluster designation (CD) cell markers, transport molecules and extra¬
cellular matrix molecules. Genes involved with T-cell recognition and MHC
presentation, namely MHC class I proteins and T-cell receptor beta chain, were
significantly up-regulated, whilst decorin, involved with cell signalling via the extra¬
cellular matrix (Tran, Griffith, & Wells 2004), solute carrier (a transport molecule),
and the surfactant proteins A and C were all down regulated.
The up regulation of the T-cell associated genes could potentially imply that the organ
was initiating the adaptive immune response cascade, and it would be reasonable to
hypothesise that this is in response to signals received from the directly challenged
segment of the lung. This would also concur with the results seen in chapter 4 where
IL 10 was up regulated in the remote segment. 1L 10 has been shown to have a central
role in the switch from innate to adaptive immunity (Mocellin et al. 2004; Yates et al.
2000; Bonig et al. 1998).
The down regulation of the surfactant protein (SP) genes is of note as these have
been implicated in the pathogenesis of ARDS (Balamugesh et al. 2003). SP-A is a
member of the collectin family, which are pattern recognition models recognised as
mediators of innate and adaptive immune functions (review: (Wright et al. 2001)). In
a study on SP-A expression in a clinical cohort of ARDS patients a lower level of the
protein was significantly associated with an infectious aetiology as opposed to a non¬
infectious one (Balamugesh et al. 2003). A further study using repeat endotoxin
challenge associated the increased expression of SP-A in whole lung with direct
endotoxin challenge (George et al. 2003).
SP-C meanwhile has been demonstrated as a protective factor in oxygen lung injury
(Ikegami et al. 2002), and its down regulation may be an anti-inflammatory reaction
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that renders the lung tissue more susceptible to inflammatory mediated tissue injury as
is implied by the results of a study by Mikawa et al demonstrating a protective role for
this protein in acid-induced lung injury in an intratracheal rabbit model (Mikawa et al.
2004).
A number of genes associated with immune and inflammatory activity were altered.
Interferon y associated genes (interferon gamma-inducible-protein 10, K.unitz
domain protein and prostaglandin endoperoxidase) were significantly up regulated as
a group within these elements, which might suggest a role for IFN signalling in the
promotion of the remote response - this is consistent with the remote IFN signalling
reported by Halloran (Flalloran et al. 1992) in a study which found increased
expression of numerous genes in remote organs and distant parts of inflamed organs
during rejection of an ascites tumour allograft and skin sensitisation by oxalozone.
The blockade of IFNy in the above study reduced remote regulation following
inflammatory stimulus suggesting that the IFNy pathway may constitute a potential
regulatory mechanism at a distance from localised stimuli.
Other Immune and inflammation associated genes altered in the remote segment
include complement protein C3. This is the initiator molecule for the alternative
complement pathway and is heavily implicated in the immune reaction to gram
negative bacteria (Mueller-Ortiz, Drouin, & Wetsel 2004; de Astorza et al. 2004;
Shankar-Sinha et al. 2004; Pishko et al. 2004; Younger et al. 2003). A recent study by
Meuller-Ortiz et al found that C3 knockout mice were significantly more at risk of
mortality due to Pseudomonas pneumonia than wild-type mice (Mueller-Ortiz,
Drouin, & Wetsel 2004), a result confirmed in principle by Younger (Younger et al.
2003). In vitro studies have demonstrated an opsination-based mechanism of innate
defence against bacterial infection by alveolar epithelial cells in an A549-based cell
ISf
line study (de Astorza et al. 2004). The increase in expression of this molecule hints at
a localised protective response contra-lateral from the focus of inflammation, an event
that has not been reported previously.
Trypsin inhibitor expression was also up regulated in the remote segment. Schmek
et al recently demonstrated that inhibition of trypsin-like proteases reduced apoptosis
of human alveolar and bronchial epithelial cells in vitro in response to pneumococcal
infection (Schmeck et al. 2004). In addition, Thomas et al have reported that trypsin
impairs adherence ofMycoplasma bovis to bovine epithelial cells in vitro (Thomas et
al. 2003) and Tamura et al have demonstrated that trypsin inhibits the adherence of
group B Streptococci to the epithelial A549 cell line (Tamura et al. 1994). These
studies would indicate that increased expression of a trypsin inhibitory molecule
might result in an increased susceptibility to bacterial colonisation in the lung.
Osteopontin - a multifunctional matricellular protein abundantly expressed during
inflammation and repair - was significantly down regulated in the remote segment
following LPS treatment. A recent microarray study on osteopontin null mice
indicated that osteopontin is a critical factor in the development of fibrosis in the
murine lung, and that the epithelium is the major cellular source of the molecule
during murine pneumonitis and bleomycin-induced fibrosis (Berman et al. 2004). This
study is consistent with others reporting a central role for osteopontin in pulmonary
fibrosis, as well as in other immune and inflammatory responses in the lung and other
organs (O'Regan 2003; Ortiz et al. 2003; Takahashi et al. 2001).
Prostaglandin D2 synthase (PG (D2)S) is a key enzyme in the generation of the
prostaglandin J and D series of molecules which are heavily implicated in immune
and inflammatory responses (Ando et al. 2003). PG (D2)S product prostaglandin J2
has been recently studied by Inoue et al in a mouse model of LPS intratracheal
ill
instillation (Inoue et al. 2003). This study presented convincing evidence that, in the
murine LPS instillation model, PG J2 had significant pro-inflammatory effects,
increasing the expression of the classical inflammatory mediators interleukin 1(3,
macrophage inflammatory protein-la, and macrophage chemoattractant protein-1 as
well as significantly increasing the degree of neutrophilic inflammation and oedema
in the lung in response to LPS. The reduced expression of PG (D2)S in the remote
segment would imply an anti-inflammatory response to LPS in the contra lateral lung.
Alpha-sl-casein expression was also significantly reduced in the remote segment,
this is intriguing as there is no published evidence of this gene's regulation or even
expression in the lung, and its main function is generally accepted to be in milk
production (Karatzas & Turner 1997; Klei et al. 1997). The expression of alpha-sl-
casein has thus far been reported in experimentally induced bovine mastitis (Le Roux,
Laurent, & Moussaoui 2003), though it also serves as an inflammagen in its own right
(Mullner, Lazar, & Hrabak 2002; Vermehren et al. 2001). The latter use of casein as
an inflammatory inducer may indicate that, if constitutively expressed, it acts as a pro¬
inflammatory mediator and its suppression seen as an anti-inflammatory effect,
however this is purely speculative and requires further investigation.
Enzymes associated with cellular respiration were significantly regulated also.
Down regulated elements in the remote segment include cytochrome c oxidase II, and
Kreb's cycle associated enzymes, whilst the cytochrome c oxidase I and III subunits
were up regulated. These alterations may indicate an increase in nitric oxide
catabolism (Brunori et al. 1999) or an adaptation to a shift in specific energy needs
(Cheng et al. 2003; Villani et al. 1998; Chandel et al. 1995). The mitochondrial gene
products represented by the sequences affected in this study may also play a role in
the generation of reactive oxygen species (ROS). Indeed Kuwano et al demonstrated
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significant alteration of the overall mitochondrial mass in human epithelial cells from
clinical patients as a result of idiopathic interstitial pneumonia (Kuwano et al. 2003)
and a corresponding increase in the level of ROS production.
Transcription factors were also affected, with 2 signal transducer and activator of
transcription (STAT) factor homologs (labelled as chromosome 18 sequences) up
regulated and Ets-2 factor down regulated. DNA-binding STAT transcription factors
have been reported to play a role in allergic lung disease (Kotsimbos et al. 1997)
where they are critical mediators of the IL 5 directed eosinophil responses (Mishra &
Rothenberg 2003; Taha et al. 2003; Yang et al. 2001). Ets-2 is poorly characterised in
the lung, though a closely related protein, Elk-3 has been implicated as a
transcriptional repressor of nitric oxide synthesis in a mouse model of endotoxaemia
(Chen et al. 2003). Ets-2 also has a suggested role in the regulation of IL-12 in an
inflammatory response in macrophages and in arthritic synovial inflammation
(Kawabata et al. 2004) though its mode of action and effects are unclear from these
studies.
The lipid and steroid metabolism mediators muscle-type carnitine
palmitoyltransferase I, lipoprotein lipase and cytochrome p450 17c were up regulated
in the remote segment 6 hours after contra-lateral local LPS challenge. Concurrently,
metabolic mediators ferritin (an iron chelator) and lectin precursor were down
regulated in the same segment.
Carnitine palmitoyltransferase (CPT) and lipoprotein lipase are not well
represented in the literature relating to lung biology, however both were shown by
Feingold et al to be down regulated in the acute phase response to LPS in a mouse
heart disease model (Feingold et al. 2004). This concurs with observations in a mouse
sepsis model by Eaton et al (Eaton et al. 2003) and a rat inflammation model using
caecal ligation puncture by Bazel et al. (Bazel et al. 1999). This latter study was of
interest in terms of bacterial inflammation as it demonstrated that sterile inflammation
failed to inhibit CPT expression whereas caecal ligation puncture significantly
inhibited it, thus implying a role for infecting bacterial compounds in the inhibition of
CPT in this model. The increases expression of CPT in this study would seem to
correlate well with the other observations that the remote response is contrary to that
seen in direct inflammation in various models.
Lipoprotein lipase, likewise, has been implicated in the response to sepsis in host
species. A review by Khovidhunkit et al of the effects of infection and inflammation
report a significant inhibition of lipoprotein lipase in sepsis (Khovidhunkit et al. 2004)
and attribute to it a protective role against septic sequelae, this study is supported by
findings in a study by Harris et al who also show inhibition of lipoprotein lipase in
LPS-induced sepsis leading to Tipemia of sepsis' (Harris, Gosnell, & Kumwenda
2000). The production of lipid and steroid mediators could be perceived as an anti¬
inflammatory or protective response to counter inflammation, though this conjecture
requires considerable investigation to determine what, is any, biological impact their
regulation might have in the progression of lung disease.
Cytochrome P450 (CYP450) has been studied in some depth due to its effects on
drug metabolism. Whilst its biological effects in the lung remain to be studied in
detail, it has been established by numerous studies that CYP450 mediated drug
metabolism is inhibited by direct inflammatory stimulus (Carcillo et al. 2003; Saitoh,
Kokue, & Shimoda 1999; Monshouwer et al. 1996). However the direct effect of LPS
on CYP450 expression is not clear as tissue expression of the molecule and its
products have been both increased (Tindberg et al. 1996) and decreased (Shimamoto
et al. 1998) in rats following inflammatory stimuli. CYP450 has not been reported to
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play a direct role in the inflammatory cascade, but certainly appears to be regulated by
its products (Bleau et al. 2003).
Ferritin, whose expression was decreased in the remote segment of the sheep lung in
this study, is an iron chelator whose primary function in infection is to withhold iron
from colonising bacteria (reviewed by Jurado (Jurado 1997)). Though its effect in
lungs are poorly studied, it has been shown to play a role in the increased bacterial
load in lungs of patients with cystic fibrosis (Reid et al. 2002). Inflammatory infection
appears to be associated with increased ferritin levels in human pus and serum
samples (Bryant, Crouse, & Deagen 2004; Tomkins 2003), but its regulation in tissue
following direct inflammation is unclear.
The reduction in expression of lectin precursor also adds to this evidence. Lectins
are critical in lung inflammation and infection as binding and recognition molecules
(Sato et al. 2002; Pavia-Ruz et al. 1994; Mariassy et al. 1989), and their expression is
closely linked with that of the surfactant proteins, which are a part of the C-lectin
family (Kuroki & Sano 1999), in response to bacterial infection (Leth-Larsen et al.
2003). The similar expression profile of lectin precursor to the surfactant proteins in
the remote segment supports this functional link.
Prostaglandin genes appeared to be consistently regulated. The prostaglandin
endoperoxidase and prostaglandin endoperoxidase associated receptor (Em4b) were
significantly up regulated and prostaglandin D2 synthase was significantly down
regulated. This concurs with observations that PGE2 and PGD2S have contrasting
effects in lungs (Zeldin et al. 2001). These genes are targets for non-steroidal ant-
inflammatory drugs (Colville-Nash & Gilroy 2001) and are therefore considered to be
pro-inflammatory in nature, however it has also been suggested that they can exert
anti-inflammatory effects in vivo (Gilroy et al. 1999).
Ovine growth hormone was significantly up regulated. Growth hormone has been
associated with inflammatory marker reduction in acute inflammation (Wu, Herndon,
& Wolf 2003; Basoglu et al. 2002; Bergad et al. 2000; Derfalvi et al. 2000) but its
mode of action is unclear (Hansen 2003).
A number of genes were altered which were either of unknown function, or could not
be identified as homologs of known genes in comparative species, and these
constitute a considerable proportion of the data (29%).
Direct segment gene expression
In common with the remote segments, MHC and T cell receptor genes represented a
significant group of up regulated elements in the directly instilled segments.
Mitochondrial gene products (diubiquitin, polyubiquitin, ATP synthase) showed a
greater trend to be up regulated in the direct segment than in the remote, though this
trend was marginal. Similarly the metabolic elements (e.g. 6-phosphogluconate
dehydrogenase, cytochrome P450) showed slightly more up regulation in the direct
than the remote segment. The pattern ofmetabolic functions altered in the direct was
similar to the remote with genes concerned with steroid and lipid metabolism
representing the majority of those up regulated. The steroid metabolic enzyme
cytochrome P450 17c, notably, demonstrated 1.7 fold up regulation in the direct
segment. Cell structure elements were down regulated in the direct segment - as was
found in the remote.
A notable difference between the direct and remote segments was observed in relation
to the expression of immune and inflammatory elements. In the direct segment there
were a considerable number of down regulated inflammatory regulators such as fetuin
(Demetriou et al. 1996), peripheral-type benzodiazepine receptor (Bribes, Bourrie, &
Casellas 2003) and histone H2A.Z - all of which have been shown to be cytokine
inhibitors, and whose down regulation could potentially enhance the inflammatory
response of the tissue.
Up regulated immune genes include prostaglandin H2 synthase (Zeldin et al. 2001)
and complement component C3 (Younger et al. 2003; Walters et al. 2002; Drouin et
al. 2001; Ault & Colten 1994), both of which are recognised inflammatory products.
Interestingly elements corresponding to inflammatory markers were also seen to be
down regulated, this included interferon regulatory factor 1, metalloproteinase tissue
inhibitor 1, interleukin 6 and intercellular adhesion molecule 1. Although it is
conceivable that these genes reached peak levels prior to 6 hours and were then down
regulated, it should be noted that the result for IL 6 is contradictory to that seen in the
real-time PCR experiment from chapter 4.
This discrepancy is initially concerning given the direct contradiction between the two
methodologies, however, a number of possible confounding factors must be
considered in the context of the microarray data. The use of a bovine analogue to the
ovine IL 6 gene sequence renders this result somewhat susceptible to cross-
hybridisation interference which might be a product of similar sequences being
expressed in the ovine genome.
Other possible confounding factors include non-specific binding to this spot as a
result of high-affinity binding motifs in the IL 6 sequence, or a highly expressed
alternative splice form being expressed in the baseline samples which would be
specifically excluded using the PCR methodology but might be picked up with the
less discriminatory microarray platform. Regardless of these potential errors, the
validation of the microarray data should engage the question of the IL 6 data directly,
as well as confirming other sequences within the data set presented.
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The growth hormone gene was down regulated in the direct segment, whilst in the
remote segment these hormones showed an increase in expression. This result is
consistent with previous studies indicating an anti-inflammatory role for growth
hormone in lung inflammation (Wu, Herndon, & Wolf 2003; Derfalvi et al. 2000).
The results from the direct segment were analysed without using a false discovery rate
correction method. False discovery rate correction methods are utilised to account for
the relatively high expected false positive count inherent in utilising standard
statistical confidence limits in large data sets. Their use typically adds to the statistical
robustness of microarray data (Reiner, Yekutieli, & Benjamini 2003; Tsai, Hsueh, &
Chen 2003;Y ang et al. 2003).
In the current context, use of a false discovery rate correction method effectively
eliminates all significant data from the analysis of the direct segment. Whilst
excluding such correction from the analysis introduces the possibility that a number of
false positive results are being identified in the direct response to LPS it does avoid
the tendency to generate false negatives that use of these techniques introduces (Yang
et al. 2003). The choice to continue with data analysis in the absence of the false
discovery rate correction was made with the assumption that any changes identified as
significant would at least reflect an underlying trend in the data and could therefore be
compared in a qualitative sense with the response in the contra lateral lung.
Direct vs. Remote
The overall expression profiles in the direct and remote segment s were very similar,
and very few elements showed high levels of change in either a positive or negative
direction. Whilst it is certainly true that microarray data analysis consistently
introduces a bias towards underestimation of gene change as compared with methods
such as PCR and that the robustness of the data analysis required as part of the
standard approach to microarray experiments reduce the number of sequences
detected as significant, it is equally true that the data acquired from this investigation
show unusually low levels of regulation of the array elements.
A further limitation in these data is the lack of apparent significant regulation of the
inflammatory markers normally associated with acute inflammation in the direct
segment, and the absence of the cytokine changes seen in the real-time PCR analysis
of cytokine changes in either segment. The similarity in expression profiles between
direct and remote segments despite the very different phenotypic changes may be
explained in terms of fundamental biology.
The genetic changes involved in the two segments appear to mostly be concerned
with baseline, non immune-specific alterations such as refocusing of the protein
manufacturing systems and redirection of the cell's energetic make-up. These
alterations are likely to underpin a very wide variety, if not most, cellular reactions in
any system in the organism. Whether the cell requires an anti-inflammatory response
or a pro-inflammatory one, the basis of the response will be a change in the cellular
machinery that governs the manufacture of the effector molecules, with the result that
the bulk of the molecular change is homogenous throughout the organism and across
stimuli.
The minority of molecules that are altered therefore represent a very small, but highly
potent, subset of those probed by this method. This is in contrast to single-gene,
specific analyses such as the RT-PCR used in the previous chapter which look at
members of that small group of effector molecules and thus show much more
dramatic changes in expression. Previous array studies support this proposition, with
the majority detailing changes in similar groups of genes as in this one (i.e. ribosomal
proteins, steroid metabolic catalysts, mitochondrial products cell cycle determinants
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and cell structure products) but in such disparate model systems as cardiac myocyte
hypertrophy, colorectal cancer (Otsuka et al. 2001) and cardiac angiotensin treatment
(Larkin et al. 2004).
Conclusions
Further validation of specific sequences of interest identified by this array experiment
will allow more certain statements to be made about the nature of the remote response
in the sheep lung, and hypothesis-driven investigation of the networks highlighted in
this study may prove important in elucidating novel mechanisms of intervention in
inflammatory lung disease, and particularly the evolution from localised inflammation
to the fulminant organ-wide inflammation characteristic of ARDS. Further validation
of the array data should comprise sequence specific techniques such as RT-PCR or
related blotting methods, as well as location specific techniques such as in situ
hybridisation methods. It is unfortunate that time constraints prevented these further
analyses from being carried out within the context of this investigation, however the
conclusions reached as a result of the study as concerns the hypothesis stated remain
valid without need for further experimental work.
Overall the microarray results show that there is a significant, complex and wide
ranging remote response and that this response is amenable to characterisation using
cDNA microarrays. The data hint at a network of highly complex genetic and
molecular interactions whose exact nature remains to be clarified. Though microarray
data are capable of standing alone as investigative results without external verification
being necessary, the possibility of cross-hybridisation with non-specific sequences
interfering with the signal obtained from each element cannot be discounted.
Further verification of individual data of interest should comprise specific transcript
analysis such as RT-PCR or Northern blotting. These methods are preferable due to
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their specificity for the elements investigated. Microarray probes based on cDNA
sequences suffer from the lack of specificity inherent in using such long stretches of
sequence, thus data obtained can indicate overall changes but individual gene
reactions of interest should be investigated separately using tools that exclude
interference or cross-hybridisation. Such verification was beyond the scope of the
present study.
The statistically significant results obtained are particularly notable due to the in vivo
approach used, and the associated wide natural variability in gene expression inherent
in using out bred sheep reared in a commercial environment.
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Chapter 7 General discussion
The results obtained from the analysis of phenotypic changes in the sheep lung
following direct instillation of E. coli LPS to a discrete segment support the assertion
that the 6 hour post-LPS ovine model is an appropriate one to mimic gram negative
bacterial sepsis in comparative species, including human (Monton & Torres 1998).
Indeed, these results indicate that the changes in lung phenotype, particularly the
cellular and histopathological changes were consistent with those previously reported
due to clinical gram-negative infection (Dehoux et al. 1994; Shimabukuro, Sawa, &
Gropper 2003) and currently accepted animal models (Kumar 1995).
The 6 hour LPS instillation model in sheep is thus far unreported in the available
literature, and this study establishes for the first time that it is appropriate for the study
of acute lung injury, a pre-requisite for studying the pathogenesis of sepsis-induced
pulmonary ARDS. No phenotypic changes were found in the segment contra-lateral
from the challenged segment, indicating that this is a suitable model for local
infection and relates well to similar segmental challenge models in terms of
phenotypic changes (Dehoux et al. 1994).
Investigation of the cytokine expression levels in the lung segment directly stimulated
with LPS showed changes in cytokine levels consistent with previously published
LPS inflammatory model studies and gram negative infection studies (Dehoux et al.
1994; Monton et al. 1999; Shanley, Warner, & Ward 1995). Classic inflammatory
markers associated with innate immune derived responses were shown to be up
regulated significantly in the instilled segment. These cytokine markers (IL 1 p, IL 6
and TNFa) are widely accepted as being associated with neutrophil infiltrates in the
lung (Xing et al. 1999; Toews 2001; Moore & Standiford 1998) and have been shown
to peak at between 6 and 24 hours in mouse lungs following LPS instillation (Ulich et
al. 1991).
The failure to demonstrate significant changes in IL 8 expression was unexpected but
may reflect a lack of expression in ovine epithelial cells in vivo. Whilst the cytokines
investigated are considered to be the 'classical' molecular markers of the innate
inflammatory response (Moore & Standiford 1998), there are other molecules which
could have been considered as candidates for inclusion in this study. Notable amongst
these are interferon gamma and IL-12, both of which play pivotal roles in the innate
immune cascade in response to LPS (Heremans et al. 2000; Zisman et al. 1997;
Gladue et al. 1994). Practical issues relating to cost and availability of validated
primer sequences governed such decisions to reject both IL-12 and interferon gamma.
In the remote segment the inflammatory markers showed no significant changes, as
would be expected and corresponding to the lack of neutrophilic infiltrate seen in the
segment. The cytokine IL 10 however was significantly up regulated approximately
seven fold. This change in the level of IL 10 conclusively establishes the ability of the
lung to react on a whole organ basis to localised inflammatory stimulus independent
of any phenotypic change. IL 10 is associated with anti-inflammatory activity and the
switch from innate to adaptive immunity (Quinn et al. 2000; Raychaudhuri et al.
2000; Shanley, Vasi, & Denenberg 2000; Thomassen, Divis, & Fisher 1996; Bonig et
al. 1998; Mocellin et al. 2004), this regulation of IL 10 clearly demonstrates for the
first time that the lung not only responds on a whole organ basis, but also that the
response is separate and distinct from the response local to the inflammatory stimulus
rather than a diminished version of the innate inflammation stimulated in the
challenged segment.
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The purpose of the up regulation of an anti-inflammatory cytokine remote from the
site of localised inflammation would logically seem to be as a protective measure
against wide ranging inflammation throughout the lung and thus preventing organ-
wide tissue damage that might lead to organ failure which is the primary cause of
death seen in pulmonary ARDS (Dokka et al. 2000; Inoue 2000; Lo, Fu, & Cryer
1998). A logical extrapolation from this observation would be that the progression
seen in ARDS is due, at least in part, to the failure of this mechanism, or indeed an
overwhelming of the system. This supposition is supported by the evidence that IL 10
has been shown to ameliorate the lung and multi-organ failure associated with
ALI/ARDS when given artificially (Lo, Fu, & Cryer 1998).
In order to investigate the nature of the remote response in lung tissue more fully, a
sensitive, quantitative platform was needed to probe the molecular profile of the
expressed genes in the remote segment. Microarrays have been established as an
appropriate and powerful technology for investigating the expression profiles of
multiple genes simultaneously. They have been used and their capability established
in a number of lung disease models - including asthma (Zimmermann et al. 2003;
Zou et al. 2002), acute sepsis (Leikauf et al. 2001) and cancer (Jiang et al. 2004;
Floang et al. 2004; Ikehara et al. 2004) in a variety of comparative species,
particularly human (reviewed by Grant (Grant et al. 2004)), mouse (reviewed by
Wigle (Wigle, Rossant, & Jurisica 2001)) and rat (reviewed by Schultz (Shultz et al.
2004)) and have been used to investigate LPS induced inflammatory responses both in
vivo (Leikauf et al. 2001) and in vitro (Fessler et al. 2002).
Due to the lack of known and characterised gene sequences in sheep, a combination
of suppressive subtractive hybridisation (SSH) library construction (Diatchenko et al.
1996) and homology searching (Altschul et al. 1990) for known sheep homologs
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within bovine libraries was used to generate probes for use on a novel ovine lung
microarray.
The SSH method generated a library consisting of approximately 1,200 clones. These
clones contained sequences representing transcripts either differentially or exclusively
expressed in the lung compared with a combined population of brain, heart, muscle,
liver and kidney transcripts. Of the 238 clone inserts sequenced, 100 different groups
of genes (contigs) were found, indicating that the library is approximately 2.5 fold
redundant. If such a relationship holds for the remaining clones, between 400 and 500
ovine genes are represented in this library. This resource is of considerable value and
represents a significant avenue for further investigation into both lung biology and
sheep genetics. The lack of any large-scale full length genome sequencing program
analogous to those for humans, rodent species and cattle fwww.genomeonline.com
(Bernal, Ear, & Kyrpides 2001; Kyrpides 1999)) adds further weight to the
significance of this library as a basis for genetic investigation in sheep. The ability to
use the clones available as starting point for characterisation and full length
sequencing of large numbers of ovine genes known to be involved in lung biology
enables this library to generate considerable knowledge concerning the ovine lung
disease model in the future.
There has been no report in the body of available literature of an ovine microarray
being used in the past, therefore the new array generated from the SSH library and
homology searches represents a unique resource in that regard. Whilst it is unlikely
not to be joined by other ovine arrays in the near future no commercial resources are
available, or likely to become available, that duplicate this microarray. The ovine lung
is highly suited to investigating a variety of pulmonary diseases, and this array is
capable of providing considerable molecular analysis for any and all of these model
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systems. Indeed this array represents a considerable avenue for molecular studies to
characterise these model systems as well as offering the potential for investigations
into fundamental ovine lung biology and related comparative respiratory physiology
and molecular biology.
The results of the array analysis confirmed the hypothesis that the lung reacts as a
whole organ to local inflammatory stimulus. The microarray results clearly
demonstrate that the response in the remote segment is complex and different to that
seen in the direct segment. The response in the remote segment involves a number of
genetic pathways and molecular networks and is a response that has not been reported
in the sheep before now. Though the overall cellular and tissue effects, and purpose of
these molecular interactions initiated in the remote segment are beyond the scope of
this project the data generated provide a unique platform for further study into the
remote response to LPS and local sepsis, as well as the fundamental innate response
of the lung to direct stimulation with bacterial LPS.
The prevalence of segmental challenge models in all areas of lung disease research
(Zangrilli et al. 1995; Koh et al. 1993; Dupuis et al. 1992; O'Grady et al. 2001; Becker
et al. 1999), and the reliance of such models on the integrity of the segmental
independence of the lung further highlights the importance of these data. Whilst the
full characterisation and hypothesis-driven investigation into the specific nature of the
remote response remains to be conducted, it is clear that any segmental challenges
will need to account for the remote, organ-wide response during selection of
appropriate controls in future studies.
A concerning feature of the microarray results was the absence of any significant up
regulation of the classical inflammatory markers in the directly challenged lung
segment. It is particularly notable that the cytokines that were seen to be up regulated
using the real-time PCR technique were not present in the lists of significantly
regulated genes. This statement excludes IL 6 although this cytokine was significantly
down regulated on analysis with the microarray, but considerably increased its
expression when analysed using real-time PCR technique.
The only cytokine altered in the remote segment by real-time PCR was IL 10 and this,
too, was not significantly altered in the microarray analysis. Some possible reasons
for these discrepancies are as follows. The length of cDNA used in printing the spots
on the microarray, along with the relatively poorly characterised nature of each clone
used render this technology susceptible to cross-hybridisation reactions, a problem
that does not affect PCR due to the highly specific design of PCR primer pairs, and
this cross hybridisation may result in a small minority of elements 'mis-firing' and
giving incorrect results. A further consequence of the relatively low specificity of
binding of array elements in this system is that the overall signal to which everything
is normalised may quench a considerable level of signal strength. It has been
established that microarray data does introduce a measurable bias towards
underestimation of signal variation between samples when compared with specificity-
dependent techniques such as PCR.
The practical and longer-term therapeutic benefits to be derived from the
manipulation of the organ wide response to LPS remain to be elucidated. The
physiological and phenotypic effects of the response are, as yet, unclear - as is the
level to which the impacted networks influence the biology of the organ when a
secondary challenge is presented. As has been shown in previous literature, this
potential secondary challenge may be the initiating factor and major determinant in
the evolution of ARDS and its associated organ failure (Pelosi et al. 2003). Further
investigation of this response may indicate the level of challenge at which any
m
protective, anti-inflammatory remote response may break down and at which the
inflammatory impact seen in ARDS becomes evident.
An initial investigation (presented in Appendix V) with limited numbers of animals
(n=6) was carried out which showed no significant changes in the numbers of
neutrophils infiltrating a contra-lateral segment following local stimulation with LPS
and then a repeat challenge in the contra-lateral lung segment. This equivocal result
would indicate that the protective response is insufficient to prevent or significantly
lower the inflammatory reaction to direct LPS challenge, however greater numbers of
replicates and a more detailed time-course analysis study would shed further light on
this aspect of the response.
The mechanism by which the lung responds remotely is also not addressed within the
scope of this project, and will require considerable work to determine. Previously
advanced hypotheses from different model systems concerning bilateral responses
have centred around the concept of neurogenic immune regulation (Barnes 1996;
Downing & Miyan 2000; Perez Fontan 2002; Tseng et al. 2001) - which has been
particularly investigated in arthritis (Lombard et al. 1999; Mapp et al. 1993; Miagkov
et al. 1998; Milligan et al. 2003; Scott, Lam, & Ferrell 1994). This area would be one
to be considered for any future investigations into the mechanism of remote
responses.
Other possible mechanisms include systemic circulation of immune regulators
following local LPS instillation. In this regard, interferon (Halloran et al. 1992) has
been suggested, though cytokines, chemokines or other immune modulators may also
serve as possible signalling molecules. The levels of these mediators are relatively
simple to investigate both at the molecular genetic and protein levels, and may
provide an initial point from which to initiate investigations into remote response to
local inflammation mechanisms.
Further investigation into these factors would be of considerable value and should
include a time-course investigation of both systemic and tissue levels of IL 10, along
with pro and other anti-inflammatory regulators and the related profiles of cellular
changes. Such a design would potentially facilitate the identification of the point at
which the inflammatory modulation in systemic and tissue compartments differs
significantly and thereby potentially renders the lung susceptible to progression rather
than resolution.
In conclusion it can be clearly stated that the lung responds on a whole organ basis to
local LPS-induce innate immune-derived inflammation. Also that the contra-lateral
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Appendices
This section contains appendices I and V in paper format. Appendices II-IV are
included on the CD-ROM disc in the back cover. Instructions for accessing each file
type, and relevant programs to be used appear within each directory as a Microsoft
Word file. The file and directory structure used on the CD is as follows:
-Appendix II
-Brushing movie clip
This directory contains a moviefile recorded via a bronchoscope
showing the brushing action used to obtain epithelial cells.
-RNA data
This directory contains originalfiles from the Agilent Bioana/yzer
software detailing the analysis oftotal RNA taken from the epithelial brushings. It
also contains imagefiles of the fluorescence traces and 'false gels 'from thosefiles.
-qPCR data
This directory contains the original Opticon Monitorfiles with real¬
time PCR data on each experiment. It also contains a spreadsheet with all original
data derived from those files and used in analysis.
-Appendix III
-Homology search results
This directory contains a spreadsheetfide detailing the ovine-bovine
library homolog list and relevant data for the bovine library clones selected for
inclusion on the microarray.
-Microarray PCR data
This directory contains a spreadsheetfde with all of the quality control
data for the PCR products used to print the microarray
-Microarray structure details
This directory contains the layoutfde for the microarray used by the
data acquisition software to identify and label the array elements.
-aRNA data
This directory contains originalfiles from the Agilent Bioanalyzer
software detailing the analysis ofamplified RNA taken from the epithelial brushings.
It also contains image files of thefluorescence traces and false gels 'from thosefiles.
-Microarray images




-Direct / Remote segment microarray data
These directories contain spreadsheetfiles with all of the raw
data acquired from the microarray images and used in the data analysis process.
m
Appendix I:
Table 1: Absolute cell counts (xlO cells /ml blood)in blood samples taken from sheep
at baseline (0 hours) and 6 hours following LPS challenge (6 hours).
Sheep Total Total
PMN PMN
(0 h) (6 h)
Total Total
lymphocytes lymphocytes
(0 h)' (6 h)
Total Total
monocytes monocytes
(0 h) (6 h)
451 3.44 8.05 4.90 3.66 0.09 0.49
063 IP 0 3.83 4.70 1.46 0.90 0.11
068 IP 2.11 5.81 6.72 2.55 0.77 0.44
0687P 2.42 5.26 3.80 1.8 0.62 0.07
0693P 0.78 6.84 9.55 4.32 0.78 0.72
0757P 0.05 0.6 3.96 3.75 0.54 0.6
086 IP 0 3.8 11.13 1.15 1.38 0.05
S12 0.63 0.63 3.56 5.48 0.09 0.19
S41 2.73 3.71 2.26 2.54 0.29 0.20
S46 2.02 2.30 1.59 1.48 0.26 0.33
S9 0.13 2.60 6.16 1.57 0.20 0.20
X26 0.99 3.18 5.15 2.34 0.20 0.48
Median 0.88 3.75 4.80 2.44 0.42 0.26
Table 2: Rectal temperatures (°C) ofsheep taken at baseline (0 hours) and at 6 hours
post-LPS challenge (6 hours).
Sheep 0 hours 6 hours Change
451 38.89 39.56 0.67
063 IP 38.89 39 0.11
068 IP 38.61 39.22 0.61
0687P 39.89 40 0.11
0693 P 39.44 39.89 0.45
0757P 39.17 39.44 0.27
086 IP 39.11 40.11 1
S12 39 39.89 0.89
S41 38.89 40.44 1.55
S46 39 40.78 1.78
S9 39.11 40.33 1.22
X26 39 40 1
Median 39 39.95 0.78
Appendix IV : Second LPS challenge contra laterally
Aims and Objectives
To determine if the changes in gene expression evinced in the contra lateral lung 6
hours after local LPS instillation modulate that lung's response to an identical
challenge.
Introduction
LPS can elicit pro- or anti-inflammatory reactions in the lung. LPS has been shown to
promote the production of cytokines by macrophages as well as the up-regulation of
adhesion molecules on endothelial cells which promotes immune cell trafficking.
LPS is also known to induce the expression of anti-inflammatory enzymes (e.g.
superoxide dismutase (SOD), catalase), heat shock proteins and inducible nitric oxide
synthase (iNOS).
The preceding chapters demonstrate that local lung inflammation induced by gram-
negative bacterial LPS induces a genotypic response in the contra lateral lung. As
many aspects of this remote response are anti-inflammatory in nature, it is
hypothesised that the phenotype of an acute inflammation induced by direct challenge
against such a background would show evidence of down-regulation. Specifically, it
is hypothesised that an LPS challenge delivered to the contra lateral lung 6 hours after
the primary challenge will result in an attenuated inflammatory response in that lung
relative to that observed following the primary challenge.
This model shares analogies with the clinical progression of pulmonary ARDS (Pelosi
et al. 2003). Direct challenge followed by a repeat of the same or similar challenge to
the same tissue has been shown to result in attenuated inflammatory effects, including
reduced neutrophil numbers (Jean et al. 1998). Dehoux et al showed that in the contra
lateral lung, the resident macrophages — a critical inflammatory mediator - are
hyporeactive following unilateral pneumonia , whilst Muehlstedt et al demonstrated
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that traumatic injury induced alterations in local lung effector cell function that could
potentially predispose the lungs of injured patients to infection .
It has been postulated that exposure to LPS can be protective to the host and reduce or
ablate the harmful effects of LPS-induced inflammation. This suggestion is supported
by the reported existence of LPS-induced preconditioning or tolerance . During
preconditioning LPS challenge at low levels renders tissues resistant to subsequent
challenge with a higher dose of LPS . The protective effect of LPS preconditioning
includes decreased mortality, improved lung function, and inhibition of macrophage
activity after secondary LPS challenge.
Other organs have also been studied for pre-conditioning effects, and the heart in
particular has been a focus for this research. The theory behind pre-conditioning is
that a minor injury to an organ will then protect the injured tissue against subsequent
damage. Evidence for this in the heart has been provided by Cohen et al using
myocardial stunning in a canine model (Cohen & Downey 1990), in the lower limb by
Harkin et al (Harkin et al. 2002), and in the liver by Peralta et al (Peralta et al. 2001).
Both of the latter groups used an ischemia-reperfusion model to precondition before
damaging the limb with a prolonged period of ischemia and then assessed the level of
protection afforded by the pre-conditioning injury.
Indeed, the theory has been expanded to include remote pre-conditioning whereby a
distant section of the organ to be protected is subject to minor injury and the whole
organ receives protection as a consequence. This process is reviewed by Przyclenk
(Przyklenk et al. 2003) and is supported by recent evidence published by Xia et al
who demonstrated significant protection granted to the heart and lungs against
ischemia / reperfusion injury, by transient occlusion of the iliac artery in sheep (Xia et
al. 2003). Although preconditioning with LPS is seen in several tissues, the
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mechanism underlying the protection against inflammatory stimuli is unclear. LPS is
known to elicit an increased expression of endothelial cell adhesion molecules such as
the selectins and it is possible that inhibition of production of adhesion molecules
accounts for part of the preconditioning response.
Results
Absolute neutrophil counts 6 hours after initial challenge in the direct segment and 6
hours after second challenge in the 'repeat' segment contra lateral to it were both
significantly higher than at baseline in the respective segments (direct: p = 0.018, n =
6; repeat: p = 0.018, n = 6). There was no statistically significant difference between
the absolute number of neutrophils in the directly challenged segments at 6 hours
when compared with the numbers in the contra lateral segment at 12 hours (repeat
challenge segment) (p = 0.402, n = 6). However the median fold change from baseline
in the repeat segment was 0.55 times that in the direct segment (150 vs. 270) which
represents close to a halving of the median change in magnitude of PMN infiltration.
No other cell types showed any significant change. Figure V. 1 shows the changes in
absolute neutrophil numbers in each segment and figure V.2 shows the same data
expressed as mean fold change from baseline in each animal sampled in the direct and
repeat segments.
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The lack of significant evidence for a modulation of the inflammatory response
following the challenge in the remote segment does not support the hypothesis stated
at the start of this chapter however this result was inconclusive and bears further
investigation.
The original intention in this study was to evaluate the comparative genetic changes
between the directly challenged lung segment at 6 hours post-LPS challenge and a
contra lateral lung segment 6 hours after a second challenge. The previous literature
suggested that the initial response elicited by the local LPS challenge would
'precondition' the lung, leading to a protective reduction in the inflammatory
response. At the genetic level this response might be expected to include reduced
production of pro-inflammatory mediators compared with those seen in the initial
challenge. The phenotypic changes in the lung were expected to be somewhat
attenuated after preconditioning, but were not expected to be eliminated as this would
be contradictory to the previously observed effects of secondary infection in clinical
scenarios.
Whilst it is true that PMN numbers in the lung are an accepted and valuable measure
of inflammation in the lung, detection of statically significant differences between the
two segments would require more samples than were available in this study. An initial
power calculation indicated that the number of samples (i.e. sheep) needed to achieve
significance would be 17, given a 0.55 fold change in PMN numbers (the level seen in
this study) and the variances in sample readings. In order for the sample size used to
find significant changes statistically, the PMN numbers in the repeat segment would
have to approximately 25% of those in the direct segment, a change that would be
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inconsistent with the previously observed models of preconditioning and endotoxin
tolerance.
A further factor in the consideration of the results is the severity of the LPS challenge
administered. As is clear from the high levels of neutrophils infdtrating the lung
space, the challenge is one of considerable potency. With such a potent challenge it is
possible that any protection, or indeed vulnerability, induced by the preconditioning
of the organ would be rendered undetectable and insufficient in terms of altering the
phenotypic outcome of the inflammatory response. Models that have been used to
evaluate similar pre-treatment in the lung have utilised different levels of stimulus,
with a more potent inflammation as a pre-treatment, followed by relatively mild
subsequent challenge.
A future experimental design would benefit from considerations such as an increase in
sample size, and some modification of the sampling procedure. A possibility for a
future study might be a combined inflammation and infection control study. The
evaluation of bacterial clearance in a mortal experiment following an inflammatory
pre-treatment would be more closely analogous to the situation in a clinical ARDS
progression, and would be of considerable value as a verification in a large animal
model of the observation that a pre-treated lung may react to subsequent infection by
improving bacterial clearance but increasing risk of mortality. Further consideration
should also be given to the length of time between primary and secondary challenges.
A longer period of time would be more in keeping with reported observations in
clinical settings where mean time between admission and development of nosocomial
pneumonia leading to ARDS is approximately 72 hours.
Unfortunately due to time constraint it was not possible to complete the evaluation of
the genetic changes in terms of either cytokine expression or microarray analysis,
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however the relevant tissue and cellular samples were archived and it is anticipated
that this investigation will occur at some point in the future. These investigations may
indicate underlying genetic trends whose are not amenable to evaluation on the basis
of neutrophil infiltration alone.
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